Increasing O
knowledge O
of O
the O
role O
of O
epigenetics O
in O
disease B-Disease
and O
the O
reversibility O
of O
these O
modifications O
explain O
why O
pharmacological O
intervention O
is O
an O
attractive O
strategy O
for O
tackling O
epigenetic-based O
disease B-Disease

Current O
therapeutic O
strategies O
, O
in O
particular O
for O
metastatic O
melanoma B-Disease
, O
do O
not O
give O
great O
results O
in O
terms O
of O
survival O

Third O
, O
DNA O
methylation O
is O
stable O
at O
different O
time O
points O
, O
such O
as O
at O
biopsy O
and O
during O
chemotherapy O
, O
and O
provides O
a O
good O
source O
of O
biomarkers O

Metabolomics O
, O
the O
study O
of O
metabolism O
at O
whole-body O
level O
, O
involves O
assessment O
of O
the O
total O
repertoire O
of O
small O
molecules O
present O
in O
a O
biological O
sample O
, O
shedding O
light O
on O
interactions O
between O
gene O
expression O
, O
protein O
expression O
, O
and O
the O
environment O

Finally O
, O
targeted O
therapy O
for O
CSCs O
by O
epigenetic O
drugs O
is O
referred O
to O
, O
which O
is O
a O
new O
approach O
in O
overcoming O
resistance O
and O
recurrence O
of O
cancer B-Disease

On O
one O
hand O
, O
it O
is O
well O
established O
that O
environmental O
factors O
have O
an O
impact O
on O
the O
epigenome O
and O
, O
therefore O
, O
on O
the O
transcriptional O
and O
translational O
machinery O
of O
specific O
cell O
types O
; O
on O
the O
other O
, O
the O
environment O
also O
plays O
an O
important O
role O
in O
the O
severity O
of O

Broader O
ethical O
and O
legal O
questions O
of O
the O
role O
of O
epigenetic O
mechanisms O
in O
the O
management O
of O
psychopathy B-Disease
beyond O
the O
criminal O
justice O
arena O
are O
also O
outlined O

Methylation O
alterations O
are O
not O
randomly O
distributed O
across O
the O
genome O
, O
but O
appear O
clustered O
at O
certain O
chromosomal O
locations O
, O
and O
significantly O
colocalize O
with O
regions O
of O
nucleosome O
retention O

Epigenetic O
modification O
of O
phenotype O
( O
molecular O
, O
cellular O
, O
morphological O
, O
physiological O
, O
and O
behavioral O
) O
can O
be O
highly O
variable O
depending O
upon O
ancestral O
environmental O
exposure O
and O
can O
contribute O
to O
apparent O
" O
random O
" O
noise O
in O
collected O
datasets O

DNA O
methylation O
is O
an O
under-investigated O
area O
in O
immune-mediated O
diseases O
, O
and O
many O
studies O
in O
the O
field O
are O
affected O
by O
experimental O
design O
limitations O
, O
related O
to O
study O
design O
, O
technical O
limitations O
of O
the O
methylation O
typing O
methods O
employed O
, O
and O
statistical O
issues O

The O
findings O
suggest O
that O
a O
number O
of O
prenatal O
adverse O
( O
e O

375 O
: O
Germline O
epigenetic O
factors O
influence O
transgenerational O
inheritance O
of O
behavioral O
traits O
upon O
changes O
in O
experience O
and O
environment O

The O
further O
use O
of O
epigenetics O
for O
diagnosis O
and O
therapy O
is O
warranted O

Understanding O
the O
molecular O
mechanisms O
underlying O
dysfunction O
of O
aging O
HSCs O
is O
an O
important O
focus O
of O
biomedical O
research O

DNA O
methylation O
is O
known O
to O
cause O
changes O
in O
gene O
expression O
of O
key O
regulatory O
genes O
in O
cancer B-Disease

We O
highlight O
on-going O
research O
that O
is O
likely O
to O
deliver O
further O
candidate O
markers O
as O
well O
as O
generating O
large O
, O
well-annotated O
sample O
banks O
that O
will O
facilitate O
future O
studies O

Exposure O
to O
heavy O
metals O
, O
bioflavonoids O
, O
and O
endocrine O
disruptors O
, O
such O
as O
bisphenol O
A O
and O
phthalates O
, O
has O
been O
shown O
to O
affect O
the O
epigenetic O
memory O
of O
an O
organism O

Unlike O
genetic O
mutations O
, O
the O
ability O
to O
reprogram O
the O
epigenetic O
landscape O
in O
the O
cancer B-Disease
epigenome O
is O
one O
of O
the O
most O
promising O
target O
therapies O
in O
both O
treatment O
and O
reversibility O
of O
drug O
resistance O

Since O
this O
nucleic O
acid O
fraction O
originates O
mainly O
in O
apoptotic O
, O
senescent O
and O
cancerous O
cells O
, O
this O
approach O
allows O
efficient O
analysis O
of O
aged O
and O
cancerous O
cell-specific O
DNA O
methylation O
patterns O
for O
diagnostic O
and O
prognostic O
purposes O

Although O
the O
published O
literature O
on O
this O
subject O
seems O
promising O
, O
the O
overall O
strength O
of O
evidence O
is O
limited O
by O
the O
small O
number O
of O
studies O
evaluating O
individual O
skeletal O
disorders O
, O
and O
also O
by O
deficiencies O
in O
key O
aspects O
of O
study O
design O

Finally O
, O
we O
evaluate O
transposon O
epigenetics O
as O
they O
relate O
to O
environmental O
exposures O
and O
explore O
the O
role O
of O
noncoding O
RNA O
as O
biomarkers O
of O
environmental O
exposures O

Conclusion O
: O
Pharmacoepigenetics O
and O
pharmacoepigenomics O
are O
new O
sub-disciplines O
in O
pharmacology O
and O
are O
likely O
to O
have O
an O
increasing O
impact O
on O
the O
use O
of O
drugs O
in O
clinical O
practice O

We O
examine O
previous O
studies O
that O
have O
attempted O
to O
predict O
treatment O
efficacy O
through O
epigenetics O
, O
provide O
an O
experimental O
model O
, O
and O
note O
the O
potential O
challenges O
at O
each O
stage O

Although O
there O
is O
much O
that O
remains O
to O
be O
discovered O
, O
this O
article O
will O
discuss O
some O
of O
genetic O
and O
environmental O
factors O
which O
appear O
important O
in O
good O
quality O
longevity O
and O
link O
known O
epigenetic O
mechanisms O
to O
themes O
identified O
by O
nonagenarians O
themselves O
related O
to O
their O
longevity O

However O
, O
identifying O
mediator O
and O
moderator O
effects O
in O
the O
interrelationship O
between O
these O
parameters O
was O
problematic O
owing O
to O
heterogeneous O
methodologies O

Although O
still O
in O
the O
early O
phase O
, O
epigenetic O
modifications O
, O
particularly O
DNA O
methylation O
and O
microRNAs O
, O
might O
have O
potential O
for O
assisting O
in O
the O
stratification O
of O
patients O
for O
treatment O
and O
complement O
or O
replace O
in O
the O
future O
biochemical O
or O
clinical O
tests O

We O
emphasize O
the O
potential O
utility O
of O
these O
tools O
in O
an O
epidemiological O
context O
, O
particularly O
in O
evaluating O
the O
impact O
of O
public O
health O
interventions O
focused O
on O
promoting O
healthy O
aging O

In O
this O
article O
, O
epigenetic O
mechanisms O
including O
DNA O
methylation O
and O
acetylation O
or O
methylation O
of O
the O
histone O
proteins O
that O
package O
DNA O
are O
described O
in O
the O
context O
of O
animal O
learning O

0 O
, O
we O
have O
added O
more O
distinctive O
features O

Advancements O
in O
genome-wide O
sequencing O
has O
broadened O
the O
view O
of O
the O
human O
methylome O
and O
revealed O
the O
organization O
of O
the O
human O
genome O
into O
large-scale O
methylation O
domains O
that O
footprint O
over O
neurologically O
important O
genes O
involved O
in O
embryonic O
development O


We O
found O
a O
few O
loci O
where O
both O
the O
transcriptional O
changes O
and O
epigenetic O
changes O
occurred O
in O
the O
pathways O
involving O
immune O
and O
inflammatory O
signalling O

A O
growing O
body O
of O
work O
has O
shown O
that O
epigenetic O
drugs O
, O
specifically O
DNA O
methyltransferase O
inhibitors O
, O
can O
upregulate O
immune O
signaling O
in O
epithelial O
cancer B-Disease
cells O
through O
demethylation O
of O
endogenous O
retroviruses O
and O
cancer B-Disease
testis O
antigens O

To O
characterize O
epigenetic O
aging O
, O
genome-wide O
5mC O
and O
5hmC O
were O
measured O
in O
longitudinal O
blood O
samples O
( O
2 O
, O
4 O
, O
and O
10 O
months O
of O
age O
) O
from O
isogenic O
mice O
using O
two O
sequencing O
methods O
- O
enhanced O
reduced O
representation O
bisulfite O
sequencing O
and O
hydroxymethylated O
DNA O

Since O
arsenic O
is O
non-mutagenic O
, O
the O
mechanism O
by O
which O
arsenic O
causes O
carcinogenesis O
is O
via O
alterations O
in O
epigenetic-regulated O
gene O
expression O

Aim O
: O
The O
aim O
of O
this O
article O
was O
to O
present O
a O
broad O
perspective O
on O
the O
current O
state O
of O
knowledge O
in O
a O
relatively O
new O
and O
complex O
field O
of O
" O
attachment O
and O
epigenetic O
processes O

Critical O
issues O
: O
Sensitive O
quantification O
of O
DNA O
methylation O
from O
degraded O
and O
minute O
quantities O
of O
DNA O
and O
high-throughput O
DNA O
methylation O
mapping O
of O
single O
cells O
still O
remain O
a O
challenge O

O O
wing O
to O
the O
versatility O
, O
reproducibility O
, O
and O
utility O
of O
this O
technique O
, O
it O
is O
an O
important O
method O
for O
any O
laboratory O
interested O
in O
studying O
the O
cellular O
, O
circuit O
, O
and O
behavioral O
consequences O
of O
in O
vivo O
neuroepigenetic O
editing O
with O
synthetic O
ZFP O
constructs O

However O
, O
the O
complexity O
, O
high-dimensionality O
, O
sparsity O
, O
and O
noise O
associated O
with O
these O
data O
pose O
challenges O
for O
extensive O
integrative O
analyses O

Derivation O
of O
a O
robust O
DNAm O
model O
that O
accurately O
distinguishes O
between O
current O
, O
former O
and O
never O
smokers O
would O
be O
particularly O
valuable O
to O
epidemiological O
research O
( O
as O
a O
more O
accurate O
smoking O
definition O
vs O

This O
is O
further O
complicated O
by O
the O
antecedent O
nonleukemic O
state O
of O
clonal O
hematopoiesis B-Disease
that O
nevertheless O
is O
associated O
with O
an O
increased O
risk O
of O
developing O
a O
hematologic O
malignancy O
and O
with O
a O
greater O
risk O
of O
mortality O
from O
ischemic O
cardiovascular O
disease B-Disease

Current O
research O
points O
towards O
a O
great O
future O
with O
novel O
drugs O
directed O
to O
the O
many O
complex O
multifactorial O
diseases O
of O
humans O
, O
which O
are O
still O
often O
poorly O
understood O
and O
difficult O
to O
treat O

org O
/ O
10 O

Finally O
, O
only O
germline-dependent O
epigenetic O
modifications O
can O
be O
truly O
transgenerational O


25 O
: O
In O
light O
of O
the O
post-genomic O
era O
, O
epigenetics O
brings O
about O
an O
opportunity O
to O
better O
understand O
how O
the O
molecular O
machinery O
works O
and O
is O
led O
by O
a O
complex O
dynamic O
set O
of O
mechanisms O
, O
often O
intricate O
and O
complementary O
in O
many O
aspects O

In O
eukaryotes O
, O
DNA O
wraps O
on O
a O
histone O
octamer O
( O
two O
copies O
of O
H2A O
, O
H2B O
, O
H3 O
and O
H4 O
) O
to O
form O
nucleosome O
, O
the O
fundamental O
unit O
of O
chromatin O

This O
non-conventional O
, O
non-genetic O
, O
inheritance O
is O
underlain O
by O
several O
mechanisms O
among O
which O
epigenetics O
is O
obviously O
central O
, O
due O
to O
the O
notion O
of O
memory O
of O
early O
decisional O
events O
during O
development O
even O
when O
this O
stimulus O
is O
gone O
, O
that O
is O
implied O
in O
Waddington O
's O
developmental O

With O
proper O
selection O
, O
histone-modifying O
enzymes O
may O
constitute O
good O
targets O
for O
therapy O

239 O
: O
Background O
: O
Lung B-Disease
cancer I-Disease
is O
one O
of O
the O
most O
malignant O
tumors B-Disease
, O
causing O
over O
1,000,000 O
deaths O
each O
year O
worldwide O

Taken O
together O
, O
these O
findings O
provide O
novel O
insights O
into O
how O
prolonged O
stress O
may O
impact O
the O
epigenome O
, O
with O
potentially O
important O
implications O
for O
stress-related O
phenotypes O

Mechanisms O
of O
epigenetics O
include O
DNA O
methylation O
(and O
demethylation O
), O
histone O
modifications O
, O
and O
non-coding O
RNAs O
such O
as O
microRNAs O

Finally O
, O
we O
review O
the O
methodological O
limitations O
that O
could O
hinder O
interpretation O
of O
epigenetic O
data O
in O
psychiatry O

264 O
: O
In O
this O
interview O
, O
Professor O
Randy O
L O
Jirtle O
speaks O
with O
Storm O
Johnson O
, O
Commissioning O
Editor O
for O
Epigenomics O
, O
on O
his O
work O
on O
genomic O
imprinting O
, O
environmental B-Disease
epigenomics I-Disease
and O
the O
fetal O
origins O
of O
disease B-Disease
susceptibility O

Epigenetics O
may O
provide O
a O
link O
between O
genetic O
and O
environmental O
factors O
and O
behavior O

722 O
: O
The O
protein O
interactome O
mediates O
crucial O
functions O
in O
transcription O
, O
chromatin O
remodeling O
, O
and O
higher-order O
structural O
organization O

This O
review O
summarizes O
the O
impact O
of O
epigenetics O
on O
the O
development O
of O
psoriasis B-Disease
and O
highlights O
challenges O
for O
the O
future O

Altogether O
, O
our O
findings O
reveal O
an O
ERK-dependent O
epigenetic O
remodelling O
of O
regulatory O
elements O
that O
results O
in O
a O
gene O
expression O
programme O
essential O
for O
driving O
EMT O

Herein O
, O
I O
propose O
a O
new O
candidate O
for O
an O
aging O
clock O
, O
based O
on O
epigenetics O
and O
the O
state O
of O
chromosome O
methylation O
, O
particularly O
in O
stem O
cells O

While O
in O
most O
reports O
genetic O
variation O
has O
been O
found O
to O
occur O
at O
relatively O
modest O
frequencies O
, O
variation O
in O
DNA O
methylation O
patterns O
seems O
to O
be O
much O
more O
frequent O
and O
in O
some O
cases O
it O
has O
been O
directly O
implicated O
in O
phenotypic O
variation O

This O
expert O
review O
offers O
a O
critical O
analysis O
of O
the O
epigenomics-guided O
drug O
discovery O
and O
development O
and O
the O
opportunities O
and O
challenges O
for O
the O
next O
decade O

computational O
tools O
) O
and O
then O
propose O
a O
conceptual O
in O
silico O
metabolic O
and O
epigenetic O
regulatory O
network O
( O
MER-Net O
) O
that O
is O
based O
on O
these O
current O
high-throughput O
methods O

Szyf O
received O
his O
PhD O
from O
the O
Hebrew O
University O
and O
did O
his O
postdoctoral O
fellowship O
in O
genetics O
at O
Harvard O
Medical O
School O
, O
joined O
the O
Department O
of O
Pharmacology O
and O
Therapeutics O
at O
McGill O
University O
in O
Montreal O
in O
1989 O
and O
is O
a O
fellow O
of O
the O
Royal O
Society O
of O
Canada O


In O
this O
chapter O
, O
we O
discuss O
first O
the O
history O
and O
milestones O
in O
the O
100+ O
years O
of O
epigenetic O
study O
, O
including O
early O
discoveries O
of O
DNA O
methylation O
, O
histone O
posttranslational O
modification O
, O
and O
noncoding O
RNA O

Epigenetic O
alterations O
are O
associated O
with O
inflammation B-Disease
and O
cardiovascular O
disease B-Disease
in O
patients O
with O
chronic O
kidney O
disease B-Disease

The O
correlation O
of O
transcription O
factors O
with O
histone O
marks O
is O
now O
well O
established O
as O
the O
center O
of O
epigenetic O
studies O
; O
therefore O
, O
precise O
knowledge O
about O
histone O
marks O
is O
critical O
to O
unravel O
their O
molecular O
function O
and O
to O
understand O
their O
role O
in O
biological O
systems O

Cord O
blood O
(CB) O
DNA O
methylation O
provides O
a O
unique O
window O
into O
the O
fetal O
epigenome O
, O
reflecting O
the O
intrauterine O
environment O
's O
impact O

Selection O
operates O
on O
the O
phenotype O
, O
and O
its O
consequences O
are O
manifest O
in O
representation O
of O
the O
genotype O
in O
successive O
generations O

To O
be O
able O
to O
incorporate O
these O
non-Mendelian O
features O
into O
quantitative O
genetic O
models O
, O
it O
is O
necessary O
to O
study O
the O
induction O
and O
the O
transgenerational O
behavior O
of O
epialleles O
in O
controlled O
settings O

But O
while O
this O
" O
policy O
translation O
" O
of O
epigenetics O
introduces O
new O
arguments O
in O
favor O
of O
public O
health O
strategies O
and O
policy-making O
, O
a O
more O
" O
clinical O
translation O
" O
of O
epigenetics O
is O
also O
emerging O

To O
reduce O
the O
complexity O
, O
we O
developed O
a O
package O
, O
called O
Snapshot O
, O
for O
clustering O
and O
visualizing O
candidate O
cis-regulatory O
elements O
( O
cCREs O
) O
based O
on O
their O
epigenetic O
signals O
during O
cell O
differentiation O

Moreover O
, O
as O
epigenetic O
modifications O
are O
highly O
plastic O
and O
responsive O
to O
the O
environment O
, O
there O
is O
much O
excitement O
around O
the O
theme O
of O
epigenetic O
therapeutics O
, O
including O
not O
only O
new O
drugs O
but O
also O
more O
informed O
patient O
advice O
on O
lifestyle O
choices O
and O
their O
impact O
on O
pathology O

523 O
: O
Epigenetics O
describes O
heritable O
alterations O
of O
gene O
expression O
that O
do O
not O
involve O
DNA O
sequence O
variation O
and O
are O
changeable O
throughout O
an O
organism O
's O
lifetime O

RNA O
interference O
, O
histone O
modification O
, O
DNA O
methylation O
and O
chromatin O
remodelling O
are O
epigenetic O
processes O
that O
control O
gene O
expression O
without O
causing O
mutations O
in O
the O
DNA O

We O
successfully O
demonstrated O
that O
this O
system O
is O
efficient O
in O
modifying O
individual O
histone O
post-translational O
modifications O

Herein O
, O
we O
review O
the O
genome-wide O
assays O
and O
analysis O
schemes O
that O
are O
used O
to O
predict O
and O
annotate O
enhancers O

In O
addition O
to O
allowing O
site-specific O
epigenetic O
editing O
, O
these O
tools O
can O
be O
paired O
with O
optogenetic O
approaches O
to O
provide O
temporal O
control O
over O
epigenetic O
processes O
, O
allowing O
unparalleled O
insight O
into O
the O
function O
of O
these O
mechanisms O

The O
first O
study O
demonstrating O
that O
skin O
fibroblasts O
from O
healthy O
centenarians O
can O
be O
rejuvenated O
by O
cell O
reprogramming O
was O
published O
in O
2011 O
and O
will O
be O
discussed O
in O
some O
detail O

However O
, O
we O
are O
now O
discovering O
that O
the O
mechanisms O
that O
regulate O
how O
genes O
are O
expressed O
tell O
a O
much O
richer O
story O
than O
our O
DNA O
alone O

Ensuing O
phenotypic O
changes O
allow O
genetically O
identical O
cells O
to O
express O
diverse O
and O
frequently O
adaptive O
phenotypes O

Design O
specifications O
are O
fundamentally O
defined O
by O
the O
choice O
of O
analysis O

It O
is O
shown O
that O
standard O
quantitative O
genetic O
modeling O
based O
on O
analyses O
of O
interindividual O
phenotypic O
variation O
misclassifies O
the O
variation O
generated O
by O
nonlinear O
epigenetic O
processes O
as O
being O
due O
to O
specific O
environmental O
influences O

569 O
: O
DNA O
methylation O
is O
a O
heritable O
but O
reversible O
epigenetic O
mechanism O
of O
control O
over O
gene O
expression O

Growing O
point O
: O
Epigenetic O
markers O
in O
ageing O
tendon O
, O
which O
are O
under-researched O
including O
genome-wide O
chromatin O
accessibility O
, O
should O
be O
investigated O

93 O
: O
The O
association O
between O
air O
pollution O
and O
a O
wide-ranging O
spectrum O
of O
acute O
and O
chronic O
disorders-including O
cardiovascular O
diseases-is O
widely O
acknowledged O

Conclusions O
: O
CandiMeth O
( O
RRID:SCR_017974 O
; O
Biotools: O
CandiMeth O
) O
allows O
rapid O
, O
quantitative O
analysis O
of O
methylation O
at O
user-specified O
features O
without O
the O
need O
for O
coding O
and O
is O
freely O
available O
at O
https://github O
.com O

More O
recently O
, O
disruptive O
technologies O
using O
innovative O
biochemistry O
came O
into O
play O

For O
the O
first O
time O
, O
the O
" O
color-specificity O
" O
of O
both O
the O
persistence O
length O
and O
the O
mean O
interaction O
energy O
are O
estimated O
, O
leading O
to O
important O
differences O
between O
epigenetic O
states O

Notably O
, O
inhibitors O
of O
enzymes O
that O
work O
in O
epigenetic O
modifications O
, O
such O
as O
DNA O
methyltransferases O
and O
histone O
deacetylases O
, O
are O
beginning O
to O
appear O
in O
the O
clinical O
setting O
to O
restore O
normal O
epigenetic O
patterns O
( O
Generali O
et O
al O

Here O
, O
I O
summarize O
our O
current O
understanding O
of O
epigenetics O
and O
it O
affects O
gene O
expression O
, O
with O
impacts O
on O
health O
and O
aging O

Recent O
studies O
have O
revealed O
that O
genetics O
, O
epigenetics O
, O
and O
environmental O
exposures O
contribute O
to O
the O
development O
of O
atopy O

ZIP13 O
deficiency O
, O
which O
is O
associated O
with O
Spondylocheirodysplastic O
Ehlers-Danlos O
syndrome O
( O
SCD-EDS O
) O
, O
increases O
DNMT O
activity O
, O
leading O
to O
dysgenesis O
of O
dermis O
via O
improper O
gene O
expressions O

Dr O
Kelsey O
received O
his O
MD O
from O
the O
University O
of O
Minnesota O
and O
Masters O
of O
Occupational O
Health O
from O
Harvard O
University O

Finally O
, O
we O
will O
discuss O
the O
application O
of O
proteomic O
methods O
in O
the O
diagnosis O
and O
prognosis O
of O
cancer B-Disease
based O
on O
epigenetic O
biomarkers O
and O
comment O
on O
their O
future O
impact O
on O
cancer B-Disease
epigenetics O

We O
propose O
that O
estimates O
obtained O
from O
GWAS O
underestimate O
heritability O
by O
not O
taking O
into O
account O
non-DNA O
(epigenetic) O
sources O
of O
heritability O

However O
, O
the O
predictive O
ability O
of O
epigenomic O
analysis O
is O
still O
limited O
for O
mechanistic O
research O
at O
a O
single O
cell O
level O

This O
will O
ultimately O
assist O
breeders O
toward O
improving O
resistance O
and O
decreasing O
yield O
losses O

9 O

397 O
: O
This O
article O
analyses O
attempts O
to O
enact O
complexity O
in O
postgenomic O
experimentations O
using O
the O
case O
of O
epigenetic O
research O
on O
biomarkers O
of O
psychosocial O
stress O

g O

Signals O
from O
the O
local O
environment O
or O
a O
history O
of O
signals O
can O
drive O
these O
variations O
, O
and O
tissues O
have O
many O
cell O
types O
that O
play O
separate O
roles O

427 O
: O
The O
Chromatin O
, O
Replication O
and O
Chromosomal O
Stability O
Conference O
took O
place O
on O
June O
20-21 O
in O
Stockholm O
, O
Sweden O

However O
, O
at O
present O
it O
is O
difficult O
to O
say O
whether O
the O
epigenetic O
point O
of O
view O
is O
being O
fully O
utilized O
in O
the O
evaluation O
of O
chemical O
safety O

Through O
the O
interaction O
of O
these O
modifications O
a O
" O
histone O
code" O
is O
emerging O
wherein O
individual O
memories O
leave O
unique O
memory O
traces O
at O
the O
molecular O
level O
with O
distinct O
time O
courses O

Despite O
the O
overall O
promise O
of O
early O
approaches O
, O
however O
, O
these O
drugs O
have O
been O
plagued O
by O
poor O
pharmacokinetic O
and O
safety/tolerability O
profiles O
due O
in O
large O
part O
to O
off-target O
effects O
and O
a O
lack O
of O
specificity O

Humpback O
skin O
samples O
were O
obtained O
from O
individuals O
with O
a O
known O
year O
of O
birth O
and O
employed O
to O
calibrate O
relationships O
between O
cytosine B-Disease
methylation I-Disease
and O
age O

Epigenetic O
marks O
or O
mediators O
including O
DNA O
methylation O
, O
histone O
modifications O
, O
and O
noncoding O
RNA O
can O
be O
studied O
at O
a O
genome O
or O
near-genome O
scale O
using O
epigenomic O
approaches O

To O
the O
best O
of O
knowledge O
, O
this O
study O
is O
first O
to O
utilize O
the O
intranuclear O
epigenomic O
signal O
to O
distinguish O
between O
CSC O
from O
different O
tissues O
with O
>99% O
accuracy O
and O
specificity O

However O
, O
successful O
crop O
improvement O
using O
CWR O
relies O
on O
identifying O
variation O
in O
genes O
controlling O
desired O
traits O
in O
plant O
germplasms O
and O
subsequently O
incorporating O
them O
into O
cultivars O

Limitations O
: O
As O
a O
narrative O
review O
, O
the O
current O
report O
was O
interpretive O
and O
qualitative O
in O
nature O

Among O
other O
factors O
, O
primary O
chromatin O
structure O
and O
epigenetics O
may O
influence O
off-target O
activity O

Herein O
we O
review O
the O
most O
promising O
epigenetic O
detection O
, O
diagnostic O
, O
prognostic O
and O
predictive O
biomarkers O
for O
the O
most O
common O
cancers B-Disease

Such O
factors O
may O
alter O
the O
DNA O
methylation O
pattern O
and O
may O
explain O
the O
partly O
high O
deviations O
between O
epigenetic O
age O
and O
chronological O
age O
in O
single O
cases O
(despite O
of O
low O
mean O
absolute O
deviations O
) O
that O
can O
also O
be O
observed O
with O
" O
epigenetic O
clocks O
" O
comprising O
a O
high O

Epigenetic O
signatures O
can O
even O
be O
inherited O
, O
resulting O
in O
transgenerational O
effects O

harvard O

Indeed O
, O
the O
possibility O
of O
looking O
directly O
at O
the O
biomolecular O
level O
allows O
us O
to O
bypass O
the O
age-old O
issues O
of O
animal O
studies O
pertaining O
to O
their O
questionable O
validity O
as O
behavioral O
models O

The O
pattern O
of O
which O
X O
chromosome O
is O
inactivated O
changes O
dynamically O
during O
mouse O
embryogenesis O
, O
depending O
on O
developmental O
stages O
and O
tissues O

In O
addition O
, O
DNA O
amplification O
is O
an O
important O
step O
when O
investigating O
other O
types O
of O
genomic O
information O
, O
for O
instance O
when O
addressing O
repeat O
, O
deletion O
, O
copy O
number O
variation O
or O
epigenetic O
regulation O
by O
DNA O
methylation O

Moreover O
, O
given O
the O
dynamic O
nature O
of O
the O
epigenetic O
marks O
, O
intense O
research O
is O
carried O
out O
to O
investigate O
the O
therapeutic O
efficacy O
of O
compounds O
exerting O
epigenetic O
properties O

This O
review O
summarizes O
the O
major O
epigenetically O
induced O
changes O
in O
radioresistant-like O
PCa O
cells O
and O
describes O
recently O
reported O
targeted O
epigenetic O
therapies O
in O
pre-clinical O
and O
clinical O
settings O

Although O
the O
field O
has O
advanced O
over O
the O
past O
several O
decades O
, O
including O
being O
recognized O
by O
EMGS O
with O
its O
own O
Special O
Interest O
Group O
, O
recently O
renamed O
Epigenomics O
, O
we O
are O
excited O
about O
the O
opportunities O
for O
environmental O
epigenetic O
science O
in O
the O
next O
50 O
years O

658 O
: O
Aim O
: O
Longevity O
accumulating O
in O
families O
has O
genetic O
and O
epigenetic O
components O

Three O
groups O
merit O
consideration O

This O
review O
highlights O
results O
from O
the O
most O
recent O
transcriptome O
research O
, O
and O
the O
meta-analyses O
performed O
, O
in O
the O
context O
of O
pig O
immunity O

This O
approach O
let O
us O
to O
distinguish O
different O
cells O
types O
based O
on O
their O
epigenomic O
profiles O
, O
thus O
recapitulating O
important O
aspects O
of O
human O
hematopoiesis B-Disease

We O
further O
suggest O
that O
systematic O
mapping O
of O
the O
loci O
influenced O
by O
age O
, O
sex O
and O
genetic O
polymorphisms O
will O
bring O
important O
biological O
insights O
as O
well O
as O
improved O
control O
of O
epigenome-wide O
association O
studies O

The O
aim O
of O
this O
chapter O
is O
to O
describe O
the O
factors O
that O
could O
affect O
the O
precise O
measurement O
of O
methylation O
levels O
and O
a O
recent O
Bayesian O
statistical O
method O
called O
MethylCal O
and O
its O
extension O
that O
have O
been O
proposed O
to O
minimize O
this O
problem O


This O
chapter O
aims O
to O
provide O
examples O
on O
these O
gene-diet O
interactions O
at O
multiple O
levels O
to O
support O
the O
need O
of O
embedding O
targeted O
dietary O
interventions O
as O
a O
way O
forward O
to O
prevent O
, O
avoid O
and O
manage O
diseases O

Alterations O
in O
epigenetic O
profiling O
may O
provide O
important O
insights O
into O
the O
etiology O
and O
natural O
history O
of O
cancer B-Disease

Together O
with O
techniques O
in O
which O
cell O
lineage O
is O
recorded O
, O
this O
multilayered O
information O
will O
provide O
insights O
into O
a O
cell O
's O
past O
history O
and O
its O
future O
potential O

The O
discovery O
that O
what O
our O
genes O
do O
depends O
in O
part O
on O
our O
experiences O
has O
shed O
light O
on O
how O
Nature O
and O
Nurture O
interact O
at O
the O
molecular O
level O
inside O
of O
our O
bodies O

We O
have O
developed O
a O
bioinformatic O
workflow O
to O
generate O
a O
chromatin O
space O
that O
allows O
to O
classify O
42 O
human O
healthy O
blood O
epigenomes O
from O
the O
BLUEPRINT O
, O
NIH O
ROADMAP O
and O
ENCODE O
consortia O
by O
their O
cell O
type O

Remarkably O
, O
epigenetic O
therapies O
combined O
with O
chemotherapies O
or O
hormone-based O
therapies O
represent O
the O
most O
promising O
strategy O

We O
demonstrate O
the O
utility O
of O
Snapshot O
using O
data O
from O
a O
consortium O
project O
for O
ValIdated O
Systematic O
IntegratiON O
( O
VISION O
) O
of O
epigenomic O
data O
in O
hematopoiesis B-Disease

Given O
the O
progress O
of O
genomic O
discovery O
in O
anorexia O
nervosa O
, O
with O
the O
identification O
of O
the O
first O
genome-wide O
significant O
locus O
, O
as O
well O
as O
animated O
discussion O
of O
epigenetic O
mechanisms O
in O
linking O
environmental O
factors O
with O
disease B-Disease
onset O
, O
our O
goal O
was O
to O
conduct O
a O
system O

``` O
Results O
: O
ChIP-S3EQ O
of O
neuronal O
nuclei O
reliably O
identified O
hPTM O
enrichment O
in O
the O
adult O
mouse O
NAc O
with O
high O
precision O
``` O

Recent O
data O
based O
on O
profiling O
of O
the O
DNA O
methylome O
of O
PCOS O
in O
different O
tissues O
provided O
consistent O
molecular O
evidence O
in O
support O
of O
epidemiological O
findings O
on O
disease B-Disease
comorbidity O
suggesting O
a O
possible O
autoimmune O
basis O
in O
the O
pathogenesis O
of O
the O
disease B-Disease

In O
this O
review O
, O
we O
examine O
how O
the O
circuit O
blueprints O
imagined O
by O
Jacob O
and O
Monod O
laid O
the O
foundation O
for O
the O
first O
synthetic O
gene O
networks O
that O
launched O
the O
field O
of O
synthetic O
biology O
in O
2000 O

It O
is O
recognized O
that O
the O
incidence O
of O
tendon O
injury O
increases O
with O
age O
, O
suggesting O
a O
deterioration O
in O
homeostatic O
mechanisms O
or O
reparative O
processes O

115 O
: O
Epigenetic O
regulators O
of O
gene O
expression O
including O
DNA O
cytosine B-Disease
methylation I-Disease
and O
posttranslational O
histone O
modifications O
could O
play O
a O
role O
for O
some O
of O
the O
molecular O
alterations O
associated O
with O
schizophrenia B-Disease

Here O
we O
highlight O
a O
flurry O
of O
recent O
activity O
to O
identify O
the O
mRNA O
profiles O
from O
thousands O
of O
single-cells O
as O
well O
as O
chromatin O
accessibility O
and O
histone O
marks O
on O
single O
to O
few O
hundreds O
of O
cells O

Mutations O
that O
affect O
epigenetic O
mechanisms O
are O
common O
in O
cancer B-Disease

Further O
, O
epigenetic O
modifications O
( O
DNA O
methylation O
, O
histone O
modifications O
, O
and O
RNA O
methylations O
) O
have O
been O
revealed O
to O
be O
key O
drivers O
in O
the O
formation O
and O
maintenance O
of O
CSCs O

Moreover O
, O
increased O
social O
support O
at O
baseline O
and O
follow-up O
was O
associated O
with O
reduced O
follow-up O
GrimAge O
acceleration O

ac O

With O
these O
objectives O
in O
mind O
, O
we O
first O
show O
how O
Waddington O
introduced O
the O
term O
" O
epigenetics O
" O
in O
a O
biological O
context O
in O
order O
to O
solve O
a O
developmental O
problem O
, O
and O
we O
then O
build O
on O
this O
by O
presenting O
Nanney O
's O
, O
Riggs O
' O
and O
Holliday O
's O
definitions O

Here O
we O
suggest O
that O
exceptional O
90-year O
old O
siblings O
have O
adopted O
a O
range O
of O
behaviours O
and O
life-styles O
which O
have O
contributed O
to O
their O
ageing-well-phenotype O
and O
which O
link O
with O
important O
public O
health O
messages O

edu O

The O
identification O
of O
the O
tissue O
of O
origin O
in O
patients O
with O
cancer B-Disease
of O
unknown O
primary O
( O
CUP O
) O
is O
an O
example O
of O
how O
epigenomics O
can O
be O
incorporated O
in O
clinical O
settings O
, O
addressing O
an O
unmet O
need O
in O
the O
diagnostic O
and O
clinical O
management O
of O
these O
patients O

The O
database O
incorporates O
11,576 O
HMEs O
identified O
from O
603 O
proteomes O
including O
483 O
fungal O
, O
32 O
plants O
and O
51 O
metazoan O
species O

Intracellular O
events O
observed O
to O
change O
with O
age O
included O
the O
methylation O
of O
bivalent O
chromatin O
domains O
, O
and O
targets O
of O
polycomb O
repressive O
complexes O

There O
is O
convincing O
evidence O
indicating O
that O
several O
foods O
have O
protective O
roles O
in O
cancer B-Disease
prevention O
, O
by O
inhibiting O
tumor B-Disease
progression O
directly O
or O
through O
modifying O
tumor B-Disease
's O
microenvironment O
that O
leads O
to O
hostile O
conditions O
favorable O
to O
tumor B-Disease
initiation O
or O
growth O

Complementing O
the O
existing O
focus O
on O
complexity O
as O
instrumental O
rhetoric O
in O
contemporary O
sciences O
, O
complexification O
directs O
analytical O
attention O
to O
the O
pragmatic O
opportunities O
that O
alternative O
( O
biosocial O
) O
complexities O
offer O
to O
collective O
, O
societal O
, O
and O
political O
thinking O
about O
science O
in O
society O

To O
demonstrate O
the O
potential O
of O
this O
technique O
, O
we O
constructed O
the O
first O
modern O
age O
profile O
of O
humpback O
whales O
off O
eastern O
Australia O
and O
compared O
the O
results O
to O
population O
structure O
5 O
decades O
earlier O

652 O
: O
Unlike O
genetics O
, O
epigenetics O
involves O
the O
modification O
of O
genome O
without O
changes O
in O
DNA O
sequences O
, O
including O
DNA O
methylation O
, O
histone O
modification O
, O
chromatin O
remodeling O
and O
noncoding O
RNA O
regulation O

We O
do O
have O
to O
disclose O
that O
the O
current O
evidence O
in O
this O
review O
is O
not O
enough O
to O
cover O
all O
the O
complex O
interactions O
between O
multiple O
epigenetic O
modifications O
and O
their O
regulations O

Clinical O
studies O
are O
needed O
to O
evaluate O
the O
optimum O
doses O
of O
dietary O
compounds O
, O
the O
safety O
profile O
of O
dosages O
, O
to O
establish O
the O
most O
efficient O
way O
of O
administration O
, O
and O
bioavailability O
, O
in O
order O
to O
maximize O
the O
beneficial O
effects O
already O
discovered O
, O
and O
to O
ensure O
replicability O

Novel O
unfolding O
research O
avenues O
include O
the O
interplay O
between O
genetic O
variants O
and O
DNA O
methylation O
patterns O
, O
and O
the O
role O
of O
long O
noncoding O
RNAs O
as O
epigenetic O
regulators O

Carefully O
selected O
core O
STR O
loci O
form O
the O
basis O
of O
intelligence-led O
DNA O
databases O
that O
provide O
investigative O
leads O
by O
linking O
unsolved O
crime O
scenes O
and O
criminals O
through O
their O
matched O
STR O
profiles O

Conclusions O
741 O
Acknowledgements O
741 O
SUMMARY O
: O
Investigating O
the O
features O
and O
implications O
of O
epigenetic O
mechanisms O
across O
the O
breadth O
of O
organisms O
and O
ecosystems O
is O
important O
for O
understanding O
the O
ecological O
relevance O
of O
epigenetics O

Research O
predating O
2009 O
and O
animal O
studies O
were O
excluded O
in O
order O
to O
review O
the O
current O
state O
of O
research O
in O
humans O

Here O
, O
we O
provide O
a O
comprehensive O
review O
of O
growing O
epigenetic O
features O
involved O
in O
AF O
pathogenesis O
and O
summarize O
the O
emerging O
epigenomic O
targets O
for O
therapy O
that O
have O
been O
explored O
in O
preclinical O
models O
of O
AF O

Such O
plasticity O
could O
be O
harnessed O
to O
approach O
age-related O
diseases O
from O
a O
novel O
perspective O

In O
multicellular O
organisms O
, O
such O
division O
is O
achieved O
through O
epigenetic O
factors O
regulating O
cell O
differentiation O
during O
development O

An O
informative O
subset O
of O
studies O
that O
examined O
candidate O
gene O
by O
environment O
(GxE) O
predictors O
of O
these O
psychiatric B-Disease
problems O
in O
individuals O
maltreated O
as O
children O
is O
reviewed O
, O
together O
with O
extant O
genome O
wide O
association O
studies O
(GWAS) O

In O
accordance O
with O
the O
notion O
of O
global O
methylation O
reprogramming O
, O
our O
preliminary O
observations O
on O
acute O
myeloid O
leukemia B-Disease
( O
AML O
) O
samples O
implied O
the O
existence O
of O
subclonally O
occurring O
focal O
methylation O
aberrance O
throughout O
the O
genome O

With O
this O
explosion O
of O
new O
data O
, O
integration O
in O
a O
systems-based O
approach-including O
complete O
phenotypic O
information-to O
male O
infertility O
is O
imperative O

Recent O
findings O
on O
the O
subject O
matter O
have O
provided O
an O
insight O
into O
the O
mechanism O
of O
epigenetic O
modifications O
, O
thus O
this O
review O
aims O
to O
present O
an O
update O
on O
the O
latest O
studies O

Finding O
associations O
between O
epigenetic O
variation O
and O
phenotype O
is O
a O
significant O
challenge O
in O
biomedical O
research O

68 O
: O
Genetic O
, O
epigenetic O
, O
and O
metabolic O
alterations O
are O
all O
hallmarks O
of O
cancer B-Disease

Using O
a O
spot-dilution O
analysis O
, O
the O
loss O
of O
antibiotic O
resistance O
phenotype O
was O
scored O
from O
0 O
to O
4 O
, O
four O
being O
maximally O
silenced O

He O
has O
authored O
or O
coauthored O
more O
than O
370 O
publications O

118 O
: O
Automated O
liquid-handling O
robots O
and O
high-throughput O
screening O
( O
HTS O
) O
are O
widely O
used O
in O
the O
pharmaceutical O
industry O
for O
the O
screening O
of O
large O
compound O
libraries O
, O
small O
molecules O
for O
activity O
against O
disease-relevant O
target O
pathways O
, O
or O
proteins O

191:Tweetable O
This O
article O
reviews O
machine O
learning O
models O
that O
leverages O
epigenomic O
data O
for O
predicting O
multifactorial O
diseases O
and O
symptoms O
as O
well O
as O
how O
such O
models O
can O
be O
utilized O
to O
explore O
new O
research O
questions O

Types O
of O
environmental O
exposure O
under O
consideration O
include O
hypnotic O
drugs O
and O
medicines O
( O
i O

Both O
genetics O
and O
epigenetics O
contribute O
to O
determining O
the O
outcome O
of O
regulatory O
gene O
expression O
systems O

Our O
results O
provide O
a O
fundamental O
understanding O
of O
the O
information-theoretic O
nature O
of O
the O
epigenome O
that O
leads O
to O
a O
powerful O
approach O
for O
studying O
its O
role O
in O
disease B-Disease
and O
aging O

It O
accurately O
recovers O
cell-type-specific O
latent O
methylation O
components O
and O
their O
proportions O

This O
has O
resulted O
in O
both O
sparsity O
of O
investigations O
into O
disease-related O
changes O
in O
DNA O
methylation O
, O
a O
paucity O
of O
robust O
findings O
, O
and O
difficulties O
comparing O
studies O
in O
the O
same O
disease B-Disease

54 O
: O
Epigenetic O
editing O
refers O
to O
the O
locus-specific O
targeting O
of O
epigenetic O
enzymes O
to O
rewrite O
the O
local O
epigenetic O
landscape O
of O
an O
endogenous O
genomic O
site O
, O
often O
with O
the O
aim O
of O
transcriptional O
reprogramming O

These O
profiles O
measure O
epigenetic O
activity O
at O
the O
nucleotide O
resolution O
and O
they O
exhibit O
distinctive O
patterns O
as O
they O
fluctuate O
along O
the O
genome O

These O
life O
history O
stages O
are O
somewhat O
arbitrary O
, O
with O
many O
traits O
spanning O
conventional O
divisions O
, O
but O
each O
period O
tends O
to O
have O
its O
own O
characteristic O
ethologies O
and O
particular O
contribution O
to O
neural O
and O
behavioral O
phenotypes O

Functional O
enrichment O
analysis O
of O
these O
genes O
can O
help O
in O
understanding O
the O
mechanisms O
leading O
to O
tumorigenesis B-Disease
due O
to O
epigenetic O
alterations O

A O
search O
of O
literature O
yielded O
a O
large O
body O
of O
publications O
between O
2008 O
and O
2018 O

Following O
this O
, O
we O
pay O
attention O
to O
key O
discoveries O
in O
the O
field O
of O
epigenetics O
that O
have O
emerged O
from O
the O
study O
of O
unusual O
and O
enigmatic O
phenomena O
in O
plants O

Hence O
, O
identifying O
CSCs O
and O
targeting O
epigenetic O
pathways O
therein O
can O
offer O
new O
insights O
into O
the O
treatment O
of O
cancer B-Disease

Ultimately O
, O
both O
genetic O
biomarkers O
and O
epigenetic O
mechanisms O
should O
be O
taken O
into O
consideration O
in O
predicting O
drug O
response O
in O
the O
course O
of O
successful O
personalized O
therapy O

389 O
: O
Histone O
modifications O
and O
DNA O
methylation O
together O
govern O
promoter O
availability O
, O
thereby O
influencing O
gene O
expression O

Our O
hope O
is O
that O
this O
review O
serves O
as O
a O
primer O
for O
anthropologists O
and O
human O
biologists O
interested O
in O
incorporating O
epigenetic O
data O
into O
their O
research O
programs O

We O
also O
describe O
how O
recent O
advances O
in O
molecular O
biology O
beyond O
the O
operon O
model-namely O
, O
programmable O
DNA- O
and O
RNA-binding O
molecules O
as O
well O
as O
models O
of O
epigenetic O
and O
posttranslational O
regulation-are O
expanding O
the O
synthetic O
biology O
toolkit O
and O
enabling O
the O
design O
of O
more O
complex O
biological O
circuits O

In O
coeliac O
disease B-Disease
, O
there O
are O
several O
questions O
both O
in O
the O
fields O
of O
genetics O
and O
epigenetics O
yet O
to O
be O
answered O

In O
particular O
, O
these O
cells O
show O
accumulation O
of O
H3K4me3 O
and O
H3K27Ac O
epigenetic O
marks O
on O
multiple O
immune O
gene O
promoters O
and O
associated O
enhancers O

Initial O
evidence O
has O
recently O
been O
gathered O
pointing O
to O
the O
possibility O
that O
the O
rate O
of O
epigenetic O
ageing O
can O
be O
slowed O
down O
or O
even O
reversed O

This O
is O
achieved O
by O
providing O
a O
survey O
of O
the O
following O
concepts O
: O
( O
i O
) O
factors O
influencing O
epigenetics O
, O
( O
ii O
) O
diseases O
arising O
from O
epigenetics O
, O
( O
iii O
) O
epigenetic O
enzymes O
as O
druggable O
targets O
along O
with O
coverage O
of O
existing O
FDA-approved O

Excitingly O
, O
our O
method O
substantially O
rejuvenated O
multiple O
cellular O
attributes O
including O
the O
transcriptome O
, O
which O
was O
rejuvenated O
by O
around O
30 O
years O
as O
measured O
by O
a O
novel O
transcriptome O
clock O

As O
an O
integrator O
of O
genetic O
and O
environmental O
inputs O
, O
and O
because O
of O
advances O
in O
measurement O
techniques O
that O
are O
highly O
reproducible O
and O
provide O
sequence O
information O
, O
the O
epigenome O
is O
a O
rich O
source O
of O
potential O
biosignatures O
of O
cardiovascular O
health O
and O
disease B-Disease

Modern O
usage O
of O
the O
term O
epigenetics O
encompasses O
both O
longer-term O
and O
transient O
changes O
and O
is O
relevant O
to O
multiple O
biological O
systems O

He O
has O
published O
over O
200 O
peer-reviewed O
articles O
as O
well O
as O
the O
books O
Liver O
Regeneration O
andCarcinogenesis O
: O
Molecular O
and O
Cellular O
Mechanisms O
, O
Environmental O
Epigenomics O
in O
Health O
and O
Disease O
: O
Epigenetics O
and O
Disease O
Origins O
and O
Environmental O
Epigenomics O
in O
Health O
andDisease O
: O
Epigenetics O
and O
Complex O
Diseases O

It O
should O
be O
easier O
to O
intervene O
in O
the O
body O
's O
age-related O
signaling O
, O
or O
even O
to O
reprogram O
the O
body O
's O
epigenetics O
, O
compared O
to O
brute-force O
repair O
of O
all O
the O
physical O
and O
chemical O
damage O
that O
accrues O
with O
age O

Overall O
, O
we O
identify O
an O
important O
epigenetic O
role O
for O
a O
number O
of O
largely O
unstudied O
genes O
in O
muscle O
hypertrophy/memory O

58 O
: O
A O
plethora O
of O
environmental O
and O
behavioral O
factors O
interact O
, O
resulting O
in O
changes O
in O
gene O
expression O
and O
providing O
a O
basis O
for O
the O
development O
and O
progression O
of O
cardiovascular B-Disease
diseases I-Disease

The O
ways O
in O
which O
these O
epigenetic O
mechanisms O
influence O
liver O
physiology O
and O
disease B-Disease
will O
be O
considered O
in O
detail O
, O
particularly O
in O
the O
context O
of O
cancer B-Disease
, O
fibrosis O
, O
and O
nonalcoholic O
steatohepatitis O

Machine O
Learning O
( O
ML O
) O
algorithms O
are O
particularly O
suited O
for O
epigenomic O
data O
analyses O
due O
to O
their O
flexibility O
and O
ability O
to O
learn O
underlying O
hidden O
structures O

Here O
, O
we O
give O
a O
historical O
overview O
of O
the O
epigenomics O
field O
and O
how O
epigenetic O
modifications O
can O
affect O
embryo O
development O
and O
disease B-Disease
etiology O

To O
date O
, O
there O
is O
almost O
no O
ethical O
debate O
about O
EE O
, O
whereas O
the O
discussions O
about O
GE O
are O
voluminous O

In O
this O
review O
, O
we O
discuss O
the O
recent O
technical O
improvements O
in O
CRISPR/Cas-based O
epigenome O
editing O
that O
have O
advanced O
clinical O
research O
and O
examine O
how O
these O
technologies O
could O
be O
improved O
for O
greater O
future O
utility O

This O
has O
led O
to O
the O
concept O
of O
persistent O
epigenetic O
changes O

Epigenetic O
age O
does O
not O
only O
estimate O
chronological O
age O
but O
can O
also O
predict O
the O
risk O
of O
chronic O
diseases O
and O
mortality O


Epigenetics O
is O
the O
expansion O
of O
classical O
genetics O
, O
the O
corresponding O
experimental O
courses O
of O
which O
have O
not O
been O
integrated O
into O
the O
current O
teaching O
system O

We O
conclude O
that O
epigenetic O
clocks O
can O
predict O
chronological O
age O
with O
relatively O
high O
accuracy O
, O
suggesting O
great O
potential O
in O
ecological O
epigenetics O

The O
reasonableness O
of O
this O
hypothesis O
is O
offset O
by O
its O
implication O
, O
that O
many O
( O
or O
most O
) O
( O
or O
all O
) O
of O
the O
cases O
of O
induced-and-inherited O
phenotypes O
that O
are O
seen O
to O
persist O
for O
generations O
are O
instead O
unmapped O
induced O
polymorphisms O
in O
the O
ribosomal O
DNA O
, O
and O

We O
have O
identified O
an O
additional O
epigenetic O
stratification O
category O
, O
the O
" O
Outlier O
Methylation O
Phenotype O
" O
( O
OMP O
) O

ageing O
or O
disease B-Disease
) O

721 O
: O
DNA O
methylation O
( O
DNAm O
) O
overwrites O
information O
about O
multiple O
extrinsic O
factors O
on O
the O
genome O

Using O
a O
wide O
variety O
of O
strategies O
and O
techniques O
ranging O
from O
simple O
ChIP O
to O
ChIP-chip O
and O
ChIP-seq O
to O
identify O
histone O
modifications O
, O
nuclease O
digestion O
to O
genome O
wide O
next O
generation O
sequencing O
to O
identify O
nucleosome O
location O
, O
and O
bisulfite O
treatment O
to O
MeDIP O
to O
identify O
DNA O

We O
propose O
that O
MER-Net O
can O
serve O
as O
a O
tool O
to O
guide O
integrated O
metabolomics O
and O
epigenomics O
research O
or O
can O
be O
modified O
to O
answer O
other O
complex O
biological O
and O
clinical O
questions O
using O
multiomics O
data O

Overall O
, O
results O
were O
inconclusive O
and O
were O
primarily O
exploratory O
in O
nature O

We O
argue O
that O
the O
integration O
of O
ethnographic O
findings O
into O
epigenomics O
will O
significantly O
improve O
disparities-focused O
study O
designs O
within O
environmental B-Disease
epigenomics I-Disease
by O
identifying O
and O
contextualizing O
the O
most O
salient O
dimensions O
of O
the O
' O
environment O
' O
that O
are O
affecting O
local O
communities O

The O
present O
chapter O
reviewed O
the O
advances O
on O
the O
epigenetics O
changes O
mainly O
DNA O
methylation O
and O
histones O
modifications O
on O
cervical O
and O
breast O
human O
cancers B-Disease

For O
DNA O
methylation O
and O
hydroxymethylation O
, O
next-generation O
sequencing O
allows O
increasingly O
inexpensive O
and O
quantitative O
whole-genome O
profiling O

First O
, O
for O
adults O
living O
through O
the O
Famine O
, O
starvation O
and O
poverty O
contributed O
to O
the O
continued O
rise O
in O
asylum O
presentations O

Statistical O
robustness O
is O
an O
essential O
prerequisite O
for O
a O
better O
understanding O
and O
interpretation O
of O
epigenetic O
modifications O
and O
helps O
to O
find O
novel O
targets O
for O
personalized O
therapeutics O
in O
psychiatric B-Disease
diseases O

g O

It O
offers O
a O
powerful O
, O
yet O
versatile O
and O
easily O
extensible O
interface O
to O
read O
, O
write O
and O
manipulate O
multiple O
genomic O
file O
formats O

Moreover O
, O
a O
strong O
link O
between O
nutrition O
and O
epigenetic O
changes O
has O
been O
established O

We O
review O
studies O
that O
used O
MS-AFLP O
to O
address O
ecological O
questions O
, O
that O
describe O
which O
taxa O
have O
been O
investigated O
, O
and O
that O
identify O
general O
trends O
in O
the O
field O

Although O
the O
mechanisms O
by O
which O
chromatin O
structure O
and O
reorganization O
as O
well O
as O
cytosine B-Disease
methylation I-Disease
influence O
gene O
expression O
are O
not O
fully O
understood O
, O
they O
are O
being O
invoked O
to O
explain O
the O
now-accepted O
long-term O
impact O
of O
the O
environment O
on O
gene O
expression O
, O
which O
appears O
to O
be O
a O
factor O

Conclusions O
: O
Estimating O
cell-type O
fractions O
and O
subsequent O
inference O
in O
EWAS O
may O
benefit O
from O
the O
use O
of O
non-constrained O
reference-based O
cell-type O
deconvolution O
methods O

Ancestral O
and O
direct O
exposures O
to O
environmental O
toxicants O
and O
altered O
nutrition O
have O
been O
shown O
to O
increase O
susceptibility O
for O
obesity B-Disease
and O
metabolic O
dysregulation O

Here O
, O
we O
review O
operational O
definitions O
of O
transgenerational O
inheritance O
and O
the O
processes O
of O
epigenetic O
programing O
during O
early O
development O

177 O
: O
The O
celebrated O
1917 O
work O
" O
On O
Growth O
and O
Form O
" O
of O
D'Arcy O
W O

However O
, O
gene O
set O
enrichment O
analysis O
did O
not O
reveal O
any O
enrichment O
for O
gene O
ontologies O

Methods O
: O
Differential O
transcription O
and O
CpG O
methylation O
patterns O
were O
compared O
between O
transgenomic O
and O
nontransgenomic O
cell O
clones O
by O
using O
gene O
chip O
microarray O
systems O

The O
protocol O
provides O
a O
detailed O
description O
for O
the O
comparative O
analysis O
of O
DNA-IP O
sequencing O
data O
including O
basic O
data O
processing O
, O
quality O
controls O
, O
and O
identification O
of O
differential O
enrichment O
using O
the O
Bioconductor O
package O
" O
MEDIPS O
" O

These O
epigenetic O
effects O
add O
to O
wanted O
and O
unwanted O
drug O
effects O
, O
contributing O
to O
mechanisms O
of O
drug O
resistance O
or O
disease-related O
and O
unrelated O
phenotypes O

Bisulfite O
treatment O
in O
conjunction O
with O
next O
generation O
sequencing O
has O
been O
a O
powerful O
tool O
for O
studying O
this O
modification O
in O
a O
quantitative O
manner O
in O
the O
context O
of O
the O
whole O
genome O
and O
with O
a O
single O
nucleotide O
resolution O

727 O
: O
Suicidal O
behaviors O
have O
been O
associated O
with O
both O
heritable O
genetic O
variables O
and O
environmental O
risk O
factors O

However O
, O
technical O
limitations O
and O
sparse O
coverage O
can O
preclude O
this O
task O

Many O
advances O
in O
medicine O
have O
been O
made O
to O
treat O
these O
conditions O
but O
there O
are O
still O
gaps O
, O
and O
an O
innovative O
and O
efficient O
therapy O
is O
needed O

251 O
: O
The O
analysis O
of O
DNA O
methylation O
has O
become O
routine O
in O
the O
pipeline O
for O
diagnosis O
of O
imprinting O
disorders O
, O
with O
many O
publications O
reporting O
aberrant O
methylation O
associated O
with O
imprinted O
differentially O
methylated O
regions O
( O
DMRs O
) O

Technology O
-based O
interventions O
such O
as O
personal O
response O
systems O
( O
PRS O
) O
have O
gained O
momentum O
, O
especially O
since O
the O
advent O
of O
cloud-/web-based O
solutions O

Considering O
that O
CVD O
preventive O
medications O
improve O
vascular O
outcomes O
in O
less O
than O
half O
of O
patients O
(often O
relative O
risk O
reductions O
range O
from O
12% O
to O
20% O
compared O
with O
placebo O
), O
precision O
medicine O
offers O
an O
attractive O
approach O
to O
refine O
the O
targeting O
of O
CVD O
medications O
to O
responsive O
individuals O

350 O
: O
Background O
: O
Epigenetic O
modification O
of O
chromatin O
plays O
a O
pivotal O
role O
in O
regulating O
gene O
expression O
during O
cell O
differentiation O

This O
package O
first O
introduces O
a O
binarized O
indexing O
strategy O
for O
clustering O
the O
cCREs O

Conclusions O
: O
A O
sufficiently O
advanced O
universal O
harmonizer O
has O
major O
medical O
implications O
, O
such O
as O
( O
i O
) O
identifying O
dysregulated O
biological O
pathways O
responsible O
for O
a O
disease B-Disease
is O
a O
powerful O
diagnostic O
tool O
; O
( O
2 O
) O
investigating O
these O
pathways O
further O
allows O
the O
biological O
community O
to O

Indeed O
, O
diseases O
such O
as O
cancer B-Disease
can O
occur O
in O
the O
offspring O
due O
to O
epigenetically-inherited O
gene O
expression O
profiles O
induced O
by O
stress O
experienced O
by O
the O
parent O

Epimutation O
and O
allied O
epigenetic O
terms O
have O
succeeded O
by O
being O
mutation-like O
and O
recognizable O
, O
yet O
have O
failed O
to O
consolidate O
for O
exactly O
the O
same O
reason O
: O
they O
are O
tied O
simultaneously O
by O
likeness O
and O
opposition O
to O
nouns O
that O
describe O
things O
that O
are O
assumed O
to O
persist O
unchanged O
over O

However O
, O
for O
the O
subset O
of O
patients O
with O
very-early O
onset O
IBD O
, O
several O
causal O
mutations O
have O
been O
found O

39 O
: O
The O
literature O
about O
Developmental O
Origins O
of O
Health O
and O
Disease O
( O
DOHaD O
) O
studies O
is O
considerably O
growing O

O O

They O
affect O
DNA O
methylation O
, O
histone O
modifications O
, O
chromatin O
remodeling O
, O
long O
noncoding O
RNAs O
, O
and O
microRNAs O

91 O
: O
The O
genetic O
material O
DNA O
in O
association O
with O
histone O
proteins O
forms O
the O
complex O
structure O
called O
chromatin O
, O
which O
is O
prone O
to O
undergo O
modification O
through O
certain O
epigenetic O
mechanisms O
including O
cytosine O
DNA O
methylation O
, O
histone O
modifications O
, O
and O
small O
RNA-mediated O
methylation O

Major O
case O
control O
studies O
that O
are O
ongoing O
in O
the O
laboratory O
include O
studies O
designed O
to O
understand O
inherited O
and O
acquired O
susceptibility O
in O
head O
and O
neck O
cancers B-Disease

012 O

It O
is O
recognized O
that O
environmental O
factors O
and O
individual O
lifestyles O
play O
important O
roles O
in O
disease B-Disease
susceptibility O
, O
but O
the O
link O
between O
these O
external O
risk O
factors O
and O
our O
genetics O
has O
been O
unclear O

Simultaneously O
, O
evolutionary O
theorists O
were O
proposing O
diverse O
selective O
mechanisms O
that O
might O
account O
for O
adaptations O
that O
are O
beneficial O
to O
the O
community O
, O
even O
as O
they O
imposed O
a O
fitness O
cost O
on O
the O
individual O

In O
this O
review O
, O
several O
natural O
compounds O
and O
their O
studies O
about O
miRNA-related O
action O
mechanism O
were O
summarized O

Measurements O
that O
are O
increasingly O
available O
range O
from O
those O
that O
identify O
transcription O
factor O
occupancy O
and O
initiation O
of O
transcription O
to O
long-lasting O
and O
heritable O
epigenetic O
marks O
such O
as O
DNA O
methylation O

597: O
Cancer B-Disease
epigenomic-environment O
is O
a O
core O
center O
of O
a O
tumor's O
genetic O
and O
epigenetic O
configuration O

Epigenetic O
regulation O
can O
convert O
a O
developmental O
or O
transient O
environmental O
signal O
into O
a O
stable O
transcriptional O
response O
, O
which O
will O
then O
be O
perpetuated O
even O
in O
the O
absence O
of O
the O
original O
stimulus O

Moreover O
, O
interactions O
between O
the O
host O
epigenome O
and O
the O
microbiome O
are O
increasingly O
recognized O
, O
and O
interventions O
of O
the O
microbiome O
could O
contribute O
to O
modulation O
of O
the O
epigenome O
with O
a O
potential O
effect O
on O
the O
overall O
goal O
of O
prevention O
of O
allergic B-Disease
diseases I-Disease

Recent O
technological O
developments O
have O
enabled O
base-pair O
resolution O
of O
various O
epigenomic O
features O
, O
leading O
to O
new O
insights O
into O
epigenetic O
regulation O

A O
technological O
overview O
is O
given O
including O
wholegenome O
microarrays O
, O
immune-specific O
arrays O
, O
small-scale O
high-throughput O
expression O
methods O
, O
high-density O
tiling O
arrays O
, O
and O
next O
generation O
sequencing O
( O
NGS O
) O

235 O
: O
It O
has O
become O
clear O
that O
in O
addition O
to O
the O
DNA O
sequence O
there O
is O
another O
layer O
of O
information O
, O
termed O
epigenetic O
modifications O
, O
that O
can O
influence O
phenotypes O
and O
traits O

An O
EpigenART O
competition O
included O
ten O
artists O
, O
creating O
a O
unique O
opportunity O
for O
artists O
and O
scientists O
to O
interact O
and O
explore O
their O
individual O
interpretations O
of O
this O
scientific O
discipline O

We O
then O
review O
more O
controversial O
topics O
: O
the O
evolution O
of O
gbM O
and O
the O
potential O
selective O
pressures O
that O
act O
on O
it O

419 O
: O
Epigenetic O
regulation O
of O
gene O
expression O
refers O
to O
heritable O
factors O
that O
are O
functionally O
relevant O
genomic O
modifications O
but O
that O
do O
not O
involve O
changes O
in O
DNA O
sequence O

84 O
- O
0 O

249 O
: O
In O
May O
2011 O
, O
the O
Canadian O
Conference O
on O
Epigenetics O
: O
Epigenetics O
Eh O
! O
was O
held O
in O
London O
, O
Canada O

503 O
: O
Cardiovascular B-Disease
diseases I-Disease
are O
the O
major O
cause O
of O
morbidity O
and O
mortality O
worldwide O

Recent O
papers O
argue O
that O
epigenetic O
marks O
acquired O
through O
experience O
are O
passed O
to O
offspring O
, O
but O
as O
in O
much O
of O
the O
field O
of O
epigenetics O
, O
there O
is O
lack O
of O
precision O
in O
the O
definitions O
and O
perhaps O
too O
much O
eagerness O
to O
translate O
animal O
research O
to O
humans O

467 O
: O
Aim O
: O
We O
previously O
reported O
changes O
of O
DNA O
methylation O
and O
transcription O
patterns O
in O
mammalian O
cells O
that O
carry O
integrated O
foreign O
DNA O

For O
example O
, O
the O
24-nt O
siRNA-involved O
RNA-directed O
DNA O
methylation O
( O
RdDM O
) O
pathway O
is O
plant-specific O
because O
of O
the O
involvements O
of O
two O
plant-specific O
DNA-dependent O
RNA O
polymerases O
, O
Pol O
IV O
and O
Pol O
V O

We O
apply O
TRIAGE O
to O
millions O
of O
genome-wide O
single-cell O
transcriptomes O
, O
diverse O
omics O
platforms O
, O
and O
eukaryotic O
cells O
and O
tissue O
types O

To O
achieve O
a O
lifespan O
beyond O
the O
longevity O
of O
individual O
cell O
types O
, O
tissue-specific O
stem O
cells O
sustain O
these O
tissues O
throughout O
the O
life O
of O
a O
human O

Dr O
Karl O
Kelsey O
, O
MD O
, O
MOH O
is O
a O
Professor O
of O
Epidemiology O
and O
Pathology O
and O
Laboratory O
Medicine O
at O
Brown O
University O

18 O
: O
Gene O
therapy O
is O
currently O
considered O
as O
the O
optimal O
treatment O
for O
inborn O
errors O
of O
metabolism O
( O
IEMs O
) O
, O
as O
it O
aims O
to O
permanently O
compensate O
for O
the O
primary O
genetic O
defect O

571 O
: O
Detection O
in O
blood O
of O
the O
genetic O
and O
epigenetic O
changes O
present O
in O
metastatic B-Disease
cancers I-Disease
is O
opening O
up O
new O
possibilities O
in O
molecular O
diagnostics O

Additionally O
, O
bisulfite O
fails O
to O
resolve O
5mC O
from O
5hmC O

Methods O
: O
In O
this O
work O
, O
we O
utilize O
crisprSQL O
, O
an O
off-target O
database O
, O
to O
analyze O
the O
effect O
of O
19 O
epigenetic O
descriptors O
on O
CRISPR-Cas9 O
off-target O
activity O

Thus O
the O
need O
for O
biomarkers O
in O
RCC O
is O
urgent O

Furthermore O
, O
DMF-ChIP-seq O
was O
capable O
of O
processing O
the O
samples O
with O
as O
few O
as O
8 O
cells O
while O
maintaining O
a O
high O
signal-to-noise O
ratio O

Furthermore O
, O
the O
mean/median O
number O
of O
methylome-wide O
significant O
findings O
was O
reduced O
by O
65,688/57,805 O
loci O
after O
more O
thorough O
QC O

Here O
we O
outline O
a O
general O
experimental O
approach O
for O
achieving O
this O
using O
crosses O
of O
epigenomically O
perturbed O
isogenic O
lines O
in O
mammalian O
and O
plant O
species O

Of O
particular O
interest O
to O
both O
evolutionary O
and O
behavioral O
biologists O
is O
the O
newly O
emerging O
field O
of O
epigenetics O
and O
behavior O

This O
review O
examines O
the O
literature O
from O
field O
and O
laboratory O
studies O
utilising O
invertebrate O
species O
exposed O
to O
environmental O
pollutants O
and O
their O
effect O
on O
DNA O
methylation O

This O
manuscript O
describes O
the O
development O
of O
a O
resource O
module O
that O
is O
part O
of O
a O
learning O
platform O
named O
``NIGMS O
Sandbox O
for O
Cloud-based O
Learning'' O
https://github O

Many O
patterns O
of O
evolution O
of O
gene O
regulation O
are O
also O
in O
agreement O
with O
the O
nearly O
neutral O
prediction O

Multiple O
studies O
have O
found O
differential O
DNA O
methylation O
(DNAm) O
between O
preterm O
and O
term O
infants O
' O
cord O
blood O
; O
however O
, O
interpretation O
of O
these O
studies O
is O
limited O
by O
the O
confounding O
factor O
of O
blood O
cell O
composition O

Potential O
results O
include O
global O
methyl O
cytosine O
content O
, O
degree O
of O
methylation O
at O
specific O
loci O
, O
or O
genome-wide O
methylation O
maps O

He O
was O
the O
inaugural O
recipient O
of O
the O
Epigenetic O
Medicine O
Award O
in O
2008 O
and O
received O
the O
STARS O
Lecture O
Award O
in O
Nutrition O
and O
Cancer B-Disease
from O
the O
National O
Cancer B-Disease
Institute O
in O
2009 O

The O
GNP O
efficiently O
generated O
SERS O
for O
structural O
functional O
molecular O
epigenetics O
and O
nuclear O
proteomics O
in O
preclinical O
models O
of O
breast O
and O
lung O
CSCs O

78 O
: O
Several O
types O
of O
epigenetic O
marks O
facilitate O
the O
complex O
patterning O
required O
for O
normal O
human O
development O

With O
the O
emergence O
of O
the O
field O
of O
epigenetics O
, O
an O
increasing O
number O
of O
drug O
discovery O
companies O
are O
beginning O
to O
screen O
compound O
libraries O
against O
a O
range O
of O
epigenetic O
targets O

87 O
: O
As O
a O
final O
function O
of O
various O
epigenetic O
mechanisms O
, O
chromatin O
regulation O
is O
a O
transcription O
control O
process O
that O
especially O
demonstrates O
active O
interaction O
with O
genetic O
elements O

This O
article O
reviews O
the O
potential O
contributions O
and O
problems O
of O
epigenetic O
research O
in O
child O
psychiatry O

Accelerated O
execution O
and O
integrated O
semi-supervised O
peak O
calling O
make O
JBR O
and O
SPAN O
next-generation O
visualization O
and O
analysis O
tools O
for O
multi-sample O
epigenetic O
data O

In O
this O
review O
, O
we O
will O
give O
an O
overview O
of O
the O
applications O
of O
MS-based O
proteomics O
in O
studying O
various O
aspects O
of O
chromatin O
biology O

Epigenetics O
can O
be O
defined O
as O
the O
study O
of O
heritable O
changes O
in O
gene O
expression O
that O
do O
not O
involve O
alterations O
in O
the O
DNA O
sequence O

``` O
Methods O
: O
We O
tested O
the O
performance O
of O
four O
epigenetic O
clocks O
on O
the O
probeset O
of O
the O
EPICv2 O
array O
using O
a O
dataset O
of O
10,835 O
samples O
``` O

I O
propose O
that O
because O
of O
the O
need O
of O
all O
biological O
systems O
to O
be O
homeostatic O
, O
we O
should O
expect O
that O
aging O
is O
controlled O
by O
multiple O
, O
independent O
timekeepers O

This O
technology O
allows O
us O
to O
identify O
structural O
changes O
in O
the O
genome O
that O
occur O
due O
to O
exposure O
to O
a O
wide O
variety O
of O
substances O
including O
alcohol O
, O
tobacco O
, O
and O
cannabis O

Most O
importantly O
, O
the O
epigenetic O
footprint O
of O
immune-related O
pathways O
is O
associated O
with O
the O
patient O
outcome O
, O
underscoring O
the O
crucial O
need O
to O
understand O
this O
process O

In O
addition O
, O
we O
will O
describe O
how O
this O
knowledge O
is O
translated O
into O
the O
clinic O

After O
completing O
her O
undergraduate O
degree O
in O
chemical O
engineering O
, O
Aydan O
shifted O
focus O
to O
molecular O
biology O
for O
her O
Master O
's O
degree O
and O
epigenetics O
during O
her O
PhD O
in O
Thomas O
Jenuwein O
's O
lab O

646 O
: O
Epigenetics O
refers O
to O
heritable O
molecular O
determinants O
of O
phenotype O
independent O
of O
DNA O
sequence O

665 O
: O
Osteoarthritis O
( O
OA O
) O
is O
a O
major O
clinical O
problem O
across O
the O
world O
, O
in O
part O
due O
to O
the O
lack O
of O
disease-modifying O
drugs O
resulting O
, O
to O
a O
significant O
degree O
, O
from O
our O
incomplete O
understanding O
of O
the O
underlying O
molecular O
mechanisms O
of O
the O
disease B-Disease

Context O
-dependent O
epigenetic O
change O
can O
be O
observed O
if O
the O
environmental O
factors O
that O
bring O
about O
the O
epigenetic O
modification O
persists O
( O
e O

This O
disagreement O
on O
a O
clear O
definition O
has O
made O
communication O
difficult O
, O
synthesis O
of O
epigenetic O
research O
across O
fields O
nearly O
impossible O
, O
and O
has O
in O
many O
ways O
biased O
methodologies O
and O
interpretations O

To O
bridge O
this O
gap O
, O
we O
introduce O
ViCAR O
( O
viewpoint O
HiCAR O
) O
, O
for O
the O
direct O
antibody-based O
capture O
of O
chromatin O
interactions O
at O
folded O
G4s O

Supplementary O
information O
: O
Supplementary O
data O
are O
available O
at O
Bioinformatics O
online O

Moving O
forward O
an O
integrative O
analysis O
of O
genomic O
, O
transcriptomic O
and O
epigenomic O
data O
, O
with O
the O
latter O
two O
coming O
from O
specific O
cell O
types O
, O
will O
provide O
an O
understanding O
that O
has O
been O
missed O
from O
genetics O
alone O

57 O
% O
of O
the O
miRNAs O
) O
of O
the O
aberrantly O
methylated O
ncRNA O
promoters O

305 O
: O
Recent O
advances O
in O
molecular O
biology O
and O
computational O
power O
have O
seen O
the O
biomedical O
sector O
enter O
a O
new O
era O
, O
with O
corresponding O
development O
of O
Bioinformatics O
as O
a O
major O
discipline O

567 O
: O
Modern O
biomedical O
scientists O
are O
often O
trapped O
in O
silos O
of O
knowledge O
and O
practice O
, O
such O
as O
those O
who O
study O
brain O
structure O
, O
function O
and O
behavior O
, O
on O
the O
one O
hand O
, O
and O
body O
systems O
and O
disorders O
, O
on O
the O
other O

Reciprocally O
, O
epigenetic O
findings O
can O
enhance O
anthropological O
understanding O
of O
human O
biological O
variation O
and O
embodiment O

339 O
: O
In O
this O
interview O
, O
Professor O
Gerd O
Pfeifer O
speaks O
with O
Storm O
Johnson O
, O
Commissioning O
Editor O
for O
Epigenomics O
, O
on O
his O
work O
to O
date O
in O
the O
field O
of O
DNA O
methylation O


This O
review O
presents O
a O
summary O
of O
the O
literature O
on O
childhood O
trauma B-Disease
and O
DNAm O
, O
highlights O
issues O
in O
the O
field O
, O
and O
proposes O
some O
potential O
solutions O

216 O
: O
MicroRNAs O
( O
miRNAs O
) O
are O
short O
noncoding O
RNAs O
with O
gene O
regulatory O
functions O

These O
factors O
affect O
how O
genes O
work O
; O
scientists O
now O
know O
that O
what O
matters O
as O
much O
as O
which O
genes O
you O
have O
( O
and O
what O
environments O
you O
encounter O
) O
is O
how O
your O
genes O
are O
affected O
by O
their O
contexts O

by O
age O
and O
tissue O
, O
it O
is O
more O
complex O
to O
find O
appropriate O
external O
weights O

EpiExplorer O
is O
available O
at O
http://epiexplorer O

We O
also O
conducted O
a O
Grey O
literature O
search O
, O
such O
as O
Google O
Scholar O

This O
approach O
can O
be O
sensitive O
to O
the O
dynamic O
interaction O
between O
biological O
predisposition O
and O
environmental O
influences O
, O
and O
is O
potentially O
more O
informative O
than O
an O
approach O
using O
static O
genetic O
code O

The O
availability O
of O
next-generation O
sequencing O
technologies O
allows O
us O
to O
study O
epigenetic O
variation O
at O
an O
unprecedented O
level O
of O
resolution O

This O
has O
been O
addressed O
by O
including O
cellular O
heterogeneity B-Disease
obtained O
through O
cytology O
at O
the O
time O
of O
collection O
or O
by O
using O
cellular O
deconvolution O
algorithms O
built O
on O
epigenetic O
data O
from O
specific O
cell O
types O

Main O
body O
: O
Here O
we O
review O
evidence O
suggesting O
that O
epigenetic O
therapeutics O
can O
deactivate O
immunosuppressive O
gene O
expression O
or O
reprogram O
tumor B-Disease
cells O
to O
activate O
antigen O
presentation O
mechanisms O

DNA O
methylation O
is O
a O
well-characterised O
epigenetic O
mechanism O
, O
and O
a O
highly O
stable O
epigenetic O
marker O
, O
that O
is O
implicated O
in O
disease B-Disease
pathogenesis O

The O
specific O
aims O
of O
the O
forum O
were O
i O
) O
to O
identify O
epigenetic O
targets O
or O
mechanisms O
of O
action O
associated O
with O
epigenetic O
modification O
relevant O
to O
paediatric O
cancers B-Disease
and O
ii O
) O
to O
define O
the O
landscape O
for O
paediatric O
drug O
development O
of O
epigenetic O
modifier O
therapies O

In O
recent O
times O
various O
studies O
implicated O
that O
, O
aberrant O
epigenetic O
mechanisms O
are O
associated O
with O
reproductive O
infertility O


This O
review O
first O
summarizes O
the O
different O
mechanisms O
by O
which O
the O
environment O
can O
model O
the O
epigenome O
: O
receptor O
signalling O
, O
energy O
metabolism O
and O
signal O
mechanotransduction O
from O
extracellular O
matrix O
to O
chromatin O

Plant O
epigenomics O
expands O
, O
the O
potential O
for O
sustainable O
agriculture O
by O
implementing O
advanced O
epigenetic O
approaches O
becomes O
increasingly O
evident O

These O
are O
the O
genes O
encoding O
heat O
shock O
proteins O
and O
genes O
associated O
with O
translation O
regulation O

418 O
: O
Motivation O
: O
With O
the O
increasing O
amount O
of O
genomic O
and O
epigenomic O
data O
in O
the O
public O
domain O
, O
a O
pressing O
challenge O
is O
to O
integrate O
these O
data O
to O
investigate O
the O
role O
of O
epigenetic O
mechanisms O
in O
regulating O
gene O
expression O
and O
maintenance O
of O
cell-identity O

From O
the O
therapeutic O
viewpoint O
, O
DNA O
demethylating O
agents O
have O
been O
approved O
for O
the O
treatment O
of O
myelodysplastic O
syndrome O
and O
histone O
deacetylase O
inhibitors O
for O
the O
treatment O
of O
cutaneous O
T-cell O
lymphoma B-Disease

Availability O
and O
implementation O
: O
The O
bigwig-loader O
installation O
instructions O
and O
source O
code O
can O
be O
accessed O
at O
https://github O
. O
com O

The O
article O
concludes O
by O
formulating O
the O
argument O
that O
this O
' O
epigenetic O
turn' O
in O
life O
sciences O
has O
some O
important O
implication O
for O
renewing O
epistemological O
basis O
of O
social O
sciences O

In O
this O
research O
field O
, O
bisulfite- O
, O
enzyme O
sensitivity- O
and O
antibody O
specificity-based O
techniques O
are O
used O
for O
DNA O
methylation O
, O
whereas O
histone O
modifications O
are O
gained O
based O
on O
antibody O
recognition O

We O
extract O
a O
biologically O
relevant O
latent O
space O
of O
LUAD O
and O
LUSC O
samples O

The O
human O
diet O
is O
a O
source O
of O
micronutrients O
, O
bioactive O
molecules O
, O
and O
mycotoxins O
that O
have O
the O
ability O
to O
alter O
DNA O
methylation O
patterns O
and O
are O
thus O
a O
contributing O
factor O
for O
both O
the O
prevention O
and O
onset O
of O
cancer B-Disease

The O
fields O
of O
genetic O
and O
environmental O
epidemiology O
primarily O
seek O
to O
identify O
genetic O
and O
environmental O
risk O
factors O
for O
disease B-Disease
, O
respectively O

Overcoming O
these O
challenges O
, O
however O
, O
could O
reveal O
unique O
opportunities O
for O
disease B-Disease
prevention O
, O
treatment O
and O
possible O
cure O

This O
model O
also O
predicted O
the O
altered O
CG O
methylation O
pattern O
of O
mutant O
oocytes O
having O
perturbed O
histone O
modification O
, O
was O
applicable O
to O
cross-species O
prediction O
of O
the O
CG O
methylation O
pattern O
of O
human O
oocytes O
, O
and O
identified O
the O
epigenetic O
crosstalk O
potentially O
important O
in O
other O
cell O
types O

It O
requires O
minimal O
efforts O
to O
build O
and O
is O
well-documented O
via O
a O
complete O
docXygen O
guide O
, O
online O
documentation O
and O
tutorials O

202 O
: O
The O
epigenetic O
and O
functional O
reprogramming O
of O
immune O
genes O
during O
induction O
of O
trained O
immunity O
is O
accompanied O
by O
the O
metabolic O
rewiring O
of O
cellular O
state O

Female O
participants O
without O
children O
were O
more O
likely O
to O
recognize O
the O
term O
epigenetics O
, O
while O
age O
also O
had O
an O
impact O

Then O
we O
review O
the O
epigenetics O
changes O
in O
response O
to O
environmental O
challenge O
during O
critical O
developmental O
windows O
, O
gametogenesis O
, O
embryogenesis O
, O
and O
fetal O
and O
postnatal O
period O
, O
with O
the O
specific O
example O
of O
diabetic B-Disease
susceptibility O

However O
, O
the O
entire O
picture O
of O
the O
epigenetic O
crosstalk O
regulating O
the O
CG O
methylation O
pattern O
is O
unknown O
especially O
in O
cells O
that O
are O
available O
only O
in O
a O
limited O
number O
, O
such O
as O
mammalian O
oocytes O

A O
growing O
body O
of O
literature O
links O
adverse O
social O
exposures O
to O
epigenetic O
mechanisms O
, O
namely O
DNA O
methylation O
, O
offering O
a O
plausible O
pathway O
through O
which O
health O
inequalities O
may O
arise O

196 O
: O
Inferring O
the O
chronological O
and O
biological O
age O
of O
individuals O
is O
fundamental O
to O
population O
ecology O
and O
our O
understanding O
of O
ageing O
itself O
, O
its O
evolution O
, O
and O
the O
biological O
processes O
that O
affect O
or O
even O
cause O
ageing O

Emerging O
work O
in O
the O
field O
of O
epigenetics O
also O
suggests O
that O
translational O
studies O
that O
integrate O
numerous O
unbiased O
genome-wide O
approaches O
will O
help O
to O
further O
unravel O
the O
genetics O
of O
stress-related B-Disease
psychiatric I-Disease
disorders I-Disease

Objectives O
: O
We O
present O
an O
overview O
of O
epigenetic O
regulation O
and O
a O
summary O
of O
reported O
evidence O
of O
environmental O
toxicants O
as O
epigenetic O
disruptors O

17 O
to O
3 O

Understanding O
the O
functions O
of O
chromatin O
in O
the O
context O
of O
the O
CNS O
will O
aid O
in O
the O
future O
development O
of O
pharmacological O
therapeutics O
aimed O
at O
alleviating O
devastating O
neurological B-Disease
disorders I-Disease

Impact O
: O
This O
approach O
provides O
novel O
insight O
into O
possible O
pleiotropic O
effects O
of O
genes O
involved O
in O
epigenetic O
processes O

Studies O
from O
these O
approaches O
have O
provided O
new O
insights O
into O
the O
molecular O
networks O
and O
processes O
involved O
in O
the O
mechanism O
of O
action O
of O
mood O
stabilizers O
, O
promoting O
a O
systems-level O
multiomics O
synergy O

Cells O
of O
the O
endocrine O
organs O
, O
which O
include O
pituitary O
, O
thyroid O
, O
thymus O
, O
pancreas O
ovary O
and O
testes O
, O
have O
been O
shown O
to O
be O
susceptible O
to O
epigenetic O
alteration O
, O
leading O
to O
both O
local O
and O
systemic O
changes O
often O
resulting O
in O
life-threatening O
metabolic B-Disease
disease I-Disease

To O
understand O
how O
these O
episodes O
'fit' O
together O
, O
it O
is O
necessary O
to O
deconstruct O
early O
life O
events O
and O
study O
each O
period O
both O
in O
its' O
own O
right O
and O
how O
it O
interacts O
with O
the O
preceding O
and O
subsequent O
stages O

744 O
: O
The O
novel O
genome-wide O
assays O
of O
epigenetic O
marks O
have O
resulted O
in O
a O
greater O
understanding O
of O
how O
genetics O
and O
the O
environment O
interact O
in O
the O
development O
and O
inheritance O
of O
diabetes B-Disease

Enacting O
complexity O
in O
this O
research O
means O
dissecting O
multiple O
so-called O
biosocial O
processes O
of O
health O
differentiation O
in O
the O
face O
of O
stressful O
experiences O

Advantages O
of O
cfDNA O
as O
analytical O
target O
have O
evoked O
a O
burst O
of O
sophisticated O
techniques O
providing O
clinically O
relevant O
information O

Although O
a O
number O
of O
bioinformatics O
tools O
have O
been O
developed O
to O
analyse O
this O
assay O
, O
they O
require O
some O
programming O
skills O
and O
experience O
in O
order O
to O
be O
usable O

This O
especially O
refers O
to O
the O
idea O
- O
common O
in O
colonial O
humoralism O
and O
epigenetics O
- O
that O
different O
types O
of O
bodies O
are O
in O
balance O
and O
closely O
linked O
with O
particular O
local O
environments O
and O
lifestyles O

535 O
: O
Accumulating O
evidence O
, O
particularly O
from O
rodent O
and O
human O
studies O
, O
shows O
that O
the O
environmental O
exposures O
and O
experience O
of O
a O
father O
prior O
to O
conception O
can O
modulate O
sperm O
epigenetics O
and O
subsequent O
offspring O
phenotypes O

8 O
% O

Their O
tails O
are O
subject O
to O
posttranslational O
modifications O
( O
PTMs O
) O
that O
together O
with O
chromatin-remodeling O
proteins O
control O
the O
access O
of O
different O
proteins O
to O
DNA O
and O
allow O
a O
precise O
response O
to O
different O
environmental O
conditions O

In O
this O
review O
, O
we O
discuss O
how O
the O
genome O
, O
epigenome O
, O
and O
transcriptome O
of O
MZ O
twins O
can O
be O
studied O
in O
an O
integrative O
manner O
from O
this O
perspective O

Not O
surprisingly O
, O
tumor-associated O
aberrations O
in O
the O
miRNA O
or O
epigenetic O
machineries O
are O
widely O
distributed O
in O
human O
cancer B-Disease
, O
and O
we O
are O
just O
starting O
to O
understand O
their O
relevance O
in O
diagnosis O
, O
prognosis O
or O
therapy O

This O
phenomenon O
has O
largely O
been O
studied O
in O
the O
context O
of O
chromatin O
modification O

Thanks O
to O
single-molecule O
DNA O
sequencing O
technologies O
, O
genome-wide O
identification O
of O
methylated O
DNA O
is O
becoming O
feasible O
on O
a O
large O
scale O
, O
providing O
the O
possibility O
to O
investigate O
more O
deeply O
the O
presence O
, O
variability O
, O
and O
roles O
of O
DNA O
methylation O

Combination O
of O
DAC O
with O
Bcl2 O
inhibitor O
venetoclax O
provides O
more O
effective O
epigenetic O
therapy O
for O
lung B-Disease
cancer I-Disease

It O
is O
even O
applicable O
to O
genomes O
that O
have O
high O
complexity O
and O
a O
large O
size O
, O
being O
the O
method O
of O
choice O
for O
the O
analysis O
of O
plant O
non-model O
systems O

This O
review O
highlights O
recent O
advances O
in O
locus-specific O
and O
whole-genome O
analysis O
of O
cfDNA O
, O
with O
a O
specific O
focus O
on O
epigenetic O
phenomena O
and O
their O
clinical O
value O

New O
tools O
available O
for O
epigenomic O
analysis O
offer O
the O
opportunity O
to O
capture O
epigenetic O
variation O
and O
integrate O
it O
into O
advanced O
(epi)breeding O
programmes O

Supplementary O
information O
: O
Supplementary O
data O
are O
available O
at O
Bioinformatics O
online O

, O
assessing O
causality O
or O
establishing O
reference O
epigenomes O
) O
but O
also O
in O
the O
ethical O
and O
social O
sphere O
( O
e O

These O
studies O
into O
cancer B-Disease
etiology O
will O
potentially O
lead O
to O
robust O
epigenetic O
markers O
for O
the O
detection O
and O
risk O
assessment O
of O
cancer B-Disease

A O
random O
subset O
of O
participants O
from O
The O
Coronary O
Artery O
Risk O
Development O
in O
Young O
Adults O
(CARDIA) O
Study O
with O
available O
whole O
blood O
at O
examination O
years O
(Y) O
15 O
and O
Y20 O
underwent O
epigenomic O
profiling O

291 O
: O
Significant O
advances O
in O
our O
understanding O
of O
the O
biology O
of O
renal O
cell O
carcinoma O
( O
RCC O
) O
have O
been O
achieved O
in O
recent O
years O

Recent O
observations O
( O
Boettiger O
et O
al O

The O
systemic O
and O
pervasive O
occurrence O
of O
DNA O
methylation O
throughout O
the O
genome O
defines O
cellular O
identity O
and O
therefore O
requires O
genome-wide O
assays O
to O
fully O
appreciate O
and O
discern O
differential O
patterns O
of O
methylation O
that O
influence O
aspects O
of O
phenotypic O
plasticity O
including O
susceptibility O
to O
common O
complex O
disease B-Disease

Epigenetic O
mechanisms O
like O
DNA O
methylation O
and O
histone O
modifications O
are O
essential O
for O
multiple O
physiological O
processes O
like O
development O
, O
establishment O
of O
tissue O
identity O
, O
imprinting O
, O
X-chromosome O
inactivation O
, O
chromosomal O
stability O
and O
gene O
transcription O
regulation O

In O
this O
review O
, O
we O
will O
outline O
the O
adaption O
of O
current O
GRS O
approaches O
to O
methylation O
data O
and O
highlight O
occurring O
challenges O

In O
2014 O
, O
he O
relocated O
to O
VAI O
to O
join O
Dr O
Peter O
Jones O
in O
building O
an O
internationally O
acclaimed O
research O
center O
focused O
on O
Epigenetics O

Psychopathy O
is O
a O
personality O
disorder B-Disease
associated O
with O
repeat O
displays O
of O
antisocial O
behaviour O
, O
and O
is O
associated O
with O
the O
disproportionate O
imposition O
of O
harm O
on O
communities O

Using O
a O
recently O
published O
set O
of O
epigenomes O
from O
four O
individual O
donors O
, O
we O
show O
that O
transfer O
learning O
across O
individuals O
allows O
eDICE O
to O
successfully O
predict O
individual-specific O
epigenetic O
variation O
even O
in O
tissues O
that O
are O
unmapped O
in O
a O
given O
donor O

Results O
: O
Of O
the O
six O
associations O
examined O
, O
only O
two O
were O
statistically O
significant O
in O
initial O
models O
adjusted O
for O
age O
and O
sex O
alone O

With O
emphasis O
on O
the O
insights O
obtained O
from O
transcriptomic O
analyses O
for O
porcine O
immunity O
, O
we O
also O
discuss O
the O
experimental O
design O
in O
pig O
immunity O
research O
and O
the O
value O
of O
the O
newly O
published O
porcine O
genome O
assembly O
in O
using O
the O
pig O
as O
a O
model O
for O
human O
immune O
response O

Although O
this O
research O
field O
is O
still O
young O
, O
these O
comprehensive O
data O
support O
not O
only O
a O
role O
for O
epigenetics O
in O
disease B-Disease
development O
, O
but O
also O
epigenetic O
alterations O
as O
a O
response O
to O
disease B-Disease

Heart O
formation O
is O
a O
complex O
morphogenetic O
process O
regulated O
by O
both O
genetic O
and O
epigenetic O
mechanisms O

Rapid O
development O
in O
the O
sequencing O
technology O
also O
enabled O
the O
establishment O
of O
these O
genome-wide O
studies O

Then O
an O
overview O
of O
the O
epigenetic O
changes O
in O
response O
to O
maternal O
environment O
during O
the O
vulnerability O
time O
windows O
, O
gametogenesis O
, O
early O
development O
, O
placentation O
and O
foetal O
growth O
, O
and O
postnatal O
period O
, O
is O
described O
, O
with O
the O
specific O
example O
of O
overnutrition O
and O
food O
deprivation O

An O
epigenome-wide O
association O
study O
for O
early-life O
exposure O
to O
hunger O
was O
performed O
in O
a O
subgroup O
( O
n O
= O
2221 O
) O
with O
whole O
blood O
DNA O
methylation O
data O

001 O
) O
higher O
GAA O
, O
respectively O

osdd O

In O
this O
paper O
, O
we O
propose O
a O
novel O
formulation O
of O
SMCCA O
, O
called O
adaptive O
SMCCA O
, O
to O
overcome O
the O
problem O
by O
introducing O
adaptive O
weights O
when O
combining O
pairwise O
covariances O

697 O
: O
The O
molecular O
mechanisms O
involved O
in O
developmental O
biology O
and O
cellular O
differentiation O
have O
traditionally O
been O
considered O
to O
be O
primarily O
genetic O

Although O
sizable O
research O
has O
been O
carried O
out O
on O
this O
topic O
, O
most O
studies O
have O
been O
done O
on O
small-scale O
samples O
, O
and O
future O
research O
is O
required O
in O
larger O
samples O
with O
better O
clinical O
characterization O
of O
suicide O
phenotypes O
to O
investigate O
these O
epigenetic O
modifications O
further O

This O
can O
have O
direct O
consequences O
for O
the O
developing O
fetus O
and O
potentially O
even O
long-term O
health O
implications O

Chirality-induced O
spin O
selectivity O
filters O
electrons O
for O
their O
spin O
along O
DNA O
and O
, O
thus O
, O
is O
not O
only O
an O
indicator O
for O
quantum O
coherence O
but O
can O
potentially O
affect O
DNA O
binding O
properties O

Further O
, O
it O
may O
allow O
the O
gradual O
achievement O
of O
whole O
body O
rejuvenation O

Here O
we O
consider O
how O
single-cell O
epigenomic O
technologies O
may O
address O
the O
current O
challenges O
faced O
by O
cancer B-Disease
clinicians O

We O
applied O
weighted O
gene O
correlation O
network O
analysis O
(WGCNA) O
and O
the O
Comb-p O
algorithm O
to O
find O
methylation O
modules O
and O
regions O
associated O
with O
incident O
CVD O
in O
the O
WHI O
dataset O

593 O
: O
Introduction O
: O
Tendon O
is O
a O
composite O
material O
with O
a O
well-ordered O
hierarchical O
structure O
exhibiting O
viscoelastic O
properties O
designed O
to O
transfer O
force O

Perhaps O
a O
less O
obvious O
secondary O
problem O
is O
to O
confine O
this O
renewal O
such O
that O
any O
induced O
recalibration O
of O
cellular O
plasticity O
is O
kept O
within O
acceptable O
physiologic O
bounds O

By O
characterizing O
environmentally O
dependent O
epigenetic O
variation O
in O
natural O
populations O
, O
we O
will O
enhance O
our O
understanding O
of O
developmental O
, O
ecological O
, O
and O
evolutionary O
phenomena O

We O
also O
illustrate O
its O
coupling O
to O
an O
implemented O
"shotgun" O
workflow O
, O
by O
which O
heavy O
arginine-labeled O
histone O
peptides O
, O
produced O
upon O
Arg-C O
digestion O
, O
are O
qualitatively O
and O
quantitatively O
analyzed O
in O
an O
LC-MS/MS O
system O
that O
combines O
ultrahigh-pressure O
liquid O
chromatography O
(UHPLC) O
with O
new-generation O

Despite O
accumulating O
evidence O
for O
the O
significance O
of O
global O
DNA O
methylation O
reprogramming O
in O
certain O
cancer B-Disease
types O
including O
myeloid B-Disease
malignancies I-Disease
, O
none O
of O
the O
bioinformatic O
tools O
are O
designed O
to O
exploit O
subclonally O
reprogrammed O
methylation O
patterns O
to O
reveal O
constituent O
populations O
of O
a O
tumor B-Disease

However O
, O
in O
fisheries O
and O
population O
dynamics O
studies O
there O
is O
a O
need O
for O
accurate O
estimation O
of O
age O
, O
something O
that O
is O
often O
impossible O
for O
some O
economically O
important O
species O
with O
the O
currently O
available O
methods O

The O
emerging O
field O
of O
epigenetics O
is O
also O
providing O
further O
insights O
into O
these O
mechanisms O

Epigenetic O
signatures O
(DNA O
methylation O
, O
mRNA O
and O
microRNA O
expression O
, O
etc O
) O
may O
serve O
as O
biomarkers O
for O
risk O
stratification O
, O
early O
detection O
, O
and O
disease B-Disease
classification I-Disease
, O
as O
well O
as O
targets O
for O
therapy O
and O
chemoprevention O

423 O
: O
Overwhelming O
evidence O
suggests O
that O
in O
addition O
to O
the O
genetic O
changes O
of O
DNA O
mutations O
, O
epigenetic O
changes O
of O
DNA O
methylation O
and O
histone O
modifications O
play O
important O
role O
in O
regulation O
of O
gene O
expression O

Besides O
the O
global O
hypomethylation O
on O
lupus B-Disease
T O
and O
B O
cells O
, O
the O
gene O
specific O
and O
site-specific O
methylation O
has O
been O
identified O
and O
documented O
to O
be O
responsible O
for O
SLE O

Given O
the O
recent O
advent O
of O
ChIP-seq O
in O
planarians O
, O
we O
propose O
future O
avenues O
of O
research O
that O
will O
identify O
the O
genomic O
targets O
of O
these O
complexes O
allowing O
for O
a O
clearer O
picture O
of O
how O
neoblast O
processes O
are O
coordinated O
at O
the O
epigenetic O
level O

The O
ability O
to O
epigenetically O
modify O
and O
regulate O
genomes O
has O
contributed O
greatly O
to O
the O
diversity O
of O
eukaryotes O
observed O
today O

Elucidating O
these O
complex O
biosocial O
loops O
is O
one O
of O
the O
main O
challenges O
animating O
epigenetics O

Similarly O
, O
the O
refinement O
and O
maturation O
of O
chromatin O
immunoprecipitation O
with O
next-generation O
sequencing O
( O
ChIP-seq O
) O
has O
made O
possible O
genome-wide O
mapping O
of O
histone O
modifications O
, O
open O
chromatin O
, O
and O
transcription O
factor O
binding O
sites O

415 O
: O
Aims O
: O
To O
develop O
a O
computational O
resource O
for O
viral O
epigenomic O
methylation O
profiles O
from O
diverse O
diseases O

In O
this O
Review O
, O
we O
discuss O
recent O
evidence O
in O
support O
of O
a O
novel O
concept O
whereby O
cell-intrinsic O
damage O
that O
accumulates O
during O
ageing O
and O
cell-extrinsic O
changes O
in O
ageing O
stem O
cell O
niches O
and O
the O
blood O
result O
in O
modifications O
of O
the O
stem O
cell O
epigenome O

However O
, O
generating O
these O
predictors O
from O
original O
source O
software O
and O
web O
servers O
is O
complex O
and O
time O
consuming O

The O
combined O
searches O
yielded O
2265 O
records O

Further O
, O
epigenetics O
may O
lead O
, O
to O
the O
identification O
of O
novel O
biomarkers O
for O
diagnosis O
and O
for O
the O
monitoring O
of O
treatment O

It O
focuses O
on O
the O
biochemical O
mechanisms O
and O
epigenetic O
variants O
at O
the O
origin O
of O
disease B-Disease
, O
leading O
to O
novel O
biomedical O
means O
of O
assessing O
epigenetic O
susceptibility O
and O
reversing O
detrimental O
epigenetic O
variants O

However O
, O
it O
is O
not O
known O
whether O
these O
changes O
are O
causative O
or O
a O
consequence O
of O
an O
underlying O
ageing O
process O

The O
recommendations O
are O
in O
line O
with O
existing O
recommendations O
, O
most O
importantly O
the O
Human O
Genome O
Variation O
Society O
nomenclature O
, O
and O
should O
facilitate O
accurate O
reporting O
and O
data O
exchange O
among O
laboratories O
and O
thereby O
help O
to O
avoid O
future O
confusion O

A O
growing O
body O
of O
research O
has O
been O
focusing O
on O
the O
role O
of O
epigenetics O
and O
metabolomics O
in O
response O
to O
mood O
stabilizers O
, O
especially O
lithium O
salts O

In O
this O
chapter O
, O
we O
review O
the O
most O
recent O
findings O
in O
several O
molecular O
pathways O
linked O
with O
the O
pathogenesis O
of O
TLE O
that O
are O
controlled O
by O
epigenetic O
mechanisms O
highlighting O
their O
potential O
utility O
as O
biomarkers O
for O
upcoming O
treatment O
strategies O

Although O
the O
potential O
adverse O
effects O
of O
environmental O
chemicals O
are O
known O
to O
the O
scientific O
community O
, O
regulatory O
agencies O
, O
and O
the O
public O
, O
little O
is O
known O
about O
the O
mechanistic O
basis O
by O
which O
these O
chemicals O
can O
induce O
long-term O
or O
transgenerational O
effects O

We O
observe O
expression-level O
reductions O
in O
multiple O
replicates O
sorted O
for O
the O
lowest O
expression O
that O
persist O
for O
several O
days O
, O
even O
after O
lifting O
the O
selection O
pressure O

Furthermore O
, O
various O
diseases O
such O
as O
cancer B-Disease
have O
been O
found O
to O
be O
associated O
with O
epigenetic O
mechanisms O

Epigenetics O
is O
a O
mechanism O
that O
might O
explain O
the O
long-lasting O
effects O
of O
chemicals O
in O
an O
organism O
, O
and O
the O
formation O
of O
a O
predisposition O
to O
various O
diseases O

Comparison O
with O
existing O
methods O
: O
S3EQ O
accurately O
generates O
both O
RNA- O
and O
ChIP-seq O
from O
a O
single O
sample O
, O
providing O
a O
clear O
advantage O
over O
existing O
methods O
which O
require O
two O
samples O

In O
contrast O
, O
the O
epigenetic O
model O
of O
aging O
straightforwardly O
explains O
both O
biologic O
phenomena O

Despite O
the O
great O
diagnostic O
advances O
made O
in O
the O
past O
decade O
, O
the O
use O
of O
traditional O
diagnostic O
procedures O
only O
enables O
the O
tissue O
of O
origin O
to O
be O
determined O
in O
30% O
of O
patients O
with O
CUP O

001 O
) O
and O
a O
1-month O
( O
P O
&lt O
; O
0 O

Identification O
of O
their O
shared O
genes O
is O
just O
one O
small O
step O
in O
the O
link O
from O
genes O
to O
their O
physical O
and O
psychological O
profiles O

This O
body O
of O
work O
has O
linked O
the O
biological O
aging O
of O
MSC O
to O
changes O
in O
their O
epigenetic O
signatures O
affecting O
growth O
, O
lifespan O
, O
self-renewal O
and O
multi-potential O
, O
due O
to O
deregulation O
of O
processes O
such O
as O
cellular O
senescence B-Disease
, O
oxidative O
stress O
, O
DNA O
damage O

After O
a O
stint O
in O
the O
USA O
for O
her O
postdoc O
at O
University O
of O
California O
, O
San O
Francisco O
( O
UCSF O
) O
, O
Aydan O
was O
awarded O
the O
Sofja O
Kovalevskaja O
Award O
to O
move O
back O
to O
Europe O
in O
2018 O
to O
start O
her O
own O
lab O

Maximising O
the O
impact O
of O
RRBS O
in O
plants O
741 O
VI O

The O
abundance O
and O
distribution O
of O
covalent O
histone O
modifications O
in O
primary O
cancer B-Disease
tissues O
relative O
to O
normal O
cells O
is O
an O
important O
but O
largely O
uncharted O
area O
, O
although O
there O
is O
good O
evidence O
for O
a O
mechanistic O
role O
of O
cancer-specific O
alterations O
in O
histone O
modifications O
in O
tumor B-Disease
etiology O
, O
drug O

This O
review O
provides O
an O
overview O
of O
social O
epigenetics O
and O
highlights O
existing O
literature O
linking O
social O
exposures-i O

This O
review O
is O
devoted O
to O
elucidate O
the O
recent O
mechanistic O
advances O
in O
regulation O
of O
genes O
by O
epigenetic O
modification O
and O
emphasizes O
their O
possible O
role O
related O
to O
reproductive O
infertility O

, O
by O
DNA O
modifying O
enzymes O

To O
fill O
this O
gap O
, O
we O
conducted O
a O
comparison O
study O
in O
which O
we O
processed O
cord O
blood O
samples O
from O
four O
newborns O
in O
duplicates O
using O
both O
the O
Illumina O
HumanMethylationEPIC O
BeadChip O
and O
the O
Illumina O
TruSeq O
Methyl O
Capture O
EPIC O
Kit O
, O
and O
evaluated O
both O
platforms O
in O
regard O

Through O
extensive O
optimization O
for O
sensitivity O
and O
multimodality O
resolution O
, O
we O
demonstrate O
that O
uCoTarget O
enables O
simultaneous O
detection O
of O
five O
histone O
modifications O
( O
H3K27ac O
, O
H3K4me3 O
, O
H3K4me1 O
, O
H3K36me3 O
, O
and O
H3K27me3 O
) O
in O
19,860 O
single O
cells O

The O
change O
of O
structure O
is O
either O
open O
chromatin O
for O
" O
active O
" O
state O
or O
closed O
chromatin O
for O
" O
inactive O
" O
state O
, O
that O
regulates O
important O
biological O
phenomenon O
like O
chromatin O
condensation O
, O
gene O
expression O
, O
DNA O
repair O
, O
cellular O
development O
, O
differentiation O
and O
homeostasis O
, O
etc O

579 O
: O
We O
have O
developed O
a O
database O
called O
dbEM O
( O
database O
of O
Epigenetic O
Modifiers O
) O
to O
maintain O
the O
genomic O
information O
of O
about O
167 O
epigenetic O
modifiers/proteins O
, O
which O
are O
considered O
as O
potential O
cancer B-Disease
targets O

GLINT O
, O
which O
does O
not O
require O
any O
programming O
proficiency O
, O
allows O
an O
easy O
execution O
of O
Epigenome-Wide O
Association O
Study O
analysis O
pipeline O
under O
different O
models O
while O
accounting O
for O
known O
confounders O
in O
methylation O
data O

g O

Because O
the O
environment O
induces O
epiallelic O
change O
, O
removing O
the O
causative O
factor O
can O
reverse O
a O
context-dependent O
epigenetic O
state O

However O
, O
there O
is O
dispute O
, O
contention O
, O
and O
caution O
as O
well O
as O
enthusiasm O
among O
these O
research O
communities O

Altered O
DNA O
methylation O
dynamics O
are O
a O
conserved O
aspect O
of O
biological O
ageing O
and O
have O
recently O
been O
modelled O
to O
predict O
chronological O
age O
among O
vertebrate O
species O

Finally O
, O
we O
use O
our O
ASM O
datasets O
for O
functional O
interpretation O
of O
disease-associated O
loci O
and O
show O
the O
advantage O
of O
utilizing O
nave O
T O
cells O
for O
understanding O
autoimmune O
diseases O

In O
this O
chapter O
, O
the O
historical O
background O
to O
plant O
epigenetic O
and O
epigenomic O
research O
is O
summarized O
, O
and O
key O
considerations O
for O
the O
interpretation O
of O
current O
data O
are O
outlined O

Recent O
work O
has O
demonstrated O
that O
the O
epigenome O
is O
already O
rejuvenated O
by O
the O
maturation O
phase O
of O
somatic O
cell O
reprogramming O
, O
which O
suggests O
full O
reprogramming O
is O
not O
required O
to O
reverse O
ageing O
of O
somatic O
cells O

The O
authors O
summarize O
the O
presentations O
, O
which O
highlight O
how O
the O
complex O
interactions O
between O
genes O
and O
environment O
may O
in O
part O
be O
mediated O
through O
epigenetic O
changes O
and O
how O
information O
about O
nutritional O
and O
other O
environmental O
stimuli O
can O
be O
transmitted O
to O
the O
next O
generation O

Here O
, O
we O
review O
research O
related O
to O
three O
domains O
of O
environmental O
exposure O
that O
point O
to O
epigenetic O
contributions O
to O
health O
disparities O
: O
nutrition O
, O
psychosocial O
stress O
, O
and O
environmental O
toxicant O
exposure O

Genotyping O
by O
sequencing O
( O
GBS O
) O
of O
the O
same O
animals O
was O
performed O
to O
detect O
single O
nucleotide O
polymorphisms O
( O
SNPs O
) O
at O
cytosines O
in O
CpG O
dinucleotides O
and O
remove O
them O
from O
the O
differential O
methylation O
analysis O

Conversely O
, O
metabolites O
and O
cofactors O
affect O
the O
expression O
and O
activity O
of O
epigenetic O
regulators O

From O
a O
quantitative O
genetics O
perspective O
, O
the O
estimation O
of O
variance O
components O
is O
achieved O
by O
means O
of O
the O
information O
provided O
by O
the O
resemblance O
between O
relatives O

81 O
: O
Acute O
myeloid O
leukemia B-Disease
( O
AML O
) O
was O
one O
of O
the O
first O
cancers B-Disease
to O
be O
sequenced O
at O
the O
level O
of O
the O
whole O
genome O

Professor O
Randy O
Jirtle O
joined O
the O
Duke O
University O
Department O
of O
Radiology O
in O
1977 O
and O
headed O
the O
Epigenetics O
and O
Imprinting O
Laboratory O
until O
2012 O

747 O
: O
Asthma B-Disease
and O
other O
allergic B-Disease
diseases I-Disease
are O
among O
the O
most O
prevalent O
chronic O
non-communicable O
diseases O
of O
childhood O

Recent O
in O
vitro O
studies O
suggest O
that O
vitamin O
C O
at O
physiological O
concentrations O
, O
combined O
with O
hypomethylating O
agents O
may O
act O
synergistically O
to O
cause O
DNA O
demethylation O
through O
active O
and O
passive O
mechanisms O
, O
respectively O

449 O
: O
Molecular O
medicine O
is O
moving O
beyond O
genomics O
to O
encompass O
the O
new O
scientific O
field O
of O
epigenetics O

We O
also O
review O
epigenome-wide O
association O
studies O
that O
have O
been O
performed O
in O
various O
tissues O
examining O
relationships O
with O
osteoporosis B-Disease
and O
fracture O

The O
long-term O
health O
burden O
and O
societal O
economic O
impact O
of O
these O
conditions O
are O
substantial O
and O
will O
continue O
with O
increasingly O
prevalent O
diagnosis O

Chromatin-associated O
marks O
are O
informative O
to O
uncover O
altered O
regulatory O
regions O
and O
transcription O
factor O
networks O
contributing O
to O
the O
development O
of O
distinct O
lymphoid O
tumors B-Disease

148 O
: O
The O
temporal O
coding O
of O
action O
potential O
activity O
is O
fundamental O
to O
nervous B-Disease
system I-Disease
function O

While O
genetic O
risk O
of O
disease B-Disease
is O
currently O
unmodifiable O
, O
there O
is O
hope O
that O
epigenetic O
risk O
may O
be O
reversible O
and O
or O
modifiable O

The O
purpose O
of O
this O
review O
is O
to O
assist O
with O
proper O
experimental O
design O
and O
consistency O
of O
approach O
in O
future O
studies O
to O
enable O
a O
better O
understanding O
of O
the O
functional O
role O
of O
DNA O
methylation O
in O
immune-mediated O
disease B-Disease

Over O
the O
past O
decades O
, O
studies O
on O
epigenetic O
information O
, O
such O
as O
DNA O
methylation O
, O
histone O
modifications O
, O
chromatin O
accessibility O
, O
and O
chromatin O
conformation O
have O
shown O
that O
these O
properties O
play O
a O
fundamental O
role O
in O
gene O
regulation O

In O
this O
chapter O
we O
provide O
information O
on O
various O
epigenetic O
mechanisms O
and O
their O
role O
in O
carcinogenesis O
, O
in O
particular O
, O
epigenetic O
modifications O
causing O
genetic O
changes O
and O
the O
potential O
clinical O
impact O
of O
epigenetic O
research O
in O
the O
future O

Although O
defective O
gene O
regulation O
often O
affects O
oncogenic O
and O
tumour-suppressor O
networks O
, O
tumour B-Disease
immunogenicity O
and O
immune O
cells O
involved O
in O
antitumour O
responses O
may O
also O
be O
affected O
by O
epigenomic O
alterations O

215 O
: O
Epigenetic O
regulation O
plays O
a O
pivotal O
role O
in O
various O
biological O
and O
disease B-Disease
processes O

Deciphering O
the O
precise O
contribution O
of O
epigenetic O
factors O
to O
autoimmunity O
, O
and O
in O
particular O
to O
lupus B-Disease
, O
has O
become O
an O
active O
research O
area O

In O
this O
review O
, O
we O
provide O
an O
overview O
of O
epigenetics O
drug O
targets O
, O
focus O
on O
approaches O
used O
for O
initial O
hit O
identification O
, O
and O
describe O
the O
subsequent O
role O
of O
structure-guided O
chemistry O
optimisation O
of O
initial O
hits O
to O
clinical O
candidates O

Although O
it O
has O
been O
widely O
reported O
that O
aberrant O
DNA O
methylation O
and O
demethylation O
are O
associated O
with O
developmental O
defects O
and O
cancer B-Disease
, O
how O
these O
epigenetic O
changes O
directly O
contribute O
to O
the O
subsequent O
alteration O
in O
gene O
expression O
or O
disease B-Disease
progression O
remains O
unclear O
, O
largely O
owing O
to O
the O

HMEs O
were O
identified O
by O
applying O
a O
search O
pipeline O
built O
upon O
profile O
hidden O
Markov O
model O
( O
HMM O
) O
to O
proteomes O

Many O
cancers B-Disease
may O
remain O
asymptomatic O
until O
relatively O
late O
stages O
; O
in O
managing O
the O
disease B-Disease
, O
efforts O
should O
be O
focused O
on O
early O
detection O
, O
accurate O
prediction O
of O
disease B-Disease
progression O
, O
and O
frequent O
monitoring O

The O
three O
most O
age-informative O
cytosine O
markers O
were O
selected O
for O
a O
humpback O
epigenetic O
age O
assay O

e O

Increased O
understanding O
would O
also O
pave O
the O
way O
to O
developing O
innovative O
tests O
for O
better O
assessment O
of O
individual O
risk O
of O
bleeding O
or O
thrombosis O

This O
article O
presents O
findings O
from O
a O
simulation O
study O
that O
examined O
the O
degree O
of O
bias O
in O
estimates O
of O
heritability O
and O
environmentality O
when O
the O
genetic O
and O
epigenetic O
similarity O
of O
MZ O
twins O
differs O
from O
1 O

Chronic O
hyperglycemia B-Disease
induces O
epigenetic O
changes O
in O
multiple O
organs O
, O
contributing O
to O
diabetic B-Disease
complications O

For O
example O
, O
mapping O
of O
open O
chromatin O
regions O
, O
post-translational O
histone O
modifications O
and O
DNA O
methylation O
across O
a O
whole O
genome O
is O
now O
feasible O
, O
and O
new O
non-coding O
regulatory O
RNAs O
can O
be O
sensitively O
identified O
via O
RNA O
sequencing O

Currently O
, O
climate O
change O
is O
one O
of O
the O
most O
important O
drivers O
of O
freshwater O
transformation O
and O
its O
effects O
include O
changes O
in O
the O
composition O
, O
biodiversity O
and O
functioning O
of O
freshwater O
ecosystems O

Dr O
Peter O
W O
Laird O
is O
a O
Professor O
at O
Van O
Andel O
Institute O
(VAI) O
in O
Grand O
Rapids O
, O
Michigan O

The O
role O
of O
underlying O
epigenetic O
processes O
in O
generation O
of O
biological O
forms O
via O
similarity O
transformations O
is O
analyzed O
within O
the O
framework O
of O
D'Arcy O
Thompson O

doi O
: O
10 O

One O
question O
that O
is O
particularly O
intriguing O
ecologists O
is O
to O
what O
extent O
epigenetic O
variation O
is O
an O
additional O
, O
and O
hitherto O
overlooked O
, O
source O
of O
natural O
variation O
in O
ecologically O
important O
traits O

Epigenomic O
studies O
of O
hypertension B-Disease
are O
beginning O
to O
emerge O
and O
hold O
great O
promise O
of O
providing O
novel O
insights O
into O
the O
mechanisms O
underlying O
hypertension B-Disease

190:Tweetable O
The O
diagnostic O
application O
of O
genome-wide O
methylation O
signatures O
is O
increasing O
in O
various O
syndromic O
forms O
of O
autism B-Disease
, O
but O
further O
studies O
are O
warranted O
to O
clarify O
whether O
epigenetic O
biomarkers O
can O
be O
of O
diagnostic O
utility O
in O
idiopathic O
ASD O

1002 O
/ O
wsbm O

Members O
from O
the O
three O
families O
of O
epigenetic O
proteins O
( O
readers O
, O
writers O
, O
and O
erasers O
) O
have O
been O
shown O
to O
be O
druggable O
using O
small-molecule O
inhibitors O

There O
are O
two O
possible O
ways O
by O
which O
arsenic O
may O
modify O
the O
epigenome-indirectly O
through O
an O
arsenic-induced O
generation O
of O
reactive O
oxygen O
species O
which O
then O
impacts O
chromatin O
remodelers O
, O
or O
directly O
through O
interaction O
and O
modulation O
of O
chromatin O
remodelers O

Here O
, O
we O
will O
review O
the O
evidence O
and O
molecular O
mechanisms O
that O
link O
5mC O
with O
the O
activity O
of O
enhancers O

Epigenetics O
research O
holds O
the O
key O
to O
understanding O
how O
environmental O
factors O
contribute O
to O
phenotypic O
variation O
in O
traits O
of O
economic O
importance O
in O
cattle O
including O
development O
, O
nutrition O
, O
behaviour O
and O
health O

In O
addition O
, O
they O
have O
the O
ability O
to O
potentially O
expand O
the O
range O
of O
screening O
conditions O
from O
often O
limited O
amounts O
of O
valuable O
sample O
, O
as O
well O
as O
reduce O
the O
usage O
of O
expensive O
reagents O

Methods O
are O
provided O
for O
identifying O
genomic O
locus O
and O
sequence O
information O
using O
gene O
names O
or O
codes O
, O
identifiers O
for O
DNA O
and O
RNA O
molecules O
and O
proteins O
; O
also O
from O
karyotype O
bands O
, O
chromosomal O
coordinates O
, O
sequences O
, O
motifs O
, O
and O
matrix-based O
patterns O

This O
study O
evaluated O
the O
evidence O
for O
-cell O
dedifferentiation O
in O
T2D O
, O
and O
T2D O
and O
examined O
experimental O
systems O
in O
which O
its O
mechanisms O
may O
be O
studied O

139 O
: O
Human O
genetic O
variation O
is O
a O
major O
resource O
in O
forensics O
, O
but O
does O
not O
allow O
all O
forensically O
relevant O
questions O
to O
be O
answered O

Moreover O
, O
epigenetics O
implies O
overcoming O
classical O
dualist O
dichotomies O
such O
as O
nature-nurture O
, O
genotype-phenotype O
or O
pathogenesis-pathoplasty O

We O
integrate O
these O
published O
methods O
into O
a O
single O
R O
function O
to O
produce O
158 O
previously O
published O
predictors O
for O
chronological O
age O
, O
biological O
age O
, O
exposures O
, O
lifestyle O
traits O
and O
serum O
protein O
levels O
using O
both O
classical O
and O
principal O
component-based O
methods O

Here O
we O
provide O
an O
integrated O
framework O
to O
address O
this O
question O

A O
literature O
search O
was O
conducted O
for O
the O
most O
pertinent O
articles O
on O
the O
epigenetic O
effects O
of O
famine O

830 O
for O
the O
discriminating O
model O
, O
outperforming O
inverse O
docking O
in O
predicting O
protein-ligand O
interactions O

Finally O
, O
we O
demonstrate O
the O
added O
value O
of O
EpiDISH O
in O
an O
EWAS O
of O
smoking O

We O
performed O
a O
literature O
review O
to O
identify O
parameters O
, O
which O
might O
be O
of O
relevance O
for O
the O
prediction O
of O
chronological O
age O
based O
on O
DNA O
methylation O

As O
programs O
scale O
to O
evaluate O
many O
new O
targets O
related O
to O
epigenetic O
expression O
, O
new O
tools O
and O
techniques O
are O
required O
to O
enable O
efficient O
and O
reproducible O
high-throughput O
epigenetic O
screening O

44 O
: O
Aging O
is O
associated O
with O
a O
wide O
range O
of O
human O
disorders O
, O
including O
cancer B-Disease
, O
diabetes B-Disease
, O
cardiovascular O
, O
and O
neurodegenerative B-Disease
diseases I-Disease

Next O
, O
findings O
from O
the O
nondental O
literature O
are O
drawn O
on O
to O
elaborate O
the O
pathways O
and O
mechanisms O
that O
link O
the O
socio-exposome O
with O
gene O
expression-or O
the O
biological O
embedding O
of O
social O
experiences O
through O
epigenetics O

Two O
specific O
types O
of O
epigenetic O
regulation O
established O
in O
early O
development O
include O
X-chromosome O
inactivation O
and O
genomic O
imprinting O
; O
they O
regulate O
gene O
expression O
in O
a O
dosage-dependent O
and O
parent-of-origin-specific O
manner O
, O
respectively O

While O
the O
evidence O
supporting O
this O
hypothesis O
is O
limited O
and O
primarily O
based O
on O
the O
epigenetic O
profiling O
of O
psychotic B-Disease
patients I-Disease
and O
animal O
models O
, O
further O
investigation O
in O
this O
area O
is O
warranted O
and O
may O
bring O
exciting O
results O

Study O
of O
DNA O
methylation O
has O
been O
an O
active O
field O
in O
cancer B-Disease
epigenomics O
research O

71 O
: O
As O
one O
of O
the O
most O
abundant O
and O
well-studied O
epigenetic O
modifications O
, O
DNA O
methylation O
plays O
an O
essential O
role O
in O
normal O
development O
and O
cellular O
biology O

org O
/ O
packages O
/ O
ChIPseeker O

In O
vivo O
partial O
reprogramming O
holds O
great O
promise O
as O
a O
possible O
therapy O
, O
but O
several O
limitations O
remain O

The O
major O
finding O
of O
our O
experiment O
was O
the O
significantly O
enhanced O
performance O
of O
the O
S-group O
over O
the O
control O
, O
suggesting O
that O
the O
Sandwich O
Model O
improves O
learning O
gain O

Here O
, O
we O
review O
the O
growing O
knowledge O
base O
of O
gene-regulatory O
mechanisms O
and O
describe O
their O
links O
to O
phenotype O
, O
proposing O
strategies O
to O
address O
widely O
recognized O
challenges O

This O
review O
examines O
recent O
studies O
of O
the O
ASD O
epigenome O
, O
detailing O
common O
gene O
pathways O
found O
to O
be O
differentially O
methylated O
in O
people O
with O
ASD O
, O
and O
considers O
how O
these O
discoveries O
may O
inform O
our O
understanding O
of O
ASD O
etiology O

Ever O
use O
of O
marijuana O
and O
each O
additional O
marijuana-year O
were O
associated O
with O
a O
6-month O
( O
P O
< O
0 O

bioconductor O

Materials O
& O
methods O
: O
Methylation O
patterns O
of O
Epstein-Barr O
virus B-Disease
and O
hepatitis O
B O
virus B-Disease
genomic O
regions O
are O
provided O
as O
web O
platform O
developed O
using O
open O
source O
Linux-Apache-MySQL-PHP O
( O
LAMP O
) O
bundle O
: O
programming O
and O
scripting O
languages O
, O
that O
is O
, O
HTML O
, O

These O
epigenomic O
data O
can O
be O
analyzed O
by O
a O
large O
number O
of O
bioinformatics O
tools O
and O
software O

The O
idea O
that O
aging O
is O
an O
epigenetic O
program O
has O
propitious O
implications O
for O
the O
feasibility O
of O
medical O
rejuvenation O

Growing O
evidence O
is O
available O
that O
the O
health O
and O
phenotype O
of O
a O
given O
individual O
is O
already O
shaped O
shortly O
before O
and O
after O
the O
time O
of O
conception O

In O
this O
review O
, O
the O
authors O
discuss O
the O
expanding O
landscape O
of O
epigenetic O
modifications O
and O
highlight O
their O
importance O
for O
future O
understanding O
of O
disease B-Disease

643 O
: O
Urothelial O
carcinoma O
is O
the O
most O
frequent O
type O
of O
bladder O
cancer B-Disease

The O
interest O
in O
epigenetics O
has O
increased O
during O
the O
last O
few O
years O
due O
to O
fundamental O
discoveries O
made O
in O
molecular O
and O
behavioral O
genetics O
, O
although O
within O
this O
framework O
factual O
knowledge O
coexists O
with O
fictional O
expectations O
and O
wrong O
concepts O

Cartilage O
has O
been O
the O
most O
widely O
studied O
tissue O
in O
OA O
, O
and O
differential O
methylation O
of O
genes O
involved O
in O
inflammation B-Disease
, O
cell O
cycle O
, O
TGF O
, O
and O
HOX O
genes O
have O
been O
confirmed O
several O
times O

Small O
-molecule O
inhibitors O
of O
these O
epigenetic O
modifying O
enzymes O
are O
known O
as O
epigenetic O
drugs O
(epi-drugs) O
, O
which O
can O
cause O
programmed O
death B-Disease
of O
tumor B-Disease
cells O
by O
affecting O
the O
cell O
cycle O
, O
angiogenesis O
, O
proliferation O
, O
and O
migration O

Epigenetic O
interactions O
included O
( O
i O
) O
drug-induced O
modulation O
of O
DNA O
methylation O
, O
( O
ii O
) O
drug-induced O
modulation O
of O
histone O
conformations O
, O
and O
( O
iii O
) O
epigenetic O
modulation O
of O
drug O
effects O
by O
interference O
with O
pharmacokinetics O
or O
pharmacodynamics O

These O
results O
will O
provide O
the O
key O
to O
understanding O
the O
mechanism O
underlying O
allelic O
heterogeneity B-Disease

Key O
to O
this O
are O
new O
discoveries O
about O
the O
fitness O
costs O
associated O
with O
DNA O
methylation O
, O
and O
new O
theories O
about O
how O
the O
fundamental O
biochemical O
mechanisms O
of O
DNA O
methylation O
introduction O
and O
maintenance O
could O
explain O
how O
new O
genome-wide O
patterns O
of O
methylation O
evolve O

org O
/ O
packages O
/ O
COCOA O
) O

Additionally O
, O
pre-analytical O
treatments O
and O
storage O
might O
introduce O
biases O
and O
fragmentation O
to O
the O
DNA O

Epigenome-wide O
analysis O
was O
performed O
from O
t0 O
and O
t1 O
saliva O
using O
the O
Illumina O
EPIC O
arrays O
that O
cover O
>860k O
probes O

Revealing O
tumor B-Disease
clonal O
complexity O
in O
an O
integrative O
and O
quantitative O
manner O
facilitates O
improved O
mutational O
characterization O
, O
understanding O
, O
and O
therapeutic O
assignments O

135 O
: O
Epigenetics O
is O
the O
study O
of O
changes O
in O
gene O
expression O
that O
occur O
without O
changes O
in O
DNA O
sequence O

The O
survey O
included O
questions O
on O
knowledge O
of O
epigenetics O
and O
perceptions O
of O
epigenetic O
concepts O
for O
self O
and O
for O
children O

, O
neural O
tube O
development O
, O
are O
detected O
by O
our O
model O
, O
demonstrating O
imaging O
epigenetic O
association O
may O
be O
overlooked O
by O
conventional O
SMCCA O

483 O
: O
High-throughput O
genomic O
sequencing O
and O
quantitative O
mass O
spectrometry O
(MS)-based O
proteomics O
technology O
have O
recently O
emerged O
as O
powerful O
tools O
, O
increasing O
our O
understanding O
of O
chromatin O
structure O
and O
function O

Advances O
in O
genetics O
have O
identified O
novel O
pathways O
and O
targets O
that O
operate O
in O
numerous O
diseases O
, O
paving O
the O
way O
for O
' O
precision O
medicine O
' O

269 O
: O
Cancer B-Disease
is O
a O
set O
of O
diseases O
that O
exhibit O
not O
only O
genetic O
mutations O
but O
also O
a O
profoundly O
distorted O
epigenetic O
landscape O

Millions O
of O
people O
worldwide O
are O
chronically O
exposed O
to O
arsenic O
through O
drinking O
water O
and O
food O

DNA O
methylation O
valleys O
exhibit O
elevated O
conservation O
and O
high O
transcription O
factor O
binding O

The O
unique O
biology O
of O
planarians O
will O
also O
allow O
us O
to O
investigate O
how O
extracellular O
signals O
feed O
into O
epigenetic O
regulatory O
networks O
to O
govern O
concerted O
neoblast O
responses O
during O
regenerative O
polarity O
, O
tissue O
patterning O
, O
and O
remodelling O

It O
is O
becoming O
increasingly O
clear O
that O
epigenetic O
mechanisms O
operate O
at O
the O
interface O
between O
the O
genetic O
code O
and O
our O
environment O
, O
and O
a O
large O
body O
of O
existing O
evidence O
supports O
the O
importance O
of O
environmental O
factors O
such O
as O
diet O
and O
nutrition O
, O
infections B-Disease
, O
and O
exposure O
to O
toxins O

In O
majority O
of O
the O
disorders O
, O
dysregulated O
OCG O
was O
noted O
to O
occur O
at O
the O
stage O
of O
formation O
of O
committed O
osteoclast O
from O
preosteoclast O

https O
: O
/ O
/ O
doi O

29 O
: O
Mechanistically O
, O
how O
epigenetic O
states O
are O
inherited O
through O
cellular O
divisions O
remains O
an O
important O
open O
question O
in O
the O
chromatin O
field O
and O
beyond O

These O
in O
turn O
are O
associated O
with O
various O
health O
conditions O
in O
different O
age O
groups O
and O
populations O

This O
chapter O
focuses O
on O
the O
causes O
and O
impact O
of O
DNA O
hypomethylation O
in O
the O
development O
of O
cancer B-Disease
and O
describes O
the O
possible O
ways O
to O
pharmacologically O
target O
it O
, O
especially O
by O
using O
a O
naturally O
occurring O
physiologic O
agent O
S-adenosylmethionine O
( O
SAM O
) O

Conflict O
of O
interest O
: O
The O
authors O
have O
declared O
no O
conflicts O
of O
interest O
for O
this O
article O

Although O
most O
of O
the O
observed O
epigenetic O
variation O
was O
additive O
and O
had O
a O
strong O
genetic O
component O
, O
we O
also O
found O
a O
small O
percentage O
of O
non-additive O
, O
potentially O
stochastic O
, O
methylation O
differences O
that O
might O
act O
as O
an O
evolutionary O
bet-hedging O
strategy O
and O
increase O
fitness O
under O
environmental O
instability O

170 O
: O
Background O
: O
Infinium O
Human O
Methylation O
BeadChip O
is O
an O
array O
platform O
for O
complex O
evaluation O
of O
DNA O
methylation O
at O
an O
individual O
CpG O
locus O
in O
the O
human O
genome O
based O
on O
Illumina O
's O
bead O
technology O
and O
is O
one O
of O
the O
most O
common O
techniques O
used O
in O
epigenome-wide O
association O

An O
emerging O
topic O
that O
promises O
to O
reveal O
new O
insights O
is O
the O
interaction O
between O
epigenetics O
and O
metabolism O


Dysregulation O
of O
gene O
expression O
and O
, O
more O
generally O
, O
genome O
organization O
and O
function O
are O
thought O
to O
contribute O
to O
age-related O
declines O
in O
cognition O

Although O
most O
mental O
diseases O
are O
influenced O
by O
genetic O
and O
environmental O
factors O
, O
finding O
genetic O
biomarkers O
that O
predict O
treatment O
efficacy O
has O
been O
challenging O

A O
progressive O
understanding O
of O
normal O
bone O
metabolism O
and O
the O
role O
of O
epigenetic O
mechanisms O
in O
multifactorial O
osteopathy O
can O
help O
us O
better O
understand O
the O
etiology O
of O
the O
disease B-Disease
and O
convert O
this O
information O
into O
clinical O
practice O

Allele O
- O
specific O
expression O
has O
been O
thought O
to O
be O
restricted O
to O
a O
few O
specific O
classes O
of O
genes O

Whereas O
previously O
separate O
experiments O
were O
required O
to O
study O
either O
epigenetic O
marking O
, O
cfNOMe O
delivers O
reliable O
results O
for O
both O
, O
enabling O
more O
comprehensive O
and O
inexpensive O
epigenetic O
cfDNA O
profiling O

Indeed O
, O
progress O
in O
understanding O
gene O
regulation O
at O
promoter O
regions O
and O
chromatin O
organization O
in O
health O
and O
disease B-Disease
has O
been O
substantial O

Based O
on O
current O
research O
, O
the O
main O
risk O
factor O
for O
LCNS O
may O
be O
air O
pollution O

Despite O
the O
wide O
variety O
of O
analytical O
techniques O
that O
have O
been O
developed O
to O
detect O
DNA O
modifications O
, O
their O
investigation O
at O
the O
single-genome O
level O
is O
only O
beginning O
to O
emerge O

Rather O
, O
molecular O
mechanisms O
of O
epigenetic O
inheritance O
are O
highly O
variable O
between O
species O

Meanwhile O
, O
research O
on O
other O
base O
modifications O
, O
including O
6-methyladenine O
and O
4-methylcytosine O
that O
are O
frequent O
in O
prokaryotes O
, O
has O
been O
impeded O
by O
the O
lack O
of O
a O
comparable O
technique O

Epigenetic O
regulatory O
mechanisms O
are O
a O
heritable O
change O
in O
a O
sequence O
of O
stable O
but O
reversible O
gene O
function O
modification O
yet O
do O
not O
affect O
the O
DNA O
primary O
sequence O
directly O


Taking O
the O
OsMET1-2 O
mutants O
and O
its O
isogenic O
wild-type O
rice O
plants O
as O
experimental O
materials O
, O
this O
course O
has O
successfully O
demonstrated O
a O
causal O
link O
between O
genetic O
mutation O
and O
epigenetic O
variation O
, O
a O
topic O
widely O
interested O
by O
the O
students O
in O
learning O
genetics O
and O
epigenetics O

To O
bridge O
this O
gap O
, O
we O
developed O
a O
tool O
for O
mapping O
and O
quantification O
of O
methylation O
differences O
at O
candidate O
genomic O
features O
of O
interest O
, O
without O
using O
coding O

At O
this O
time O
in O
the O
annals O
of O
epigentics O
research O
, O
it O
is O
appropriate O
to O
revisit O
some O
of O
the O
important O
discoveries O
that O
have O
helped O
advance O
the O
field O
to O
its O
current O
state O

49 O
: O
The O
heart O
is O
the O
first O
organ O
to O
be O
functional O
in O
the O
fetus O

e O

48 O
: O
Advances O
in O
molecular O
biology O
technologies O
have O
allowed O
uncovering O
the O
role O
of O
epigenetic O
regulation O
in O
several O
complex O
diseases O
, O
such O
as O
cancer B-Disease
and O
neurodegenerative B-Disease
disorders I-Disease

This O
disturbing O
pro-Lysenko O
movement O
, O
which O
is O
accompanied O
by O
a O
growing O
sympathy O
for O
Stalin O
, O
claims O
to O
have O
its O
scientific O
roots O
in O
modern O
epigenetics O
, O
specifically O
the O
heritability O
of O
variation O
by O
mechanisms O
other O
than O
changes O
in O
DNA O
sequence O

The O
examples O
are O
in O
the O
form O
of O
breast B-Disease
cancer I-Disease
case O
studies O
, O
and O
the O
data O
sets O
were O
procured O
from O
the O
public O
repository O
Gene O
Expression O
Omnibus O

Large O
- O
scale O
numerical O
experiments O
show O
that O
adaptive O
SMCCA O
converges O
as O
fast O
as O
conventional O
SMCCA O

Overlapping O
genes O
in O
comparison O
1 O
were O
involved O
in O
processes O
like O
limb O
morphogenesis O
and O
phenotypes O
like O
abnormal O
jaw O
morphology O
and O
hypopigmentation O

Cancer B-Disease
-induced O
metabolic O
changes O
alter O
the O
epigenetic O
landscape O
, O
especially O
modifications O
on O
histones O
and O
DNA O
, O
thereby O
promoting O
malignant O
transformation O
, O
adaptation O
to O
inadequate O
nutrition O
, O
and O
metastasis O

Furthermore O
, O
some O
research O
in O
individuals O
with O
anorexia O
nervosa O
suggests O
the O
presence O
of O
reversible O
, O
malnutrition-induced O
epigenetic O
alterations O
that O
' O
reset O
' O
as O
patients O
recover O

As O
such O
, O
it O
is O
likely O
that O
a O
threshold O
for O
cumulative O
risk O
may O
exist O
that O
, O
if O
surpassed O
, O
culminates O
in O
a O
predisposition O
to O
disease B-Disease
and O
ultimately O
an O
observed O
phenotype O
in O
offspring O

The O
serum O
levels O
of O
these O
and O
other O
hormones O
are O
associated O
with O
three O
specific O
phases O
that O
compose O
the O
endometrial O
cycle O
: O
menstrual O
, O
proliferative O
, O
and O
secretory O

The O
percent O
methylation O
at O
each O
CpG O
site O
was O
determined O
, O
and O
then O
agglomerative O
hierarchical O
cluster O
analysis O
was O
used O
to O
create O
a O
model O
to O
indicate O
sample O
origin O

In O
this O
article O
, O
I O
report O
from O
Select O
Biosciences O
Epigenetics O
Europe O
2010 O
industry O
conference O
held O
on O
14-15 O
September O
2010 O
at O
The O
Burlington O
Hotel O
, O
Dublin O
, O
Ireland O

However O
, O
the O
range O
of O
DNA O
methylation O
profiling O
techniques O
can O
make O
selecting O
the O
appropriate O
protocol O
a O
challenge O


The O
high O
sensitivity O
of O
the O
UHPLC-MS/MS O
methodology O
and O
the O
use O
of O
calibration O
standards O
of O
pure O
nucleosides O
allow O
for O
the O
accurate O
quantification O
of O
DNA O
methylation O

Specifically O
, O
complexification O
can O
be O
defined O
as O
producing O
, O
stabilizing O
, O
and O
normalizing O
novel O
experimental O
systems O
that O
are O
supposed O
to O
improve O
techno-scientific O
enactments O
of O
complexity O

Here O
we O
review O
latest O
findings O
on O
chromatin O
related O
mechanisms O
and O
hypothesize O
how O
their O
impairment O
might O
contribute O
to O
the O
altered O
epigenome O
of O
cancer B-Disease
cells O

As O
such O
, O
epigenetic O
drugs O
comprise O
an O
important O
new O
field O
in O
cancer B-Disease
therapy O
; O
however O
, O
drug O
development O
is O
a O
high-cost O
and O
time-consuming O
procedure O

However O
, O
the O
epigenome O
and O
metabolome O
are O
both O
highly O
complex O
and O
dynamic O
biological O
networks O
in O
vivo O

Despite O
the O
very O
different O
organisms O
and O
biological O
processes O
investigated O
, O
the O
overarching O
question O
has O
been O
if O
and O
how O
an O
organism O
's O
epigenome O
registers O
and O
records O
external O
cues O
and O
relays O
this O
information O
to O
its O
progeny O

More O
broadly O
, O
the O
article O
suggests O
the O
relevance O
of O
a O
sociology O
of O
complexification O
for O
STS O
approaches O
to O
complexity O
in O
scientific O
practices O

99 O
: O
In O
this O
interview O
, O
Professor O
Moshe O
Szyf O
speaks O
with O
Storm O
Johnson O
, O
Commissioning O
Editor O
for O
Epigenomics O
, O
on O
his O
work O
to O
date O
in O
the O
field O
of O
social O
epigenetics O

This O
review O
will O
explore O
new O
insights O
into O
the O
established O
therapeutic O
paradigms O
targeting O
oxidative O
stress O
, O
inflammation B-Disease
and O
endoplasmic O
reticulum O
stress O
with O
the O
focus O
on O
recent O
clinical O
developments O

Beyond O
genetic O
alterations O
, O
lymphoid O
tumors B-Disease
also O
show O
widespread O
epigenomic O
changes O

Recently O
, O
accumulating O
evidence O
has O
indicated O
that O
immune-related O
pathways O
are O
epigenetically O
dysregulated O
in O
cancer B-Disease

Implications O
for O
preventive O
intervention O
are O
discussed O

Various O
epigenetic O
mechanisms O
may O
also O
be O
involved O
in O
the O
pathogenesis O
of O
preeclampsia O
and O
intrauterine O
growth O
restriction O

The O
main O
mechanisms O
in O
epigenetics O
are O
DNA O
methylation O
, O
histone O
modifications O
, O
and O
non-coding O
RNAs O
( O
ncRNAs O
) O

Therefore O
, O
application O
of O
diagnostic O
assays O
to O
detect O
epigenetic O
alterations O
will O
provide O
new O
insight O
into O
the O
characterization O
and O
treatment O
of O
neurodevelopmental O
disorders O

Although O
the O
two O
subspecies O
have O
been O
characterized O
and O
compared O
at O
genome-wide O
level O
and O
at O
specific O
loci O
, O
their O
epigenetic O
diversity O
has O
not O
yet O
been O
explored O

No O
significant O
associations O
were O
estimated O
for O
PhenoAge O
acceleration O

A O
small O
pool O
of O
hematopoietic O
stem O
cells O
( O
HSCs O
) O
in O
the O
bone O
marrow O
is O
responsible O
for O
the O
lifetime O
maintenance O
of O
these O
populations O

454 O
: O
Selection O
of O
agricultural O
animals O
for O
improved O
performance O
based O
on O
genetics O
has O
seen O
significant O
progress O
made O
over O
the O
past O
few O
decades O

i O
FACE O
is O
based O
on O
time O
series O
analysis O
of O
intraindividual O
variation O
of O
a O
single O
pair O
of O
genetically O
related O
subjects O

Moreover O
, O
we O
consider O
the O
Jensen-Shannon O
distance O
between O
sample-specific O
energy O
landscapes O
as O
a O
measure O
of O
epigenetic O
dissimilarity O
and O
demonstrate O
its O
effectiveness O
for O
discerning O
epigenetic O
differences O

Known O
as O
epigenetic O
mechanisms O
, O
these O
include O
DNA O
methylation O
, O
chromatin O
conformational O
changes O
through O
histone O
modifications O
, O
ncRNAs O
and O
, O
most O
recently O
, O
5-hydroxymethylcytosine O

However O
, O
although O
evolution O
by O
natural O
selection O
requires O
new O
heritable O
traits O
to O
be O
produced O
and O
transmitted O
, O
it O
does O
not O
prescribe O
, O
per O
se O
, O
the O
mechanisms O
by O
which O
this O
is O
operated O

Here O
, O
we O
describe O
the O
importance O
of O
including O
epigenetics O
in O
genetic O
and O
environmental O
epidemiology O
studies O
, O
provide O
a O
conceptual O
framework O
when O
considering O
epigenetic O
data O
in O
population-based O
studies O
and O
touch O
upon O
the O
many O
challenges O
that O
lie O
ahead O

28 O
: O
Dysregulation O
of O
the O
epigenome O
drives O
aberrant O
transcriptional O
programmes O
that O
promote O
cancer B-Disease
onset O
and O
progression O

720 O
: O
Accurate O
detection O
of O
epimutations O
in O
tumor B-Disease
cells O
is O
crucial O
for O
- O
understanding O
the O
molecular O
pathogenesis O
of O
cancer B-Disease

334 O
: O
The O
concept O
of O
intergenerational O
transmission O
of O
trauma B-Disease
plays O
a O
fundamental O
role O
in O
psychoanalysis O

320 O
: O
DNA O
methylation O
serves O
to O
mark O
DNA O
as O
either O
a O
directed O
epigenetic O
signaling O
modification O
or O
in O
response O
to O
DNA O
lesions O

612 O
: O
In O
a O
recent O
article O
in O
this O
journal O
, O
A O

com O
/ O
david O
- O
juan O
/ O
ChromDet O

We O
explore O
genetic O
and O
genomic O
technologies O
and O
the O
potential O
of O
analyzing O
individual-specific O
drug O
metabolism O
to O
predict O
and O
influence O
drug O
response O
and O
associated O
clinical O
outcomes O

We O
examine O
methodological O
considerations O
, O
how O
best O
to O
conduct O
preprocessing O
and O
analysis O
of O
DNA O
methylation O
data O
sets O
, O
and O
the O
latest O
methods O
, O
technologies O
and O
discoveries O
in O
this O
rapidly O
advancing O
field O

524 O
: O
Genetic O
studies O
of O
epigenetic O
modifiers O
such O
as O
DNA O
methyltransferases O
and O
histone O
acetyltransferases O
have O
revealed O
a O
critical O
role O
for O
epigenetic O
regulation O
during O
brain O
development O
and O
function O

He O
is O
the O
Founding O
Director O
of O
the O
Center O
for O
Environmental O
Health O
and O
Technology O
and O
Head O
of O
the O
Environmental O
Health O
Section O
at O
the O
Department O
of O
Epidemiology O

The O
protocol O
consists O
of O
the O
following O
major O
steps O
: O
bisulfite O
conversion O
of O
non-methylated O
cytosines O
to O
uracils O
, O
the O
locus-specific O
PCR O
amplification O
of O
converted O
DNA O
, O
restriction O
digestion O
, O
the O
analysis O
of O
restriction O
patterns O
on O
the O
gel O
, O
and O
the O
quantification O
of O
these O
restriction O
patterns O
using O

162 O
: O
Dissecting O
intercellular O
epigenetic O
differences O
is O
key O
to O
understanding O
tissue O
heterogeneity B-Disease

Interestingly O
, O
this O
epigenetic O
variation O
is O
significantly O
correlated O
with O
long-term O
differences O
in O
herbivory O
, O
but O
only O
weakly O
with O
herbivory-related O
DNA O
sequence O
variation O
, O
which O
suggests O
that O
besides O
habitat O
, O
substrate O
and O
genetic O
variation O
, O
epigenetic O
variation O
may O
be O
an O
additional O
, O
and O
at O

The O
present O
paper O
focuses O
on O
recent O
research O
suggesting O
a O
direct O
correlation O
between O
psychological O
trauma B-Disease
and O
DNA O
modifications O

Availability O
and O
implementation O
: O
GLINT O
is O
a O
command-line O
software O
, O
freely O
available O
at O
https O
: O
/ O
/ O
github O

With O
the O
benefits O
of O
high O
efficiency O
and O
sensitivity O
in O
DPI O
analysis O
, O
the O
system O
provides O
great O
promise O
in O
studying O
epigenetic O
regulation O
during O
various O
biological O
processes O

These O
findings O
highlight O
gene O
regulatory O
mechanisms O
at O
both O
cell-specific O
and O
systemic O
levels O
that O
may O
be O
involved O
in O
fetal O
immune O
system O
maturation O

In O
particular O
, O
ecological O
epigenetics O
has O
the O
potential O
to O
explain O
how O
populations O
endure O
( O
or O
fail O
to O
endure O
) O
profound O
and O
rapid O
environmental O
change O

7 O
: O
Food O
allergy O
is O
a O
global O
health O
problem O
, O
particularly O
in O
developed O
countries O

While O
the O
earliest O
approaches O
were O
nonspecific O
and O
were O
at O
best O
useful O
for O
quantification O
of O
total O
methylated O
cytosines O
in O
the O
chunk O
of O
DNA O
, O
this O
field O
has O
seen O
considerable O
progress O
and O
development O
over O
the O
past O
decades O

Today O
, O
clarification O
of O
this O
issue O
is O
more O
pressing O
than O
ever O
because O
profiling O
efforts O
and O
epigenome-wide O
association O
studies O
( O
EWAS O
) O
continuously O
provide O
comprehensive O
datasets O
depicting O
epigenomic O
differences O
between O
tissues O
and O
disease B-Disease
states O

We O
developed O
a O
software O
package O
called O
MethLAB O
( O
http://genetics O

Analysis O
of O
DNA O
modification O
patterns O
relies O
increasingly O
on O
sequencing-based O
profiling O
methods O

The O
developmental O
systems O
perspective O
offers O
a O
distinctive O
, O
coherent O
, O
integrative O
way O
to O
understand O
the O
relationships O
between O
evolution O
, O
epigenetics O
, O
development O
, O
and O
the O
effects O
of O
experienced O
contexts O

They O
can O
be O
inherited O
from O
one O
generation O
to O
the O
next O

DNA O
methylation O
could O
not O
explain O
this O
association O

This O
review O
provides O
important O
insights O
into O
the O
advanced O
epigenetic O
pathways O
to O
improve O
plant O
tolerance O
to O
toxic O
heavy O
metals O
and O
metalloid O
stress O

325 O
: O
Chromatin O
Immunoprecipitation O
( O
ChIP O
) O
is O
a O
method O
used O
to O
detect O
DNA-protein O
interactions O
in O
vivo O

In O
this O
chapter O
, O
we O
attempt O
to O
discuss O
the O
mechanisms O
underpinning O
the O
metabolic O
and O
epigenetic O
interplay O
in O
immune O
cells O
of O
the O
TME O
and O
how O
modulating O
these O
events O
can O
boost O
the O
application O
of O
existing O
anticancer O
immunotherapy O

This O
new O
field O
of O
research O
has O
been O
dubbed O
"epitranscriptomics" O
, O
in O
analogy O
to O
best-known O
epigenomics O
, O
to O
stress O
the O
potential O
of O
ensembles O
of O
RNA O
modifications O
to O
constitute O
a O
post-transcriptional O
regulatory O
layer O
of O
gene O
expression O
orchestrated O
by O
writer O
, O
reader O
, O
and O
eraser O
RNA-binding O

Failed O
samples O
were O
related O
to O
poor O
bisulphite O
conversion O
rather O
than O
to O
sequencing O
or O
library O
preparation O

This O
paper O
describes O
a O
new O
model O
, O
the O
Artificial O
Epigenetic O
Regulatory O
Network O
( O
AERN O
) O
which O
builds O
upon O
existing O
models O
by O
adding O
an O
epigenetic O
control O
layer O

These O
technologies O
provide O
us O
with O
new O
insights O
into O
the O
molecular O
basis O
of O
intratumoral O
heterogeneity B-Disease
and O
help O
uncover O
key O
molecular O
events O
and O
driving O
mechanisms O
in O
tumor B-Disease
development O

297 O
: O
Understanding O
pharmacogenetic O
differences O
in O
drug O
response O
and O
tolerability O
has O
been O
an O
important O
area O
of O
research O
in O
personalized O
medicine O
, O
but O
the O
clinical O
utility O
of O
pharmacogenetics O
testing O
has O
not O
been O
established O

, O
HOX O
genes O
) O
as O
being O
epigenetically O
regulated O

We O
discuss O
the O
implications O
for O
understanding O
the O
benefits O
of O
diploidy O
, O
and O
the O
mechanisms O
shaping O
brain O
development O
, O
function O
, O
and O
disease B-Disease

Further O
, O
we O
evaluated O
the O
AI O
analysis O
of O
DNA O
methylation O
for O
the O
prediction O
of O
CoA O

It O
is O
important O
to O
address O
the O
use O
of O
epigenetic O
pathways O
in O
new O
approaches O
to O
molecular O
diagnosis O
and O
novel O
targeted O
treatments O
across O
the O
clinical O
spectrum O

Here O
we O
present O
epigenetic O
clocks O
for O
African O
and O
Asian O
elephants O

422 O
: O
The O
legal O
system O
has O
been O
preparing O
for O
an O
explosion O
of O
epigenetic O
issues O
in O
public O
health O
, O
environmental O
regulation O
and O
litigation O

6 O
million O
dollars O
in O
the O
initial O
year O

The O
inclusion O
of O
leukemia B-Disease
epigenomes O
in O
the O
healthy O
hematological O
chromatin O
sample O
space O
gives O
us O
insights O
on O
the O
healthy O
cell O
types O
that O
are O
more O
epigenetically O
similar O
to O
the O
disease B-Disease
samples O

``` O
The O
epigenetic O
age O
at O
t0 O
and O
t1 O
were O
highly O
correlated O
with O
chronological O
age O
and O
with O
each O
other O
( O
r O
= O
0 O
``` O

Conclusion O
: O
Childhood O
hunger O
is O
a O
risk O
factor O
for O
depressive B-Disease
symptoms I-Disease
and O
CVD O
at O
older O
age O

Progress O
in O
next-generation O
sequencing O
, O
along O
with O
increasing O
methodological O
complexity O
, O
has O
led O
to O
the O
compilation O
of O
genome-wide O
maps O
of O
DNA O
methylation O
, O
histone O
modifications O
, O
RNA O
expression O
, O
and O
more O

Scalable O
single-cell O
CUT&Tag O
can O
be O
combined O
with O
distinct O
platforms O
to O
distinguish O
cellular O
identity O
, O
epigenetic O
features O
and O
even O
spatial O
chromatin O
profiling O

The O
markers O
- O
BCAS4 O
, O
CG06379435 O
, O
VE_8 O
, O
and O
ZC3H12D O
- O
were O
amplified O
together O
and O
then O
sequenced O
via O
pyrosequencing O

g O

Epigenetic O
aberrations O
are O
crucial O
to O
urothelial O
carcinoma O
development O
and O
progression O

Obesity O
is O
often O
associated O
with O
overnutrition O
and O
a O
sedentary O
lifestyle O
, O
but O
clearly O
other O
factors O
also O
increase O
the O
susceptibility O
of O
metabolic B-Disease
disease I-Disease
states O

In O
the O
present O
work O
, O
we O
link O
the O
current O
body O
of O
knowledge O
and O
earlier O
pre-genomic O
concepts O
in O
order O
to O
propose O
a O
new O
definition O
of O
epigenetics O
that O
is O
faithful O
to O
its O
regulatory O
nature O

109 O
: O
Research O
on O
epigenetic O
mechanisms O
is O
gaining O
traction O
, O
yet O
is O
poorly O
understood O
by O
criminologists O
and O
behavioral O
scientists O

Moreover O
, O
a O
kinetic O
model O
can O
be O
extracted O
from O
each O
dataset O

There O
are O
two O
classes O
of O
epigenetic O
drugs O
undergoing O
trials O
for O
treating O
the O
idiopathic O
mental B-Disease
disorders I-Disease
: O
DNA O
methyltransferase O
and O
histone O
deacetylase O
inhibitors O

Nevertheless O
, O
the O
implementation O
of O
epidrugs O
in O
clinical O
practice O
is O
very O
scarce O
and O
mainly O
limited O
to O
haematological O
malignancies B-Disease

edu O

Pattern O
of O
DNA O
methylation O
and O
expression O
of O
histone-modifying O
enzymes O
have O
been O
successfully O
used O
for O
risk O
stratification O

This O
domain O
of O
research O
will O
likely O
change O
how O
we O
think O
about O
the O
origins O
of O
human O
nature O

40 O
: O
Epigenetic O
modification O
, O
such O
as O
DNA O
methylation O
( O
DNAm O
) O
, O
is O
a O
mechanism O
that O
can O
help O
explain O
how O
early O
adversities O
can O
engender O
long-term O
vulnerability O
for O
mental O
health O
problems O

However O
, O
looking O
at O
specific O
genes O
requires O
bespoke O
coding O
for O
which O
wet-lab O
biologists O
or O
clinicians O
are O
not O
trained O

We O
consider O
what O
has O
historically O
been O
understood O
by O
the O
term O
" O
epigenetics O
" O
before O
turning O
to O
the O
advances O
in O
biochemistry O
, O
molecular O
biology O
, O
and O
genetics O
which O
have O
led O
to O
current-day O
definitions O
of O
the O
term O

Specifically O
, O
we O
summarize O
methods O
used O
to O
extricate O
biologic O
signals O
from O
technical O
noise O
, O
and O
statistical O
approaches O
to O
capture O
meaningful O
variability O
based O
on O
the O
research O
hypothesis O

We O
collected O
buccal O
swabs O
from O
217 O
canids O
( O
207 O
domestic O
dogs O
and O
10 O
grey O
wolves O
) O
and O
used O
targeted O
bisulphite O
sequencing O
to O
measure O
methylomes O

282 O
: O
Epigenetic O
targets O
are O
of O
significant O
importance O
in O
drug O
discovery O
research O
, O
as O
demonstrated O
by O
the O
eight O
approved O
epigenetic O
drugs O
for O
treatment O
of O
cancer B-Disease
and O
the O
increasing O
availability O
of O
chemogenomic O
data O
related O
to O
epigenetics O

The O
sharing O
concept O
of O
both O
HH O
and O
MH O
is O
gene-environment O
interaction O
, O
which O
is O
also O
a O
key O
concept O
in O
epigenetics O

Here O
, O
we O
will O
summarize O
and O
discuss O
epigenetic O
patterns O
in O
autoimmune/inflammatory B-Disease
disorders O
, O
underlying O
molecular O
alterations O
and O
their O
effects O
on O
gene O
expression O
and O
immune O
phenotypes O

428 O
: O
As O
one O
of O
the O
most O
frequent O
skeletal O
anomalies O
, O
developmental O
dysplasia O
of O
the O
hip O
( O
DDH O
) O
is O
characterized O
by O
a O
considerable O
range O
of O
pathology O
, O
from O
minor O
laxity O
of O
ligaments O
in O
the O
hip O
joint O
to O
complete O
luxation O

We O
apply O
these O
recommendations O
for O
imprinted O
DMRs O
that O
are O
commonly O
assayed O
in O
clinical O
laboratories O
and O
show O
how O
they O
support O
standardized O
database O
submission O

Moreover O
, O
external O
stimulation O
and O
physiological O
aging O
may O
also O
participate O
in O
this O
phenomenon O

Their O
long-term O
effects O
are O
unclear O
at O
this O
point O
, O
but O
many O
ongoing O
studies O
are O
attempting O
to O
elucidate O
the O
pathophysiological O
effects O
of O
such O
gene-environment O
interactions O

5-hmC O
is O
considered O
to O
be O
one O
of O
the O
forms O
of O
epigenetic O
modification O
and O
is O
suggested O
as O
an O
intermediate O
step O
in O
a O
semi-active O
loss O
of O
DNA O
methylation O
mark O

These O
approaches O
have O
the O
potential O
to O
capture O
and O
integrate O
multiple O
dimensions O
of O
individual O
cancer B-Disease
cells O
, O
thereby O
revealing O
tumor B-Disease
heterogeneity B-Disease
and O
epigenetic O
features O

In O
public O
health O
terms O
, O
a O
modifiable O
cause O
of O
the O
large O
majority O
of O
cases O
of O
a O
disease B-Disease
may O
have O
been O
identified O
, O
with O
a O
wild O
goose O
chase O
continuing O
in O
an O
attempt O
to O
discipline O
the O
random O
nature O
of O
the O
world O
with O
respect O
to O
which O
particular O
individuals O
will O
succumb O

Its O
detection O
is O
still O
based O
on O
methods O
with O
low O
sensitivity O
and O
although O
standard O
pathological O
and O
clinical O
variables O
provide O
important O
prognostic O
information O
, O
these O
parameters O
seem O
to O
be O
insufficient O
to O
accurately O
predict O
the O
behavior O
of O
these O
tumors B-Disease

A O
large O
number O
of O
these O
markers O
arose O
in O
an O
attempt O
to O
better O
understand O
the O
molecular O
mechanisms O
involved O
in O
bladder O
carcinogenesis O
and O
tumor B-Disease
progression O
and O
how O
these O
may O
translate O
into O
diagnostic O
or O
prognostic O
tools O

NGS O
- O
based O
studies O
have O
provided O
detailed O
and O
comprehensive O
views O
of O
epigenetic O
modifications O
for O
the O
genomes O
of O
many O
species O
and O
cell O
types O

, O
cell O
fate O
specification O
and O
maturation O
) O
, O
homeostasis O
and O
stress O
responses O
( O
e O

Although O
the O
hunt O
for O
genetic O
alterations O
in O
head O
and O
neck O
cancer B-Disease
has O
continued O
in O
the O
past O
two O
decades O
, O
with O
unequivocal O
proof O
of O
a O
genetic O
role O
in O
multistage O
head O
and O
neck O
carcinogenesis O
, O
epigenetic O
alteration O
in O
association O
with O
promoter O
CpG O

709 O
: O
Many O
recent O
epigenetic O
studies O
utilize O
the O
advantages O
of O
CRISPR/dCas9 O
based O
tools O
in O
linking O
certain O
epigenetic O
modification O
with O
gene O
expression O
regulation O

This O
review O
discusses O
the O
potential O
for O
epigenomic O
drugs O
to O
impact O
on O
the O
germline O
epigenome O
and O
subsequent O
offspring O
and O
aims O
to O
foster O
further O
examination O
into O
the O
possible O
effects O
of O
these O
drugs O
on O
gametes O

This O
information O
is O
obtained O
from O
public O
resources O
viz O

By O
combining O
data O
from O
the O
BLUEPRINT O
Epigenome O
Project O
with O
a O
novel O
analytical O
approach O
, O
these O
authors O
were O
able O
to O
measure O
the O
degree O
of O
transcriptional O
and O
epigenetic O
variability O
across O
a O
wide O
panel O
of O
samples O
and O
types O
of O
immune O
cell O

Its O
unique O
characteristics O
-- O
being O
simultaneously O
stable O
and O
dynamic O
, O
present O
vast O
opportunities O
for O
cell O
function O
regulation O
, O
maintaining O
and O
executing O
different O
cell O
type O
programmes O

Greenness O
metrics O
were O
associated O
with O
significantly O
lower O
DNAmAgeAC O
based O
on O
GrimAge O
acceleration O
, O
suggesting O
slower O
biological O
aging O
with O
higher O
greenness O
based O
on O
both O
NDVI O
and O
EVI O
in O
300-2,000m O
buffer O
areas O

Such O
integration O
allowed O
highly O
sensitive O
tests O
starting O
with O
100 O
cross-linked O
cells O
for O
ChIP O
or O
500 O
pg O
of O
genomic O
DNA O
for O
MeDIP O
(compared O
to O
10(6)-10(7) O
cells O
for O
ChIP O
and O
1-10 O
g O
of O
DNA O
for O
MeDIP O
in O
conventional O
assays O

529 O
: O
Epigenetic O
control O
plays O
an O
important O
role O
in O
gene O
regulation O
through O
chemical O
modifications O
of O
DNA O
and O
post-translational O
modifications O
of O
histones O

As O
conserved O
regulatory O
mechanisms O
in O
gene O
expression O
, O
epigenetic O
mechanisms O
participate O
in O
almost O
all O
the O
important O
biological O
processes O
ranging O
from O
basal O
development O
to O
environmental O
response O

Revealing O
diet-epigenetic O
relationships O
has O
the O
potential O
to O
transform O
nutrition O
science O
by O
increasing O
our O
fundamental O
understanding O
of O
: O
( O
i O
) O
the O
role O
of O
nutrients O
in O
biological O
systems O
, O
( O
ii O
) O
the O
resilience O
of O
living O
organisms O
in O
responding O
to O
environmental O
perturbations O
, O
and O
( O

Targeted O
methylation O
polymerase O
chain O
reaction O
(PCR)-based O
analyses O
are O
among O
the O
most O
universal O
and O
commonly O
used O
techniques O
in O
research O

By O
applying O
DMF-ChIP-seq O
, O
H3K27ac O
histone O
modification O
of O
early O
embryonic O
cells O
during O
differentiation O
was O
profiled O
for O
the O
investigation O
of O
epigenomic O
landscape O
dynamics O

We O
outline O
commonly O
used O
normalization O
procedures O
and O
list O
issues O
to O
consider O
regarding O
data O
preprocessing O

94 O
: O
Gene O
expression O
in O
the O
aging O
brain O
depends O
on O
transcription O
signals O
generated O
by O
senescent O
physiology O
, O
interacting O
with O
genetic O
and O
epigenetic O
programs O

Hypermethylation O
in O
these O
genes O
might O
play O
a O
crucial O
rule O
in O
the O
co-occurrence O
of O
obesity B-Disease
and O
mood B-Disease
disorders I-Disease

Age O
associated O
epigenetic O
changes O
are O
routinely O
linked O
with O
pathologies O
, O
including O
cardiovascular O
disease B-Disease
, O
cancer B-Disease
, O
and O
Alzheimer's B-Disease
disease I-Disease
; O
moreover O
, O
epigenetic O
clocks O
are O
capable O
of O
correlating O
biological O
age O
with O
chronological O
age O
in O
many O
species O
including O
humans O

We O
describe O
here O
the O
adaptation O
of O
SILAC O
to O
the O
analysis O
of O
histones O
, O
in O
both O
standard O
and O
spike-in O
setups O

g O

However O
, O
due O
to O
the O
lack O
of O
efficient O
collection O
, O
standardized O
quality O
control O
, O
and O
analysis O
procedures O
, O
efficiently O
integrating O
and O
reusing O
these O
data O
remain O
considerable O
challenges O

This O
knowledge O
can O
possibly O
be O
used O
to O
revolutionize O
animal O
breeding O
and O
to O
increase O
human O
and O
animal O
health O
worldwide O

The O
aim O
of O
this O
COST O
action O
launched O
in O
2020 O
is O
: O
( O
1 O
) O
to O
define O
standardized O
pipelines O
and O
methods O
used O
in O
the O
study O
of O
epigenetic O
mechanisms O
in O
plants O
, O
( O
2 O
) O
update O
, O
share O
, O
and O
exchange O
findings O
in O
epigenetic O
responses O
to O
environmental O
stresses O

In O
the O
present O
research O
, O
we O
have O
tested O
whether O
promoter O
DNA O
methylation O
of O
a O
set O
of O
Wnt/non-Wnt O
genes O
such O
as O
[ O
cadherin-2 O
( O
CDH2 O
) O
] O
, O
" O
present O
in O
circulation O
" O
, O
could O
serve O
as O
" O
bone-marrow O
biopsy O
surrogate O
" O
and O
help O
in O

Over O
the O
last O
2 O
decades O
, O
in O
an O
effort O
to O
overcome O
these O
issues O
, O
research O
has O
sought O
to O
identify O
the O
genetic O
basis O
for O
AF O
thereby O
gaining O
insight O
into O
the O
regulatory O
mechanisms O
governing O
its O
pathophysiology O

The O
identification O
of O
epigenetic O
marks O
that O
are O
transmitted O
to O
the O
next O
generations O
is O
of O
primary O
importance O
for O
their O
use O
in O
breeding O
and O
for O
the O
development O
of O
new O
cultivars O
with O
a O
broad-spectrum O
of O
tolerance/resistance O
to O
abiotic O
and O
biotic O
stresses O

Using O
an O
online O
questionnaire O
, O
this O
study O
investigated O
the O
Australian O
public O
's O
understanding O
, O
views O
, O
and O
opinions O
of O
epigenetics O
and O
related O
concepts O
, O
including O
the O
concepts O
of O
the O
developmental O
origins O
of O
health O
and O
disease B-Disease
( O
DOHaD O
) O
and O
the O
first O
1000 O
days O

5-month O
( O
P O
< O
0 O

( O
2 O
) O
Methods O
: O
This O
systematic O
review O
was O
conducted O
in O
accordance O
with O
the O
PRISMA O
statement O
and O
registered O
in O
Prospero O

His O
research O
has O
looked O
at O
the O
mechanisms O
through O
which O
variations O
in O
tumor B-Disease
cells O
derive O
, O
and O
cell O
differentiation O
in O
cancers B-Disease
such O
as O
medullary O
thyroid O
carcinoma O
and O
small-cell O
lung O
carcinoma O

Further O
studies O
should O
be O
dedicated O
to O
strength O
these O
preliminary O
findings O
, O
in O
larger O
multicenter O
cohorts O
, O
to O
identify O
reliable O
directions O
for O
biomarker O
research O
and O
clinical O
practice O

637 O
: O
The O
analysis O
of O
epigenetic O
modifications O
in O
allergic B-Disease
diseases I-Disease
has O
recently O
attracted O
substantial O
interest O
because O
epigenetic O
modifications O
can O
mediate O
the O
effects O
of O
the O
environment O
on O
the O
development O
of O
or O
protection O
from O
allergic B-Disease
diseases I-Disease

Additionally O
, O
they O
increase O
the O
risk O
of O
mortality O

Recent O
advances O
in O
the O
development O
of O
pharmacoepigenetic O
biomarkers O
and O
epidrugs O
are O
also O
discussed O

Development O
of O
epigenome O
editing O
tools O
enables O
a O
functional O
dissection O
of O
the O
link O
between O
altered O
epigenetic O
changes O
and O
disease B-Disease
outcomes O

Initially O
, O
the O
erratic O
expression O
behavior O
of O
transgenes O
was O
considered O
a O
nuisance O
that O
impeded O
the O
impact O
and O
efficiency O
of O
a O
new O
technology O

It O
is O
mainly O
mediated O
by O
Th2 O
cell O
and O
IgE O
produced O
by O
B O
cells O

61 O
: O
Epigenetic O
changes O
frequently O
occur O
in O
human O
gastric O
cancer B-Disease

This O
chapter O
describes O
a O
protocol O
for O
bisulfite O
sequencing O
adapted O
to O
a O
single-cell O
format O
that O
allows O
for O
capturing O
the O
methylation O
signal O
from O
up O
to O
50% O
CpG O
nucleotides O
in O
each O
cell O

In O
this O
review O
, O
we O
discuss O
the O
potential O
applications O
of O
epigenetics O
in O
bovine O
research O
, O
using O
breakthroughs O
in O
human O
and O
murine O
research O
to O
signpost O
the O
way O

370 O
: O
Behavioral O
genetic O
evidence O
offers O
a O
useful O
way O
to O
disentangle O
some O
of O
the O
multifactorial O
etiological O
pathways O
toward O
the O
now O
clearly O
multidimensional O
construct O
of O
female O
sexual O
dysfunction O
( O
FSD O
) O
and O
has O
already O
shown O
its O
potential O
in O
providing O
a O
better O
understanding O
of O

depression B-Disease
with O
diabetes B-Disease
or O
cardiovascular O
disease B-Disease

The O
amalgamation O
of O
epidemiology O
and O
epigenetics O
has O
created O
a O
scientific O
discipline O
termed O
epigenetic O
epidemiology O

Much O
emphasis O
has O
been O
made O
to O
describe O
the O
genetic O
influence O
, O
whereas O
the O
epigenetic O
part O
is O
not O
fully O
understood O

This O
paper O
summarizes O
the O
dynamic O
expression O
pattern O
of O
Dnmt O
genes O
and O
the O
roles O
of O
DNA O
methylation O
from O
early O
embryogenesis O
to O
organogenesis O
in O
both O
mice O
and O
zebrafish O
, O
specifically O
, O
how O
DNA O
methylation O
and O
histone O
modifications O
cooperatively O
regulate O
gene O
transcription O
during O
these O
processes O

Availability O
: O
NGS++ O
was O
written O
in O
C++ O
using O
the O
C++11 O
standard O

Outside O
of O
biomedicine O
, O
social O
scientists O
have O
long O
recognized O
the O
impact O
of O
the O
social O
and O
physical O
environment O
on O
individuals O
and O
populations O
but O
have O
not O
usually O
connected O
these O
effects O
with O
changes O
in O
underlying O
biology O

Here O
, O
we O
present O
a O
review O
of O
these O
methods O
and O
their O
promise O
to O
influence O
our O
studies O
on O
the O
epigenome O
for O
endocrine O
research O
and O
perhaps O
to O
uncover O
novel O
therapeutic O
options O
in O
disease B-Disease
states O

It O
reintroduces O
long O
forgotten O
exclusionary O
and O
stereotypic O
perspectives O
on O
indigenous O
and O
mestizos O
, O
and O
biologizes O
as O
well O
as O
racializes O
social-cultural O
differences O
among O
human O
groups O

437 O
: O
Background O
: O
Epigenetics O
is O
changing O
the O
widely O
accepted O
linear O
conception O
of O
genome O
function O
by O
explaining O
how O
environmental O
and O
psychological O
factors O
regulate O
the O
activity O
of O
our O
genome O
without O
involving O
changes O
in O
the O
DNA O
sequence O

10 O
) O
discovered O
between O
preterm O
and O
term O
infants O
compared O
to O
the O
<1000 O
prematurity-DM O
sites O
identified O
in O
white O
blood O
cell O
populations O

g O

In O
cancer B-Disease
epidemiology O
, O
epigenetic O
biomarkers O
offer O
advantages O
over O
other O
types O
of O
biomarkers O
because O
they O
are O
expressed O
against O
a O
person O
's O
genetic O
background O
and O
environmental O
exposure O
, O
and O
because O
epigenetic O
events O
occur O
early O
in O
cancer B-Disease
development O

446 O
: O
Background O
: O
On O
a O
tide O
of O
big O
data O
, O
machine O
learning O
is O
coming O
to O
its O
day O

In O
a O
previous O
study O
, O
this O
resemblance O
was O
described O
as O
a O
function O
of O
the O
epigenetic O
variance O
component O
and O
a O
reset O
coefficient O
that O
indicates O
the O
rate O
of O
dissipation O
of O
epigenetic O
marks O
across O
generations O

 O
2019 O
Wiley O
Periodicals O
, O
Inc O

The O
first O
group O
of O
theories O
can O
be O
indicated O
as O
referring O
to O
the O
gene-centric O
paradigm O

Disruption O
of O
gene O
expression O
patterns O
which O
are O
governed O
by O
epigenetics O
can O
result O
in O
autoimmune O
diseases O
, O
cancers B-Disease
, O
and O
various O
other O
maladies B-Disease

Epigenetic O
signaling O
involves O
changes O
on O
the O
structure O
of O
chromatin O
; O
such O
changes O
are O
often O
triggered O
and O
maintained O
by O
the O
post-translational O
modification O
of O
chromatin O
proteins O
and/or O
DNA O

g O

In O
this O
way O
, O
they O
can O
contribute O
to O
heritable O
phenotypic O
variation O
in O
natural O
and O
experimental O
populations O
independent O
of O
DNA O
sequence O

We O
also O
show O
that O
epigenetically O
driven O
effects O
are O
strongly O
enriched O
in O
repressed O
regions O
and O
near O
transcription O
start O
sites O
, O
whereas O
the O
genetically O
regulated O
CpGs O
are O
enriched O
in O
enhancers O

Intriguingly O
, O
the O
observed O
scaling O
laws O
lack O
consistent O
interpretation O
in O
polymer O
physics O

Yet O
, O
both O
these O
different O
epistemological O
aspects O
of O
epigenetics O
still O
coexist O

We O
provide O
evidence O
that O
genetic O
changes O
from O
multiple O
sources O
do O
indeed O
occur O
in O
these O
experiments O
and O
explore O
several O
avenues O
by O
which O
these O
changes O
could O
be O
causal O
to O
the O
apparent O
inheritance O
of O
epigenetic O
changes O

Gene O
promoter O
region O
hypermethylation O
, O
genomic O
global O
hypomethylation O
, O
histone O
modifications O
, O
and O
alterations O
of O
noncoding O
RNAs O
are O
major O
epigenetic O
changes O
in O
gastric O
cancer B-Disease

Termed O
as O
19 O
epigenetic O
features/scores O
, O
they O
consist O
of O
6 O
experimental O
epigenetic O
and O
13 O
computed O
nucleosome O
organization-related O
features O

A O
growing O
list O
of O
studies O
show O
that O
environmental O
stimuli O
can O
affect O
aging O
and O
longevity O
through O
conserved O
pathways O
which O
, O
in O
turn O
, O
modulate O
chromatin O
states O

Lastly O
, O
we O
pose O
examples O
of O
relevant O
scientific O
questions O
worth O
exploring O

Additional O
studies O
inclusive O
of O
diverse O
populations O
and O
other O
psychosocial O
stressors O
are O
needed O

Recent O
findings O
: O
Epigenetics O
is O
a O
new O
frontier O
in O
cancer B-Disease
research O
with O
tremendous O
impact O
on O
our O
thinking O
and O
understanding O
of O
biological O
phenomena O
and O
complex O
diseases O
, O
notably O
cancer B-Disease

readthedocs O

de O

g O

There O
is O
anticipation O
that O
DNA O
methylation O
may O
close O
gaps O
in O
our O
understanding O
of O
disease B-Disease
etiology O
, O
and O
how O
certain O
risk O
factors O
affect O
health O
and O
disease B-Disease
, O
but O
also O
that O
it O
has O
potential O
as O
a O
biomarker O
for O
disease B-Disease

Moreover O
, O
targeting O
epigenetic O
reader O
proteins O
, O
such O
as O
bromodomain O
proteins O
, O
emerged O
as O
a O
new O
field O
in O
drug O
development O
and O
the O
first O
studies O
underscored O
the O
potential O
of O
these O
drugs O
not O
only O
in O
malignant O
and O
inflammatory O
conditions O
but O
also O
in O
autoimmune O
diseases O

mpi-inf O

Active O
work O
includes O
several O
studies O
of O
individual O
susceptibility O
to O
cancer B-Disease

This O
review O
summarizes O
published O
findings O
of O
inherited O
CMPs O
with O
a O
specific O
focus O
on O
the O
potential O
role O
of O
epigenetic O
mechanisms O
in O
regulating O
these O
cardiac O
disorders O

The O
short-term O
response O
of O
cells O
to O
oxidative O
stress O
is O
well O
understood O
, O
but O
the O
mechanisms O
behind O
long-term O
consequences O
require O
further O
clarification O

net O
/ O
raghava O
/ O
dbem O

555: O
Mood O
stabilizers O
are O
the O
cornerstone O
in O
treatment O
of O
mood B-Disease
disorders I-Disease
, O
but O
their O
use O
is O
characterized O
by O
high O
interindividual O
variability O

Epigenetics O
provides O
a O
promising O
avenue O
for O
both O
targeted O
individual O
intervention O
and O
public O
health O
messaging O

Conclusion O
: O
An O
adapted O
FLoSS O
from O
data O
collectable O
postnatally O
may O
be O
a O
feasible O
tool O
to O
study O
unbiased O
epigenetic O
predictors O
for O
longevity O

Discussion O
: O
Until O
recently O
, O
efforts O
to O
apply O
epigenomic O
data O
in O
toxicology O
and O
risk O
assessment O
were O
restricted O
by O
an O
incomplete O
understanding O
of O
epigenomic O
variability O
across O
tissue O
types O
and O
populations O

Conclusions O
: O
These O
findings O
suggest O
cumulative O
and O
recent O
marijuana O
use O
are O
associated O
with O
age-related O
epigenetic O
changes O
that O
are O
related O
to O
lifespan O

655 O
: O
A O
new O
approach O
helps O
to O
assess O
the O
impact O
of O
accelerated O
epigenetic O
aging O
on O
the O
risk O
of O
cancer B-Disease

Recent O
findings O
: O
Epigenetics O
describes O
three O
major O
phenomena O
: O
DNA O
modification O
via O
methylation O
, O
histone O
sidechain O
modifications O
, O
and O
short O
noncoding O
RNA O
sequences O
which O
work O
in O
concert O
to O
regulate O
gene O
transcription O
in O
a O
heritable O
fashion O

Because O
they O
can O
not O
escape O
stress O
, O
they O
have O
to O
develop O
mechanisms O
of O
remembering O
stress O
exposures O
somatically O
and O
passing O
it O
to O
the O
progeny O

With O
error-corrected O
methylation O
patterns O
, O
PRISM O
focuses O
on O
a O
short O
individual O
genomic O
region O
harboring O
dichotomous O
patterns O
that O
can O
be O
split O
into O
fully O
methylated O
and O
unmethylated O
patterns O

Epigenetic O
abnormalities O
can O
be O
causally O
involved O
in O
cancer B-Disease
development O
(driver) O
and O
can O
also O
be O
present O
as O
a O
passenger O

At O
a O
molecular O
level O
, O
it O
is O
marked O
by O
the O
gradual O
alterations O
of O
biomolecules O

76 O
: O
Purpose O
of O
review O
: O
Epigenetic O
studies O
are O
transforming O
our O
understanding O
of O
a O
variety O
of O
complex O
pathological O
conditions O
including O
cancer B-Disease
, O
autoimmune O
, O
and O
inflammatory O
diseases O

We O
showcase O
our O
transfection O
protocol O
optimization O
using O
HEK293T O
Lenti-X O
and O
breast B-Disease
cancer I-Disease
MCF-7 O
cell O
lines O
, O
using O
a O
single-guide O
RNA-containing O
plasmid O

591 O
: O
The O
interaction O
between O
metabolic O
and O
epigenetic O
events O
shapes O
metabolic O
adaptations O
of O
cancer B-Disease
cells O
and O
also O
helps O
rewire O
the O
proliferation O
and O
activity O
of O
surrounding O
immune O
cells O
in O
the O
tumor B-Disease
microenvironment O
( O
TME O
) O

Although O
researchers O
have O
been O
focusing O
on O
DNA O
methylation O
when O
studying O
monozygotic O
( O
MZ O
) O
twins O
, O
a O
great O
model O
in O
epigenetics O
research O
, O
interactions O
between O
genetics O
and O
epigenetics O
in O
chromatin O
level O
are O
expected O
to O
be O
an O
imperative O
research O
trend O
in O
the O
future O

We O
will O
particularly O
concentrate O
on O
the O
applicability O
of O
epigenetic O
alterations O
as O
biomarkers O
for O
improved O
diagnosis O
, O
prognosis O
, O
and O
prediction O

Together O
these O
techniques O
enable O
precision O
manipulation O
of O
cellular O
epigenomes O
and O
the O
exploration O
of O
the O
therapeutic O
potential O
of O
epigenetic O
targets O
in O
human O
disease B-Disease

With O
the O
investigation O
of O
transgene O
silencing O
effects O
, O
however O
, O
it O
soon O
became O
clear O
that O
transgenes O
had O
helped O
us O
in O
a O
rather O
unexpected O
way O
to O
identify O
novel O
molecular O
pathways O
that O
were O
highly O
relevant O
to O
plant O
development O
and O
evolution O

scMET O
is O
available O
at O
https://github O

Differential O
histone O
valleys O
exhibit O
concordance O
with O
differential O
DNase O
signal O
at O
cell O
line O
specific O
valleys O

168 O
: O
Epigenetic O
mechanisms O
play O
an O
important O
role O
in O
the O
regulation O
of O
cell O
type-specific O
gene O
activities O
, O
yet O
how O
epigenetic O
patterns O
are O
established O
and O
maintained O
remains O
poorly O
understood O

Availability O
and O
implementation O
: O
The O
Haystack O
pipeline O
is O
implemented O
as O
an O
open-source O
, O
multiplatform O
, O
Python O
package O
called O
haystack_bio O
freely O
available O
at O
https://github O

152 O
: O
Epigenetic O
modification O
has O
been O
implicated O
in O
a O
wide O
range O
of O
diseases O
and O
the O
ability O
to O
modulate O
such O
systems O
is O
a O
lucrative O
therapeutic O
strategy O
in O
drug O
discovery O


188 O
: O
What O
is O
known O
and O
objective O
: O
There O
is O
increasing O
evidence O
that O
epigenetics O
plays O
a O
major O
role O
in O
the O
pathogenesis O
of O
the O
idiopathic O
mental B-Disease
disorders I-Disease

450 O
: O
Background O
: O
Epigenetic O
heterogeneity B-Disease
within O
a O
tumour B-Disease
can O
play O
an O
important O
role O
in O
tumour B-Disease
evolution O
and O
the O
emergence O
of O
resistance O
to O
treatment O

384 O
: O
Interindividual O
variability O
of O
DNA O
methylation O
is O
a O
mechanism O
of O
the O
epigenetic O
drift O
in O
aging O

Areas O
timely O
for O
developing O
research O
: O
Metanalysis O
through O
integration O
of O
multiple O
datasets O
and O
platforms O
will O
enable O
a O
holistic O
understanding O
of O
the O
epigenome O
in O
ageing O
and O
its O
relevance O
to O
disease B-Disease

724 O
: O
Background O
: O
Epigenetic O
disturbances O
are O
crucial O
in O
cancer B-Disease
initiation O
, O
potentially O
with O
pleiotropic O
effects O
, O
and O
may O
be O
influenced O
by O
the O
genetic O
background O


82 O
: O
Epidemiology O
is O
the O
branch O
of O
science O
that O
investigates O
the O
causes O
and O
distribution O
of O
disease B-Disease
in O
populations O
in O
order O
to O
provide O
preventative O
measures O
and O
promote O
human O
health O

Conclusion O
: O
These O
results O
demonstrate O
that O
epigenetic O
aging O
is O
dynamic O
and O
changes O
after O
exposure O
to O
trauma B-Disease

These O
comparisons O
indicate O
that O
the O
quality O
of O
our O
ensemble O
technique O
exceeds O
that O
of O
single O
tool O
approaches O
, O
enhances O
existing O
peak-calling O
ensembles O
, O
and O
results O
in O
epigenetic O
profiles O
of O
higher O
confidence O

We O
thus O
developed O
an O
age O
predictor O
in O
fish O
that O
is O
highly O
accurate O
( O
0 O

Although O
the O
recent O
high-throughput O
methods O
for O
DNA O
methylation O
analysis O
have O
various O
advantages O
, O
they O
require O
high O
levels O
of O
technical O
expertise O
, O
costly O
equipment O
, O
and O
reagents O

Recently O
, O
interest O
has O
been O
growing O
in O
transferring O
GRS O
approaches O
to O
DNA O
methylation O
data O
( O
methylation O
risk O
scores O
, O
MRS O
) O
, O
which O
can O
be O
used O
1 O
) O
as O
biomarkers O
for O
environmental O
exposures O
, O
2 O
) O
in O
association O
analyses O
in O
which O
single O
CpG O
sites O
do O

Potential O
candidate O
genes O
found O
associated O
to O
fibromyalgia O
are O
SLC64A4 O
, O
TRPV2 O
, O
MYT1L O
, O
and O
NRXN3 O

750 O
: O
Evolutionary O
change O
is O
a O
product O
of O
selection O

Global O
alterations O
to O
the O
DNA O
methylation O
landscape O
contribute O
to O
alterations O
in O
the O
transcriptome O
and O
deregulation O
of O
cellular O
pathways O

In O
this O
chapter O
, O
we O
describe O
( O
1 O
) O
how O
to O
perform O
quantitative O
trait O
locus O
( O
QTL O
) O
analysis O
using O
histone O
modification O
levels O
as O
traits O
and O
( O
2 O
) O
how O
to O
integrate O
these O
data O
with O
information O
on O
RNA O
expression O
for O
the O
elucidation O
of O
the O
epigenetic O
control O
of O

723 O
: O
Background O
: O
Advances O
in O
understanding O
of O
cancer B-Disease
biology O
, O
genomics O
, O
epigenomics O
, O
and O
immunology O
have O
resulted O
in O
development O
of O
several O
therapeutic O
options O
that O
expand O
cancer B-Disease
care O
beyond O
traditional O
chemotherapy O
or O
radiotherapy O
, O
including O
individualized O
treatment O
strategies O
, O
novel O
treatments O
based O

In O
2017 O
, O
ShortCutsTV O
produced O
the O
English O
documentary O
' O
Are O
You O
What O
Your O
Mother O
Ate O
? O
The O
Agouti O
Mouse O
Study O
' O
based O
on O
his O
pioneering O
epigenetic O
research O

In O
fact O
, O
it O
has O
been O
estimated O
that O
approximately O
45% O
of O
epigenetic O
researchers O
today O
identify O
cancer/oncology O
as O
their O
main O
area O
of O
focus O
vis--vis O
their O
epigenetic O
research O
efforts O

This O
allows O
them O
to O
serve O
as O
protein-based O
epigenetic O
elements O
that O
are O
readily O
broadcast O
through O
mitosis O
and O
meiosis O

From O
January O
to O
March O
2020 O
, O
we O
conducted O
an O
online O
survey O
of O
189 O
epigenetic O
researchers O
working O
in O
31 O
countries O

The O
redirected O
cellular O
expression O
is O
a O
consequence O
of O
either O
indirect O
epigenetic O
regulation O
where O
cellular O
signaling O
or O
transcriptional O
dysregulation O
occurs O
or O
direct O
epigenetic O
regulation O
where O
epigenetic O
cofactors O
such O
as O
histone O
deacetylases O
are O
targeted O

Taking O
those O
factors O
into O
account O
( O
H4 O
) O
should O
result O
in O
increased O
heritability O
estimates O

We O
introduce O
a O
computational O
method O
, O
TRIAGE O
, O
which O
uses O
discordance O
between O
gene-repressive O
tendency O
and O
expression O
to O
identify O
genetic O
drivers O
of O
cell O
identity O

662 O
: O
The O
human O
epigenome O
may O
link O
environmental O
exposures O
and O
commensal O
microbiota O
changes O
to O
host O
pathology O
in O
respect O
to O
the O
developmental O
origins O
of O
inflammatory O
bowel O
diseases O
( O
ulcerative O
colitis O
[ O
UC O
] O
and O
Crohn's O
disease B-Disease
[ O
more O
appropriately O
Crohn O

35 O
: O
Epigenetics O
research O
in O
evolutionary O
biology O
encompasses O
a O
variety O
of O
research O
areas O
, O
from O
regulation O
of O
gene O
expression O
to O
inheritance O
of O
environmentally O
mediated O
phenotypes O

36 O
], O
P O
= O
0 O

We O
illustrate O
how O
scMET O
facilitates O
the O
characterization O
of O
epigenetically O
distinct O
cell O
populations O
and O
how O
it O
enables O
the O
formulation O
of O
novel O
hypotheses O
on O
the O
epigenetic O
regulation O
of O
gene O
expression O

Gene O
editing O
strategies O
aim O
to O
correct O
the O
actual O
genetic O
mutation O
, O
while O
circumventing O
issues O
associated O
with O
conventional O
compensation O
gene O
therapy O

Furthermore O
, O
we O
can O
postulate O
that O
such O
variations O
exist O
between O
transformed O
macrophage-like O
cell O
lines O
and O
primary O
macrophages O
obtained O
from O
healthy O
volunteers O

We O
built O
predictive O
models O
with O
high O
accuracy O
for O
small O
molecules O
' O
epigenetic O
target O
profiling O
through O
a O
systematic O
comparison O
of O
the O
machine O
learning O
models O
trained O
on O
different O
molecular O
fingerprints O

We O
built O
a O
machine O
learning O
model O
named O
epiNet O
to O
predict O
CG O
methylation O
patterns O
based O
on O
other O
epigenetic O
features O
, O
such O
as O
histone O
modifications O
, O
but O
not O
DNA O
sequence O

The O
aim O
of O
this O
review O
is O
to O
provide O
an O
overview O
of O
the O
epigenetics O
and O
epigenetic O
mechanisms O
in O
diabetes B-Disease
and O
diabetes B-Disease
complications O
, O
and O
the O
focus O
is O
on O
the O
emerging O
evidence O
for O
aberrant O
epigenetic O
mechanisms O
in O
DR O

This O
paradigm O
change O
now O
uses O
DNA O
and O
epigenetic O
markers O
to O
forecast O
characteristics O
that O
are O
useful O
to O
triage O
further O
investigative O
work O

Mutagen O

We O
update O
on O
the O
most O
current O
clinical O
studies O
focusing O
on O
epigenetic O
changes O
involved O
in O
bacterial-host O
interactions O
and O
their O
putative O
role O
as O
biomarkers O
or O
drug O
targets O
to O
improve O
precision O
medicine O
and O
personalized O
therapy O
in O
critical O
illness B-Disease
and O
transplantation O
setting O

Our O
article O
introduces O
EE O
into O
bioethics O
by O
translating O
knowledge O
from O
science O
to O
ethics O
and O
by O
comparing O
the O
risks O
of O
EE O
with O
those O
of O
GE O

, O
via O
next-generation O
sequencing O
) O

223 O
: O
Epigenome O
editing O
refers O
to O
the O
directed O
alteration O
of O
chromatin O
marks O
at O
specific O
genomic O
loci O
by O
using O
targeted O
EpiEffectors O
which O
comprise O
designed O
DNA O
recognition O
domains O
( O
zinc O
finger O
, O
TAL O
effector O
, O
or O
modified O
CRISPR/Cas9 O
complex O
) O
and O
catalytic O
domains O
from O

480 O
: O
In O
this O
interview O
, O
Professor O
Peter O
W O
Laird O
speaks O
with O
Storm O
Johnson O
, O
Commissioning O
Editor O
for O
Epigenomics O
, O
on O
his O
work O
to O
date O
in O
the O
field O
of O
cancer B-Disease
epigenetics O

e O

Methods O
: O
Articles O
were O
identified O
using O
the O
following O
terms O
: O
( O
[ O
( O
DNA O
methylation O
) O
AND O
( O
epigenetic O
clock O
) O
] O
OR O
[ O
( O
DNA O
methylation O
) O
AND O
( O
epigenetic O
age O
) O
] O
) O
AND O
( O
discrimination O
OR O
trauma B-Disease
) O

Moreover O
, O
mutual O
interactions O
between O
genetic O
mutations O
and O
epigenetic O
alterations O
remain O
unclear O

Thus O
, O
epigenetic O
epidemiology O
studies O
are O
needed O
in O
the O
near O
future O
to O
evaluate O
the O
carcinogenesis O
of O
LCNS O
according O
to O
chronic O
exposure O
to O
air O
pollution O
and/or O
viral O
infections B-Disease

, O
SALL1 O
, O
WNT5 O
, O
LRP1b O
, O
CDH2 O
) O
in O
patients O
' O
liquid-biopsies O
was O
clinically O
significant O
showing O
high O
positive O
correlation O
in O
the O
pre-B O
ALL O
cases O
( O
p-value O
< O
0 O

Numerous O
studies O
have O
highlighted O
the O
role O
of O
genetic O
and O
epigenetic O
factors O
in O
this O
disease B-Disease

Epigenetics O
is O
emerging O
as O
perhaps O
the O
most O
important O
mechanism O
through O
which O
the O
lifestyle-choices O
we O
make O
can O
directly O
influence O
the O
genome O

This O
Review O
highlights O
the O
complexity O
of O
neurodegenerative B-Disease
diseases I-Disease
and O
the O
variability O
in O
patient O
responses O
to O
pharmacotherapy O
, O
emphasizing O
the O
influence O
of O
genetic O
polymorphisms O
on O
the O
pharmacokinetics O
and O
pharmacodynamics O
of O
drugs O
used O
to O
treat O
those O
conditions O

16 O
: O
Accumulating O
epidemiological O
, O
clinical O
, O
and O
experimental O
evidence O
supports O
the O
conclusion O
of O
a O
critical O
role O
of O
epigenetic O
factors O
in O
immune O
programming O

Recently O
, O
we O
have O
demonstrated O
that O
a O
semi-supervised O
peak O
calling O
approach O
( O
SPAN O
) O
allows O
for O
robust O
analysis O
of O
multiple O
epigenetic O
profiles O
while O
preserving O
individual O
sample O
statistics O

We O
also O
manually O
curated O
related O
biological O
and O
clinical O
information O
for O
each O
profile O
, O
allowing O
users O
to O
better O
browse O
and O
compare O
cfDNA O
epigenomes O
at O
a O
specific O
stage O
( O
such O
as O
early- O
or O
metastasis-stage O
) O
of O
cancer B-Disease
development O

Yet O
, O
the O
underlying O
mechanism O
and O
the O
mode O
of O
inheritance O
have O
not O
been O
conclusively O
established O

Upon O
analyzing O
the O
selected O
features O
further O
, O
we O
found O
out O
evidences O
, O
which O
support O
the O
Antagonistic O
pleiotropy O
theory O
of O
aging O

Altogether O
, O
literature O
data O
indicate O
aberrant O
expression O
and O
dysregulated O
activity O
of O
MALAT1 O
in O
human O
malignancies B-Disease
and O
envision O
MALAT1 O
targeting O
as O
a O
novel O
treatment O
strategy O
against O
cancer B-Disease

According O
to O
the O
World O
Health O
Organization O
, O
asthma O
affects O
>7 O

Furthermore O
, O
the O
targetable O
nature O
of O
epigenetic O
modifications O
provides O
a O
unique O
opportunity O
to O
alter O
treatment O
paradigms O
and O
provide O
new O
therapeutic O
options O
for O
patients O
whose O
malignancies B-Disease
possess O
these O
aberrant O
epigenetic O
modifications O
, O
paving O
the O
way O
for O
new O
and O
personalized O
medicine O

Greenness-DNAmAgeAC O
associations O
were O
estimated O
using O
a O
within-sibship O
design O
fitted O
by O
linear O
mixed O
effect O
models O
, O
adjusting O
for O
familial O
clustering O
and O
important O
covariates O

Well-known O
epigenetic O
mechanisms O
encompass O
DNA O
methylation O
, O
chromatin O
remodeling O
( O
histone O
modifications O
) O
, O
and O
RNA O
interference O

Implementation O
of O
EPISTRUCTURE O
is O
available O
in O
GLINT O
, O
our O
recently O
released O
toolset O
for O
DNA O
methylation O
analysis O
at O
: O
http://glint-epigenetics O

Furthermore O
, O
JBR O
includes O
the O
capability O
for O
peak O
optimization O
, O
i O

We O
analysed O
the O
relationship O
between O
genetic O
background O
and O
methylation O
patterns O
in O
natural O
hybrids O
of O
two O
genetically O
divergent O
fish O
species O
with O
different O
mating O
systems O
, O
Kryptolebias O
hermaphroditus O
( O
self-fertilizing O
) O
and O
K O

However O
, O
the O
mechanistic O
link O
between O
epigenetic O
modifications O
and O
abnormalities O
in O
nutrition O
remains O
elusive O

This O
study O
reports O
one O
of O
the O
first O
epigenetic O
clocks O
in O
plants O
and O
demonstrates O
the O
universality O
of O
age-associated O
DNA O
methylation O
dynamics O
which O
can O
inform O
conservation O
and O
management O
practices O
, O
as O
well O
as O
our O
ecological O
and O
evolutionary O
understanding O
of O
biological O
ageing O
in O
plants O

702 O
: O
Clonal O
propagation O
is O
frequently O
used O
in O
commercial O
plant O
breeding O
and O
biotechnology O
programs O
because O
it O
minimizes O
genetic O
variation O
, O
yet O
it O
is O
not O
uncommon O
to O
observe O
clonal O
plants O
with O
stable O
phenotypic O
changes O
, O
a O
phenomenon O
known O
as O
somaclonal O
variation O

To O
help O
researchers O
understand O
some O
of O
the O
misconceptions O
in O
the O
field O
and O
to O
communicate O
the O
science O
accurately O
to O
each O
other O
and O
the O
lay O
audience O
, O
here O
we O
review O
the O
basis O
for O
many O
of O
the O
assumptions O
made O
about O
what O
are O
currently O
referred O
to O
as O
epigenetic O
processes O

738 O
: O
There O
is O
a O
growing O
perception O
that O
DNA O
methylation O
may O
be O
influenced O
by O
exogenous O
and O
endogenous O
parameters O

343 O
: O
Asthma B-Disease
is O
a O
heterogeneous O
group O
of O
conditions O
that O
typically O
begin O
in O
early O
life O
and O
result O
in O
recurrent O
, O
reversible O
bronchial O
obstruction O

Therefore O
, O
there O
is O
a O
need O
for O
innovative O
public O
health O
strategies O
that O
target O
factors O
associated O
with O
aging O
and O
the O
development O
of O
tools O
to O
assess O
the O
effectiveness O
of O
these O
strategies O
accurately O

The O
complex O
interaction O
between O
DNA O
methylation O
, O
histone O
modifications O
, O
protein O
complexes O
and O
microRNAs O
has O
become O
better O
appreciated O
in O
the O
context O
of O
both O
local O
and O
long O
range O
epigenetic O
control O
of O
transcription O
in O
both O
normal O
cellular O
differentiation O
and O
tumorigenesis B-Disease

96 O
; O
q O
= O
0 O

Meanwhile O
, O
multiomics O
may O
be O
modified O
by O
a O
multitude O
of O
social O
exposures O
, O
cumulatively O
along O
the O
life O
course O
and O
at O
various O
time O
points O
from O
conception O
onward O
, O
also O
referred O
to O
as O
the O
socio-exposome O

Empirical O
studies O
to O
investigate O
the O
role O
of O
epigenetics O
in O
trans-generational O
gene O
regulation O
and O
disease B-Disease
require O
appropriate O
model O
organisms O

However O
, O
understanding O
the O
functional O
and O
clinical O
consequences O
of O
the O
associated O
alleles O
has O
not O
followed O
the O
same O
pace O

Greater O
extrinsic O
age O
acceleration O
was O
associated O
with O
taking O
fewer O
steps O
(regression O
coefficient O
(95% O
CI) O
- O
0 O

742 O
: O
Arsenic O
is O
a O
naturally O
occurring O
metal O
carcinogen O
found O
in O
the O
Earth O
's O
crust O

In O
this O
chapter O
we O
will O
discuss O
the O
various O
ways O
by O
which O
inorganic O
arsenic O
affects O
the O
epigenome O
with O
consequences O
in O
health O
and O
disease B-Disease

739 O
: O
Background O
: O
Given O
associations O
linking O
early O
life O
adversity O
, O
pubertal O
timing O
, O
and O
biological O
aging O
, O
we O
examined O
the O
direct O
and O
indirect O
effects O
of O
early O
life O
trauma B-Disease
on O
adult O
biological O
aging O
( O
via O
age O
of O
menarche O
) O

If O
epigenetic O
mechanisms O
point O
to O
the O
deep O
socio-environmental O
embeddedness O
of O
our O
health O
, O
we O
conclude O
, O
future O
designs O
and O
methods O
of O
this O
research O
may O
require O
an O
improved O
methodological O
consideration O
of O
a O
biosocial O
perspective O

Epigenetic O
mechanisms O
, O
such O
as O
DNA O
methylation O
, O
act O
at O
the O
interface O
of O
genetic O
and O
environmental O
risk O
and O
protective O
factors O

We O
discuss O
targeting O
of O
these O
enzymes O
for O
therapeutic O
gain O

As O
such O
, O
any O
observed O
phenotypic O
changes O
including O
organ O
development O
, O
aging O
, O
and O
the O
occurrence O
of O
disease B-Disease
could O
be O
driven O
by O
epigenetic O
mechanisms O
in O
the O
presence O
of O
stable O
cellular O
DNA O
sequences O

In O
Australia O
, O
some O
Indigenous O
researchers O
and O
clinicians O
are O
embracing O
epigenetic O
science O
as O
a O
framework O
for O
theorising O
the O
slow O
violence O
of O
colonialism O
as O
it O
plays O
out O
in O
intergenerational O
legacies O
of O
trauma B-Disease
and O
illness B-Disease

Although O
many O
studies O
have O
focused O
on O
the O
genes O
that O
impact O
aging O
, O
the O
nongenetic O
regulation O
of O
aging O
is O
gaining O
increasing O
attention O

447 O
: O
Background O
: O
The O
rapid O
and O
major O
advances O
being O
made O
in O
epigenetics O
are O
impacting O
pharmacology O
, O
giving O
rise O
to O
new O
sub-disciplines O
in O
pharmacology O
, O
pharmacoepigenetics O
, O
the O
study O
of O
the O
epigenetic O
basis O
of O
variation O
in O
response O
to O
drugs O
; O
and O
pharmacoepigenomics O

In O
this O
study O
, O
we O
demonstrate O
the O
miniaturization O
of O
a O
methyltransferase O
assay O
using O
Echo O
liquid O
handlers O
and O
two O
different O
assay O
technologies O
: O
AlphaLISA O
from O
PerkinElmer O
and O
EPIgeneous O
HTRF O
from O
Cisbio O

jp O
/ O
packages O
/ O
3 O


So O
far O
, O
only O
few O
publications O
dealing O
with O
forensic O
age O
estimation O
address O
these O
confounding O
factors O

Here O
we O
review O
available O
techniques O
and O
future O
possibilities O
, O
arguing O
that O
the O
full O
potential O
of O
single-cell O
epigenetic O
studies O
will O
be O
realized O
through O
parallel O
profiling O
of O
genomic O
, O
transcriptional O
, O
and O
epigenetic O
information O

However O
, O
when O
describing O
these O
scientific O
advances O
as O
' O
epigenetic O
' O
, O
we O
encounter O
the O
problem O
that O
this O
term O
means O
different O
things O
to O
different O
people O
, O
starting O
within O
the O
scientific O
community O
and O
amplified O
in O
the O
popular O
press O

193 O
: O
Epigenetic O
control O
of O
genome O
function O
is O
an O
important O
regulatory O
mechanism O
in O
diverse O
processes O
such O
as O
lineage O
commitment O
and O
environmental O
sensing O
, O
and O
in O
disease B-Disease
etiologies O
ranging O
from O
neuropsychiatric O
disorders O
to O
cancer B-Disease

165 O
: O
Epigenomics O
is O
the O
study O
of O
the O
physical O
modifications O
, O
associations O
and O
conformations O
of O
genomic O
DNA O
sequences O
, O
with O
the O
aim O
of O
linking O
these O
with O
epigenetic O
memory O
, O
cellular O
identity O
and O
tissue-specific O
functions O

As O
ROS O
and O
NO O
are O
hallmarks O
of O
stress O
responses O
, O
we O
predict O
that O
they O
are O
also O
pivotal O
in O
mediating O
chromatin O
dynamics O
during O
environmental O
responses O

We O
also O
provide O
strong O
evidence O
that O
the O
Sandwich O
Model O
enhances O
student O
engagement O
and O
satisfaction O

We O
also O
summarize O
state O
of O
the O
art O
techniques O
for O
evaluating O
the O
epigenome O
, O
environmental O
epigenetic O
analysis O
, O
and O
the O
emerging O
field O
of O
epigenome O
editing O

Nevertheless O
, O
findings O
from O
studies O
conducted O
so O
far O
have O
only O
explained O
a O
small O
proportion O
of O
the O
observed O
variability O
, O
suggesting O
that O
factors O
other O
than O
DNA O
variants O
could O
be O
involved O

Progress O
in O
CB O
epigenetics O
research O
promises O
personalized O
medicine O
approaches O
, O
potentially O
transforming O
our O
understanding O
of O
developmental O
programming O
and O
offering O
novel O
interventions O
to O
promote O
lifelong O
health O
from O
the O
earliest O
stages O
of O
life O

Here O
, O
we O
employ O
variational O
autoencoders O
( O
VAEs O
) O
, O
an O
unsupervised O
deep O
learning O
framework O
, O
on O
450K O
DNA O
methylation O
data O
of O
TCGA-LUAD O
and O
TCGA-LUSC O
to O
learn O
latent O
representations O
of O
the O
DNA O
methylation O
landscape O

The O
importance O
of O
epigenetics O
in O
development O
is O
now O
being O
assessed O
in O
many O
nonmodel O
species O

Specifically O
, O
we O
focus O
on O
the O
development O
of O
dual O
hybrids O
to O
exploit O
multitargeting O
of O
key O
epigenetic O
molecules O
deregulated O
in O
cancer B-Disease
; O
the O
study O
of O
epigenetic-synthetic O
lethality O
interactions O
as O
a O
mechanism O
to O
address O
loss-of-function O
mutations O
, O
and O
the O
combination O
of O
epidrugs O
with O

278 O
: O
Crop O
wild O
relatives O
( O
CWRs O
) O
are O
recognized O
as O
the O
best O
potential O
source O
of O
traits O
for O
crop O
improvement O


O O
efforts O
include O
studies O
of O
paternal O
epigenetic O
inheritance O
in O
the O
ERC-funded O
project O
PATER O

Experiments O
on O
datasets O
from O
the O
Roadmap O
Epigenome O
Project O
and O
BluePrint O
Data O
Analysis O
Portal O
(BDAP) O
show O
that O
the O
performance O
of O
Epi-MSA O
is O
better O
than O
existing O
competitive O
methods O
, O
and O
Epi-MSA O
also O
has O
a O
smaller O
standard O
deviation O
, O
which O
shows O
that O
Epi-MSA O
is O
effective O
and O
stable O

In O
the O
case O
of O
the O
beef O
cattle O
dataset O
, O
the O
posterior O
estimate O
of O
transgenerational O
epigenetic O
variability O
was O
very O
low O
and O
a O
model O
comparison O
test O
indicated O
that O
a O
model O
that O
did O
not O
included O
it O
was O
the O
most O
plausible O

Epigenetic O
dysregulation O
is O
potentially O
reversible O
which O
makes O
it O
attractive O
as O
targets O
for O
cancer B-Disease
prevention O

Results O
: O
A O
total O
of O
551 O
families O
contributed O
to O
adapted O
FLoSS O
, O
with O
a O
mean O
score O
of O
-0 O

, O
due O
to O
noise O
during O
development O
or O
environmental O
variations O

The O
acquired O
knowledge O
may O
in O
the O
future O
serve O
as O
a O
solid O
foundation O
for O
developing O
newer O
, O
increasingly O
effective O
methods O
of O
treating O
psoriasis B-Disease

653 O
: O
Methods O
to O
measure O
chromatin O
contacts O
at O
genomic O
regions O
bound O
by O
histone O
modifications O
or O
proteins O
are O
important O
tools O
to O
investigate O
chromatin O
organization O

In O
addition O
, O
epigenetic O
mechanisms O
would O
be O
related O
to O
psychopathology O
, O
as O
in O
the O
case O
of O
schizophrenia B-Disease

This O
industry O
conference O
was O
extremely O
well O
attended O
with O
a O
global O
pool O
of O
delegates O
representing O
the O
academic O
research O
community O
, O
biotechnology O
companies O
and O
pharmaceutical O
companies O
, O
as O
well O
as O
the O
technology/tool O
developers O

Epigenetic O
therapies O
hold O
promise O
for O
a O
wide O
range O
of O
biological O
applications O
, O
from O
cancer B-Disease
treatment O
to O
the O
establishment O
of O
induced O
pluripotent O
stem O
cells O

Humpback O
whales O
exemplify O
this O
as O
they O
have O
a O
lifespan O
comparable O
to O
humans O
, O
mature O
sexually O
as O
early O
as O
4 O
years O
and O
have O
no O
reliable O
visual O
age O
indicators O
after O
their O
first O
year O

In O
addition O
, O
novel O
forms O
of O
random O
monoallelic O
expression O
that O
impact O
many O
autosomal O
genes O
have O
been O
described O
in O
vitro O
and O
in O
vivo O

The O
analysis O
was O
performed O
at O
seven O
time O
points O
, O
taking O
into O
account O
the O
control O
conditions O
, O
heat O
stress O
, O
and O
recovery O
to O
control O
conditions O
after O
the O
stress O
treatment O
was O
discontinued O

378 O
: O
The O
human O
epigenome O
plays O
a O
key O
role O
in O
determining O
cellular O
identity O
and O
eventually O
function O

dbEM O
maintains O
the O
genomic O
information O
like O
mutations O
, O
copy O
number O
variation O
and O
gene O
expression O
in O
thousands O
of O
tumor B-Disease
samples O
, O
cancer B-Disease
cell O
lines O
and O
healthy O
samples O

409 O
: O
The O
past O
decade O
of O
life O
sciences O
research O
has O
been O
driven O
by O
progress O
in O
genomics O

DNA O
methylation O
profiling O
was O
the O
focus O
of O
the O
majority O
of O
studies O
, O
but O
several O
studies O
also O
measured O
microRNA O
profiles O

Finally O
, O
strategies O
to O
address O
these O
challenges O
through O
the O
development O
of O
improved O
evidence-based O
epigenetic O
therapeutics O
and O
through O
combining O
pharmacological O
and O
behavioural O
approaches O
are O
presented O

Understanding O
the O
functional O
role O
of O
these O
modifications O
in O
gene O
regulation O
, O
normal O
development O
, O
and O
pathological O
conditions O
requires O
the O
ability O
to O
localize O
these O
modifications O
in O
genomic O
DNA O

331: O
Sperm O
, O
eggs O
and O
embryos O
are O
made O
up O
of O
more O
than O
genes O
, O
and O
there O
are O
indications O
that O
changes O
to O
non-genetic O
structures O
in O
these O
elements O
of O
the O
germline O
can O
also O
be O
inherited O

Lastly O
, O
it O
seems O
intuitive O
that O
germline- O
and O
context-dependent O
epigenetic O
modifications O
interact O
, O
resulting O
in O
the O
individual O
variation O
observed O
in O
behaviors O
, O
but O
until O
now O
this O
hypothesis O
has O
never O
been O
tested O
experimentally O

Here O
, O
we O
discuss O
our O
understanding O
of O
the O
interplay O
that O
exists O
between O
genetic O
and O
epigenetic O
mechanisms O
in O
these O
disorders O
, O
highlighting O
the O
nascent O
field O
of O
epigenetic O
epidemiology O
- O
which O
focuses O
on O
analyzing O
relationships O
between O
the O
epigenome O
and O
environmental O
exposures O
, O
development O
and O
aging O

We O
explore O
the O
issues O
surrounding O
using O
epigenetics O
to O
identify O
those O
at O
increased O
risk O
of O
NCDs O
, O
including O
the O
concept O
of O
predictive O
testing O
of O
children O

592 O
: O
Over O
the O
past O
decade O
, O
bioethicists O
, O
legal O
scholars O
and O
social O
scientists O
have O
started O
to O
investigate O
the O
potential O
implications O
of O
epigenetic O
research O
and O
technologies O
on O
medicine O
and O
society O

In O
this O
Perspective O
, O
we O
revisit O
the O
Waddington O
diagram O
in O
light O
of O
the O
emerging O
recognition O
that O
plasticity O
is O
part O
and O
parcel O
of O
adult O
regeneration O

We O
report O
, O
for O
the O
first O
time O
in O
humans O
, O
genome-wide O
DNA O
methylation O
( O
850,000 O
CpGs O
) O
and O
gene O
expression O
analysis O
after O
muscle B-Disease
hypertrophy I-Disease
( O
loading O
) O
, O
return O
of O
muscle O
mass O
to O
baseline O
( O
unloading O
) O
, O
followed O
by O
later O
hypertrophy O
( O
reloading O
) O

633 O
: O
Relational O
developmental O
systems O
' O
theories O
emphasize O
that O
any O
facet O
of O
individual O
structure O
or O
function O
is O
embodied O
with O
other O
features O
of O
the O
individual O
and O
with O
the O
characteristics O
of O
his O
or O
her O
proximal O
and O
distal O
ecology O
, O
including O
culture O
and O
history O

The O
up-to-date O
research O
findings O
point O
to O
the O
relationship O
between O
abnormal O
DNA O
methylation O
and O
SLE O
, O
which O
has O
attracted O
considerable O
interest O
worldwide O

uk O

I'm O

Only O
few O
of O
the O
association O
signals O
correspond O
to O
nonsynonymous O
coding O
variation O
with O
a O
clear O
effect O
on O
protein O
function O

g O

Advancing O
technology O
allowing O
genome-scale O
interrogation O
of O
epigenetic O
marks O
provides O
a O
rapidly O
expanding O
view O
of O
the O
complexity O
and O
diversity O
of O
the O
epigenome O

Embodiment O
means O
that O
biological O
, O
psychological O
, O
and O
behavioral O
attributes O
of O
the O
person O
, O
in O
fusion O
with O
the O
contexts O
of O
human O
development O
, O
have O
a O
temporal O
parameter O

Current O
approaches O
such O
as O
epigenetics O
and O
gene-environment O
interactions O
were O
used O
to O
identify O
candidate O
biomarkers O
for O
anxiety O
disorders O
to O
assess O
determinants O
of O
disease B-Disease

Rapid O
advances O
in O
chemical O
biology O
and O
functional O
genomics O
have O
facilitated O
exploration O
of O
targeting O
epigenetic O
proteins O
, O
yielding O
effective O
strategies O
to O
target O
transcription O
while O
reducing O
toxicities O
to O
untransformed O
cells O

As O
these O
samples O
contain O
a O
mix O
of O
white O
blood O
cells O
and O
buccal O
epithelial O
cells O
that O
can O
vary O
within O
a O
population O
, O
this O
cellular O
heterogeneity B-Disease
may O
confound O
EWAS O

657 O
: O
The O
evolutionary O
history O
of O
modern O
humans O
means O
much O
more O
than O
their O
demographic O
past O

From O
a O
clinical O
point O
of O
view O
, O
targeted O
regulation O
of O
disease-related O
genes O
offers O
novel O
therapeutic O
avenues O
for O
many O
diseases O

We O
developed O
bioinformatic O
pipelines O
for O
quality O
control O
and O
standard O
data O
processing O
and O
an O
easy-to-use O
web O
interface O
to O
facilitate O
the O
query O
, O
visualization O
and O
download O
of O
these O
cell-free O
epigenome O
data O

603 O
: O
All O
reproductively O
competent O
adults O
have O
gone O
through O
puberty O

1 O
years O
for O
the O
pan-tissue O
clock O
, O
P O
< O
0 O

In O
this O
review O
, O
we O
argue O
that O
selected O
insects O
can O
be O
used O
as O
models O
for O
human O
diseases O
with O
an O
epigenetic O
component O
because O
the O
underlying O
molecular O
mechanisms O
( O
DNA O
methylation O
, O
histone O
acetylation O
and O
the O
expression O
of O
microRNAs O
) O
are O
evolutionarily O
conserved O

Major O
challenges O
include O
how O
to O
determine O
the O
clinical O
validity O
and O
actionability O
of O
epigenetic O
results O
, O
and O
considerations O
related O
to O
environmental O
exposures O
and O
epigenetic O
marks O
, O
including O
circumstances O
warranting O
the O
sharing O
of O
results O
with O
family O
members O
and O
third O
parties O

Because O
epigenetic O
mechanisms O
link O
gene O
regulation O
to O
environmental O
cues O
and O
developmental O
trajectories O
, O
their O
contribution O
to O
asthma O
and O
allergy O
pathogenesis O
is O
under O
active O
investigation O

Epigenetic O
alterations O
in O
cancer B-Disease
development O
and O
progression O
may O
be O
the O
basis O
for O
the O
individual O
variation O
in O
drug O
response O

Supplementary O
information O
: O
Supplementary O
data O
are O
available O
at O
Bioinformatics O
online O

Recent O
studies O
have O
revealed O
that O
epigenetic O
reprogramming O
, O
such O
as O
altered O
expression O
or O
relocation O
of O
DNA/histone O
modulators O
accompanied O
with O
chromatin O
structure O
remodeling O
, O
can O
lead O
to O
transcriptional O
plasticity O
in O
tumor B-Disease
cells O
, O
thereby O
driving O
their O
transformation O
towards O
a O
persistent O
state O

693 O
: O
Background O
: O
The O
human O
endometrium O
is O
a O
highly O
dynamic O
tissue O
whose O
function O
is O
mainly O
regulated O
by O
the O
ovarian B-Disease
steroid O
hormones O
estradiol O
and O
progesterone O

553 O
: O
The O
Illumina O
HumanMethylation450 O
BeadChip O
has O
become O
a O
popular O
platform O
for O
interrogating O
DNA O
methylation O
in O
epigenome-wide O
association O
studies O
( O
EWAS O
) O
and O
related O
projects O
as O
well O
as O
resource O
efforts O
such O
as O
the O
International O
Cancer B-Disease
Genome O
Consortium O
( O
ICGC O
) O
and O
the O
International O

In O
addition O
to O
the O
'maternal' O
interactions O
, O
there O
has O
been O
increasing O
interest O
in O
the O
epigenetic O
mechanisms O
through O
which O
'paternal' O
influences O
on O
offspring O
development O
can O
be O
achieved O

Changes O
of O
DNA O
methylation O
levels O
and O
patterns O
have O
been O
widely O
studied O
in O
several O
diseases O
, O
especially O
cancer B-Disease
, O
where O
interest O
has O
focused O
on O
biomarkers O
for O
early O
detection O
of O
cancer B-Disease
development O
, O
accurate O
diagnosis O
, O
and O
response O
to O
treatment O
, O
but O
have O
also O
been O
shown O
to O

Environmental O
insults O
can O
reprogram O
the O
epigenome O
of O
the O
germline O
( O
sperm O
and O
eggs O
) O
, O
which O
transmits O
the O
susceptibility O
for O
disease B-Disease
to O
future O
generations O
through O
epigenetic O
transgenerational O
inheritance O

e O

We O
used O
data O
from O
( O
i O
) O
cancer B-Disease
survivors O
who O
had O
undergone O
different O
therapies O
, O
( O
ii O
) O
breast B-Disease
cancer I-Disease
patients O
and O
controls O
, O
and O
( O
iii O
) O
an O
exercise-based O
interventional O
study O
, O
to O
test O
the O
ability O
of O
our O
model O
to O
detect O
alterations O
in O
epigenetic O
age O

Summary O
: O
Published O
evidence O
over O
the O
last O
12-18 O
months O
indicates O
that O
targeting O
epigenetic O
factors O
can O
be O
efficacious O
in O
cancer B-Disease
and O
inflammatory O
disease B-Disease

As O
the O
understanding O
of O
epigenetic O
processes O
improves O
, O
so O
will O
the O
ability O
to O
use O
these O
data O
in O
the O
clinic O
to O
improve O
patient O
care O

However O
, O
when O
applied O
reiteratively O
in O
the O
context O
of O
epigenetics O
research O
these O
approaches O
are O
strongly O
synergistic O
in O
nature O

For O
instance O
, O
regenerants O
were O
particularly O
affected O
by O
the O
inheritance O
of O
root-specific O
epigenetic O
imprints O
, O
which O
were O
associated O
with O
an O
increased O
accumulation O
of O
salicylic O
acid O
in O
leaves O
and O
accelerated O
plant O
senescence B-Disease

Yet O
, O
research O
on O
the O
development O
of O
epigenetic O
biomarkers O
often O
pulls O
in O
a O
direction O
that O
departs O
from O
a O
view O
of O
biological O
determinants O
of O
health O
embedded O
in O
their O
social O
and O
material O
environment O

72 O
: O
Bisulfite O
sequencing O
is O
a O
powerful O
technique O
to O
detect O
5-methylcytosine O
in O
DNA O
that O
has O
immensely O
contributed O
to O
our O
understanding O
of O
epigenetic O
regulation O
in O
plants O
and O
animals O

First O
, O
aberrant O
DNA O
methylation O
can O
be O
present O
at O
a O
high O
level O
in O
noncancerous O
tissues O
, O
and O
because O
its O
level O
can O
correlate O
with O
cancer B-Disease
risk O
, O
it O
is O
useful O
as O
a O
cancer B-Disease
risk O
marker O

365 O
: O
Environmental O
stress O
is O
ubiquitous O
in O
modern O
societies O
and O
can O
exert O
a O
profound O
and O
cumulative O
impact O
on O
cell O
function O
and O
health O
phenotypes O

Each O
exposure O
has O
effects O
that O
may O
persist O
across O
the O
life O
course O
and O
in O
some O
instances O
may O
be O
transmitted O
to O
offspring O
via O
epigenetic O
inheritance O

Throughout O
I O
support O
the O
view O
that O
the O
Baldwin O
effect O
and O
genetic O
assimilation O
, O
even O
if O
they O
are O
quite O
close O
, O
should O
not O
be O
conflated O
, O
and O
that O
drawing O
a O
line O
between O
these O
concepts O
is O
helpful O
in O
order O
to O
better O
understand O
where O
epigenetic O
inheritance O
might O
endorse O

This O
article O
is O
part O
of O
a O
discussion O
meeting O
issue O
'Frontiers O
in O
epigenetic O
chemical O
biology O
' O

While O
females O
and O
males O
show O
no O
significant O
differences O
in O
predicted O
DNA O
methylation O
age O
, O
ovariectomy O
results O
in O
significant O
age O
acceleration O
in O
females O

Among O
the O
different O
combinations O
investigated O
, O
a O
combination O
of O
five O
imprinted O
genes O
comprising O
IGF2-H19 O
DMR O
, O
IG-DMR O
, O
ZAC O
, O
KvDMR O
, O
and O
PEG3 O
( O
AUC O
= O
0 O

Key O
challenges O
in O
the O
study O
of O
DNA O
methylation O
are O
also O
discussed O
, O
including O
tissue O
specificity O
, O
the O
stability O
of O
measures O
, O
timing O
of O
sample O
collection O
, O
statistical O
considerations O
, O
batch O
effects O
, O
and O
challenges O
related O
to O
analysis O
and O
interpretation O
of O
data O

151 O
: O
Genomic O
predisposition O
fails O
to O
fully O
explain O
the O
onset O
of O
complex O
diseases O
, O
which O
is O
well O
illustrated O
by O
the O
largely O
incomplete O
concordance O
among O
monozygotic O
twins O


He O
is O
the O
founding O
codirector O
of O
the O
Sackler O
Institute O
for O
Epigenetics O
and O
Psychobiology O
at O
McGill O
and O
is O
a O
Fellow O
of O
the O
Canadian O
Institute O
for O
Advanced O
Research O
Experience-Based O
Brain O
and O
Biological O
Development O
program O

Methods O
: O
Here O
, O
we O
undertook O
module- O
and O
region-based O
DNA O
methylation O
analyses O
of O
incident O
CVD O
in O
the O
Women O
's O
Health O
Initiative O
( O
WHI O
) O
and O
Framingham O
Heart O
Study O
Offspring O
Cohort O
( O
FHS O
) O
in O
order O
to O
find O
more O
robust O
epigenetic O
biomarkers O
for O
cardiovascular O

adaptive O
mechanisms O

Understanding O
ancestral O
environmental O
insults O
and O
epigenetic O
transgenerational O
impacts O
on O
future O
generations O
will O
be O
critical O
to O
fully O
understand O
the O
etiology O
of O
obesity B-Disease
and O
to O
develop O
preventative O
therapy O
options O

We O
defined O
one O
of O
these O
phenomena O
as O
" O
epigenetic O
toxicity O
" O
, O
in O
which O
chemicals O
affect O
epigenetic O
regulation O
and O
result O
in O
undesirable O
effects O
on O
living O
organisms O

Method O
availability O
: O
https://github O


These O
P-t-C O
draw O
on O
existing O
guidance O
on O
the O
return O
of O
genetic O
research O
results O
, O
while O
also O
integrating O
the O
IHEC O
Bioethics O
Workgroup's O
ELSI O
research O
on O
and O
discussion O
of O
the O
issues O
associated O
with O
epigenetic O
data O
as O
well O
as O
the O
experience O
of O
a O
return O
of O
results O
pilot O
study O
by O

This O
proportionality O
was O
generally O
confirmed O
, O
also O
under O
the O
presence O
of O
environmental O
fluctuations O
and O
sexual O
recombination O
in O
diploids O
, O
and O
was O
explained O
from O
an O
evolutionary O
robustness O
hypothesis O
, O
in O
which O
an O
evolved O
robust O
system O
suppresses O
the O
so-called O
error O
catastrophe O
-- O
the O
destabilization O

However O
, O
over O
the O
past O
several O
years O
, O
these O
advances O
in O
the O
ability O
to O
measure O
genetic O
( O
or O
heritable O
) O
contributions O
to O
medical O
illness B-Disease
have O
been O
joined O
by O
advances O
in O
epigenetic O
( O
or O
acquired O
) O
contributions O
to O
common O
medical O
illnesses O

A O
deep O
understanding O
of O
epigenetics O
offers O
the O
potential O
for O
fresh O
insights O
into O
the O
basis O
for O
complex O
chronic O
diseases O
and O
improved O
diagnostic O
and O
prognostic O
tools O

The O
alteration O
of O
DNA O
methylation O
patterns O
has O
been O
found O
to O
be O
related O
to O
many O
diseases O
, O
including O
cancer B-Disease

Age O
causes O
characteristic O
DNAm O
changes O
that O
are O
thought O
to O
be O
not O
only O
major O
drivers O
of O
normal O
ageing O
but O
also O
precursors O
to O
diseases O
, O
cancer B-Disease
being O
one O
of O
these O

Our O
tool O
is O
available O
from O
the O
Galaxy O
ToolShed O
, O
GitHub O
repository O
, O
and O
also O
as O
a O
Docker O
image O

639 O
: O
Inborn O
errors O
of O
immunity O
( O
IEIs O
) O
comprise O
a O
variety O
of O
immune O
conditions O
leading O
to O
infections B-Disease
, O
autoimmunity O
, O
allergy O
, O
and O
cancer B-Disease

Here O
, O
we O
argue O
that O
fish O
species O
, O
which O
have O
been O
recently O
domesticated O
, O
can O
provide O
model O
systems O
to O
study O
epigenetic O
drivers O
in O
human O
self-domestication O

Yet O
the O
function O
and O
implication O
of O
negative O
definition O
for O
scientific O
discourse O
has O
thus O
far O
received O
scant O
attention O

Increasing O
data O
suggests O
that O
some O
answers O
to O
these O
challenges O
could O
be O
found O
in O
the O
area O
of O
epigenetics O

These O
changes O
are O
the O
result O
of O
a O
complex O
cross-talk O
between O
several O
molecular O
mechanisms O
that O
is O
in O
turn O
orchestrated O
by O
genetic O
and O
environmental O
factors O

Finally O
, O
we O
discuss O
the O
potential O
functions O
of O
gbM O
that O
may O
affect O
organismal O
phenotypes O
: O
gene O
expression O
stabilization O
and O
upregulation O
, O
inhibition O
of O
aberrant O
transcription O
( O
reverse O
and O
internal O
) O
, O
prevention O
of O
aberrant O
intron O
retention O
, O
and O
protection O
against O
TE O
insertions O

Of O
the O
~2 O

This O
study O
demonstrates O
an O
efficient O
multiplexed O
body O
fluid O
identification O
process O
utilizing O
DNA O
methylation O
that O
can O
be O
easily O
implemented O
in O
forensic O
laboratories O

Path O
models O
evaluated O
whether O
early O
life O
trauma B-Disease
predicted O
early O
pubertal O
timing O
and O
thereby O
, O
adult O
epigenetic O
age O
acceleration O
( O
indexed O
via O
four O
epigenetic O
clocks O
: O
Horvath O
DNAm O
Age O
, O
Hannum O
DNAm O
Age O
, O
DNAm O
PhenoAge O
, O
and O
DNAm O
GrimAge O
) O

This O
review O
discusses O
epigenetic O
reprogramming O
in O
the O
germ-line O
and O
the O
transmission O
of O
epigenetic O
information O
to O
the O
following O
generation O

Although O
the O
inheritance O
of O
epigenetically O
controlled O
traits O
acquired O
through O
environmental O
impact O
is O
a O
matter O
of O
debate O
, O
it O
is O
well O
documented O
that O
environmental O
cues O
lead O
to O
epigenetic O
changes O
, O
including O
chromatin B-Disease
modifications I-Disease
, O
that O
affect O
cell O
differentiation O
or O
are O
associated O
with O
plant O
acclimation O
and O

Supported O
by O
validation O
using O
mass O
spectrometry O
and O
pyrosequencing O
, O
we O
demonstrate O
reproducible O
( O
R(2)>0 O

Availability O
and O
implementation O
: O
The O
MATLAB O
implementation O
of O
HopLand O
is O
available O
at O
https O
: O
/ O
/ O
github O

Nutrients O
can O
influence O
the O
epigenetic O
status O
through O
several O
mechanisms O
, O
such O
as O
DNA O
methylation O
, O
histone O
modifications O
, O
and O
miRNA-dependent O
gene O
silencing O

100 O
( O
- O
0 O

gevry@usherbrooke O

240 O
: O
Cancer B-Disease
stem O
cells O
( O
CSCs O
) O
are O
a O
subpopulation O
of O
cells O
within O
tumors B-Disease
that O
possess O
the O
stem O
cell O
characteristics O
of O
self-renewal O
, O
quiescence O
, O
differentiation O
, O
and O
the O
ability O
to O
recapitulate O
the O
parental O
tumor B-Disease
when O
transplanted O
into O
a O
host O

g O

The O
epigenome O
was O
rejuvenated O
to O
a O
similar O
extent O
, O
including O
H3K9me3 O
levels O
and O
the O
DNA O
methylation O
ageing O
clock O

We O
encourage O
the O
scientific O
community O
to O
apply O
methodologically O
sound O
approaches O
using O
genome-wide O
designs O
including O
epigenome-wide O
association O
studies O
(EWAS) O
, O
to O
increase O
sample O
sizes O
, O
and O
to O
broaden O
the O
focus O
to O
include O
all O
eating O
disorder B-Disease
types O

He O
has O
been O
elected O
as O
a O
member O
of O
the O
American O
Society O
for O
Clinical O
Investigation O
, O
and O
has O
received O
numerous O
awards O
, O
including O
the O
Edmund O
L O
Dubois O
, O
MD O
, O
Memorial O
Lectureship O
Award O
from O
the O
American O
College O
of O
Rheumatology O
in O
recognition O
for O
his O
work O
in O
lupus B-Disease

The O
emergence O
of O
single-cell O
epigenomic O
technologies O
has O
introduced O
the O
exciting O
possibility O
of O
linking O
genetic O
and O
transcriptional O
heterogeneity B-Disease
in O
the O
context O
of O
cancer B-Disease
biology O

This O
article O
argues O
that O
social O
epigeneticists O
make O
far-reaching O
claims O
by O
selecting O
elements O
from O
research O
labelled O
epigenetics O
in O
biology O
while O
ignoring O
widely O
confirmed O
scientific O
facts O
in O
genetics O
and O
cell O
biology O
, O
such O
as O
the O
dependence O
of O
epigenetic O
marks O
on O
DNA O
sequence-specific O
events O
, O
or O
the O
lack O

Using O
this O
method O
, O
we O
analyzed O
chromatin O
immunoprecipitation O
( O
ChIP O
) O
- O
and O
RNA O
- O
sequencing O
data O
from O
the O
nucleus O
accumbens O
( O
NAc O
) O
of O
the O
same O
animal O

Therefore O
, O
this O
paper O
mainly O
reviews O
the O
epigenetic O
changes O
in O
the O
pathogenesis O
of O
peripheral O
T-cell O
lymphoma B-Disease
and O
the O
advancement O
of O
epigenetic-targeted O
drugs O
in O
the O
treatment O
of O
peripheral O
T-cell O
lymphoma B-Disease
( O
PTCL O
) O

180 O
: O
Much O
controversy O
surrounds O
the O
idea O
of O
transgenerational O
epigenetics O

These O
new O
emerging O
concepts O
at O
the O
interface O
of O
nutrition O
and O
epigenetics O
were O
discussed O
, O
and O
future O
research O
needs O
identified O
by O
leading O
experts O
at O
the O
26th O
Marabou O
Symposium O
entitled O
' O
Nutrition O
, O
Epigenetics O
, O
Genetics O
: O
Impact O
on O
Health O
and O
Disease O
' O

Conclusions O
: O
Whilst O
the O
reported O
metadata O
provides O
useful O
insight O
into O
the O
plausible O
involvement O
of O
epigenetic O
glitches O
in O
leukemogensis O
, O
our O
findings O
strengthen O
the O
remarkable O
functional O
consequences O
of O
dysregulated O
Wnt O
signaling O
genes O
in O
the O
hematological O
malignancies B-Disease
besides O
offering O
a O
nov O

As O
a O
case O
study O
, O
we O
discuss O
the O
development O
of O
models O
for O
11 O
sets O
of O
inhibitors O
of O
histone O
deacetylases O
( O
HDACs O
) O
, O
which O
are O
one O
of O
the O
major O
epigenetic O
target O
families O
that O
have O
been O
screened O

g O

32 O
: O
Growing O
evidence O
suggests O
that O
aberrant O
epigenetic O
regulation O
of O
gene O
function O
is O
strongly O
related O
to O
the O
genesis O
of O
cancer B-Disease

The O
laboratory O
is O
also O
involved O
in O
a O
case O
control O
study O
of O
asbestos-associated O
mesothelioma O
, O
arsenic O
exposure O
, O
cigarette O
smoking O
and O
bladder O
cancer B-Disease

17 O
) O

This O
second O
volume O
of O
Plant O
Epigenetics O
and O
Epigenomics O
: O
Methods O
in O
Molecular O
Biology O
builds O
on O
the O
work O
of O
its O
predecessor O
to O
describe O
cutting-edge O
tools O
for O
plant O
epigenetic O
and O
epigenomic O
research O
, O
and O
embrace O
crop O
and O
forestry O
species O
as O
well O
as O
natural O
populations O
and O
further O

We O
observed O
an O
interactive O
effect O
of O
child O
sex O
abuse O
(CSA) O
and O
biological O
parent O
psychopathology O
(i O

We O
describe O
how O
large-scale O
epigenetic O
studies O
of O
twins O
can O
improve O
our O
understanding O
of O
how O
genetic O
, O
environmental O
and O
stochastic O
factors O
impact O
upon O
epigenetics O
, O
and O
how O
such O
studies O
can O
provide O
a O
comprehensive O
understanding O
of O
how O
epigenetic O
variation O
affects O
complex O
traits O

These O
contributions O
demonstrate O
numerous O
opportunities O
exist O
for O
the O
analysis O
of O
longitudinal O
data O
in O
future O
epigenetic O
studies O

It O
is O
, O
therefore O
, O
a O
mistake O
to O
treat O
phrases O
like O
' O
germline O
inheritance O
' O
and O
' O
genetic O
inheritance O
' O
as O
simple O
synonyms O
, O
and O
bioethical O
discussion O
should O
expand O
its O
focus O
beyond O
alterations O
to O
the O
genome O
when O
considering O
the O
ethics O
of O
germline O
modification O

However O
, O
few O
studies O
have O
systematically O
summarized O
the O
analysis O
and O
detection O
methods O
for O
epigenetic O
modification O

Transcription O
factors O
, O
including O
the O
glucocorticoid O
, O
oestrogen O
and O
androgen O
receptors O
, O
interact O
with O
these O
epigenetic O
mechanisms O
in O
a O
very O
dynamic O
manner O
to O
modify O
transcription O
of O
genes O
and O
consequently O
contribute O
to O
physiological O
processes O
, O
health O
and O
disease B-Disease

140 O
: O
Society O
prizes O
the O
rapid O
translation O
of O
basic O
biological O
science O
into O
ways O
to O
prevent O
human O
illness B-Disease

These O
drug-induced O
epigenetic O
adaptations O
mediate O
enduring O
changes O
in O
brain O
function O
which O
contribute O
to O
life-long O
, O
drug-related O
behavioral O
abnormalities O
that O
define O
addiction O

In O
particular O
, O
they O
give O
access O
to O
the O
distribution O
of O
the O
radii O
of O
gyration O
for O
domains O
of O
different O
linear O
length O
and O
associated O
with O
different O
transcriptional O
activity O
states O
: O
active O
, O
inactive O
or O
repressed O

33 O
weeks O
and O
has O
similar O
properties O
to O
the O
recently O
described O
human O
epigenetic O
clock O

Zinc O
is O
required O
for O
the O
activity O
of O
various O
epigenetic O
enzymes O
, O
such O
as O
DNA O
methyltransferases O
( O
DNMTs O
) O
, O
histone O
acetyltransferases O
( O
HATs O
) O
, O
histone O
deacetylases O
( O
HDACs O
) O
, O
and O
histone O
demethylases O
, O
which O
poss O

This O
study O
queries O
the O
unicellular O
chlorophyte O
, O
Chlamydomonas O
reinhardtii O
using O
a O
three O
step O
" O
epigenetic O
assay O
" O
design O
to O
phenotypically O
track O
the O
variegation O
of O
a O
randomly O
integrated O
Paromomycin O
resistance O
transgene(s) O
( O
PmR O
) O

284 O
: O
The O
thyroid O
gland O
, O
necessary O
for O
normal O
human O
growth O
and O
development O
, O
functions O
as O
an O
essential O
regulator O
of O
metabolism O
by O
the O
production O
and O
secretion O
of O
appropriate O
levels O
of O
thyroid O
hormone O

Environmental O
factors O
have O
the O
potential O
to O
alter O
the O
epigenome O
, O
allowing O
genes O
that O
are O
silenced O
to O
be O
activated O
and O
vice O
versa O

We O
also O
measured O
genotypes O
at O
over O
one O
thousand O
single O
nucleotide O
polymorphisms O
(SNPs) O

440 O
: O
Disease O
diagnosis O
using O
cell-free O
DNA O
( O
cfDNA O
) O
has O
been O
an O
active O
research O
field O
recently O

emory O

However O
, O
the O
technical O
noise O
in O
epigenomic O
datasets O
and O
the O
many O
dimensions O
( O
features O
) O
examined O
make O
it O
challenging O
to O
effectively O
extract O
biologically O
meaningful O
inferences O
from O
these O
datasets O

Recent O
molecular O
evidence O
shows O
that O
epialleles O
often O
display O
high O
levels O
of O
transgenerational O
instability O

In O
contrast O
, O
substantial O
changes O
to O
our O
environment O
as O
part O
of O
our O
modern O
life O
style O
have O
not O
only O
led O
to O
a O
significant O
reduction O
of O
certain O
infectious B-Disease
diseases I-Disease
but O
also O
seen O
the O
exponential O
increase O
in O
complex O
traits O
including O
obesity B-Disease
and O
multifactorial O
diseases O
such O
as O
autoimmune O
disorders O

, O
GluR2 O
, O
GLRA2 O
, O
and O
GLRA3 O
) O
, O
growth O
factors O
( O
e O

Search O
, O
BLAST O
, O
Alignment O
and O
Profile O
based O
prediction O

Echo O
liquid O
handlers O
can O
transfer O
compounds O
, O
samples O
, O
reagents O
, O
and O
beads O
in O
submicroliter O
volumes O
to O
high-density O
assay O
formats O
using O
only O
acoustic O
energy-no O
contact O
or O
tips O
required O

Recent O
studies O
have O
shown O
that O
epigenetic O
modifications O
orchestrate O
the O
epithelial-mesenchymal O
transition O
and O
eventually O
fibrosis O
of O
the O
renal O
tissue O

Future O
directions O
: O
Developments O
in O
DNA O
sequencing O
technologies O
as O
well O
as O
the O
methods O
for O
identification O
and O
mapping O
of O
5-hydroxymethylcytosine O
are O
expected O
to O
augment O
our O
current O
understanding O
of O
epigenomics O

For O
example O
, O
in O
Down B-Disease
syndrome I-Disease
, O
duplication O
of O
the O
21(st) O
chromosome O
, O
which O
contains O
the O
amyloid O
beta O
precursor O
protein O
(APP) O
gene O
, O
leads O
to O
accumulation O
of O
amyloid O
beta O
and O
Alzheimer's B-Disease
disease I-Disease
pathology O
and O
multiplication O
of O
APP O
gene O
is O
shown O
to O
be O

Summary O
: O
Identification O
of O
changes O
in O
epigenetically O
regulated O
control O
mechanisms O
in O
joint O
tissues O
has O
provided O
novel O
insight O
into O
underlying O
mechanism O
of O
ongoing O
osteoarthritis O
disease B-Disease
pathophysiology O

Here O
, O
potential O
sources O
of O
such O
stochastic O
epigenetic O
variability O
in O
animals O
are O
explored O
, O
with O
a O
focus O
on O
DNA O
methylation O

The O
mammalian O
zinc O
dependent O
HDAC O
family O
is O
subdivided O
into O
three O
classes O
: O
class O
I O
( O
HDACs O
1-3 O
, O
8 O
) O
, O
class O
II O
( O
IIa O
: O
HDACs O
4 O
, O
5 O
, O
7 O
, O
9 O
; O
IIb O
: O
HDACs O
6 O
, O
10 O
) O
and O
class O
IV O

160 O
: O
Epigenetics O
, O
broadly O
defined O
as O
the O
regulation O
of O
gene O
expression O
without O
alteration O
of O
the O
genome O
, O
has O
become O
a O
field O
of O
tremendous O
interest O
in O
neuroscience O
, O
neurology O
, O
and O
psychiatry O

Future O
research O
should O
address O
the O
limitations O
of O
this O
study O
by O
using O
racially O
diverse O
samples O

The O
only O
in O
vivo O
study O
reporting O
that O
a O
number O
of O
organs O
of O
old O
progeric O
mice O
can O
be O
rejuvenated O
by O
cyclic O
partial O
reprogramming O
will O
also O
be O
described O
in O
some O
detail O

The O
characterization O
of O
epigenetic O
age O
prediction O
variation O
provides O
useful O
metrics O
to O
contextualize O
the O
relevance O
of O
epigenetic O
age O
alterations O

High-throughput O
bisulfite O
sequencing O
methods O
, O
such O
as O
reduced-representation O
bisulfite O
sequencing O
( O
RRBS O
) O
or O
whole O
genome O
bisulfite O
sequencing O
( O
WGBS O
) O
, O
provide O
an O
opportunity O
to O
identify O
the O
genomic O
regions O
of O
disordered O
or O
heterogeneous O
DNA O
methylation O
, O
which O
might O
be O
associated O
with O

To O
this O
end O
, O
epigenetics O
aims O
to O
discover O
the O
molecular O
mechanisms O
that O
explain O
how O
different O
nutrients O
and O
hormones O
, O
environmental O
changes O
, O
and O
emotional O
, O
social O
and O
cognitive O
experiences O
modify O
gene O
expression O
and O
behaviors O
, O
even O
permanently O
so O

Archer O
about O
his O
experiences O
in O
academia O
, O
struggles O
he O
has O
faced O
, O
and O
thoughts O
on O
addressing O
racial O
bias O

Both O
simulation O
and O
real-data O
analysis O
show O
the O
outperformance O
of O
adaptive O
SMCCA O
in O
terms O
of O
feature O
selection O
over O
conventional O
SMCCA O
and O
SMCCA O
with O
fixed O
weights O

Included O
are O
exemplary O
classes O
of O
chromatin-associated O
epigenomic O
writers O
( O
DOT1L O
and O
EZH2 O
) O
, O
erasers O
( O
LSD1 O
) O
and O
readers O
( O
BRD4 O
) O

The O
DOHaD O
theory O
was O
more O
accurately O
understood O
than O
the O
first O
1000 O
days O
or O
epigenetics O
itself O

Conclusion O
: O
This O
paper O
provides O
a O
comprehensive O
review O
of O
the O
emerging O
analytical O
and O
experimental O
approaches O
of O
single-cell O
sequencing O
in O
various O
omics O
, O
focusing O
specifically O
on O
epigenomics O

The O
4th O
intron O
is O
strongly O
methylated O
in O
both O
sexes O
and O
the O
5th O
intron O
is O
unmethylated O
in O
both O
sexes O

Our O
work O
supports O
the O
existence O
of O
heritable O
stress O
response O
in O
plants O
and O
demonstrates O
that O
genetic O
changes O
prevail O

rahmani@gmail O

Thus O
, O
the O
present O
manuscript O
is O
an O
attempt O
to O
encompass O
all O
the O
molecular O
events O
starting O
at O
the O
presynaptic O
dopamine O
terminals O
to O
reach O
the O
nucleus O
of O
postsynaptic O
neurons O
to O
explain O
how O
specific O
neurotransmitters O
and O
signaling O
cascades O
produce O
persistent O
genetic O
modifications O
, O
which O
shift O
neur O

Epigenetic O
mechanisms O
, O
particularly O
DNA O
methylation O
and O
miRNA O
expression O
, O
attract O
increasing O
attention O
as O
potential O
links O
between O
the O
genetic O
and O
environmental O
determinants O
of O
health O
and O
disease B-Disease


590 O
: O
Background O
: O
DNA O
methylation O
microarrays O
are O
widely O
used O
in O
clinical O
epigenetics O
and O
are O
often O
processed O
using O
R O
packages O
such O
as O
ChAMP O
or O
RnBeads O
by O
trained O
bioinformaticians O

distribution O
of O
sequences O
within O
the O
genome O
, O
elimination O
of O
DNA O
during O
formation O
of O
somatic O
nuclei O
) O

There O
are O
many O
factors O
to O
take O
into O
consideration O
before O
beginning O
analysis O
of O
DNA O
methylation O
in O
animals O

424 O
: O
The O
main O
objective O
of O
this O
conference O
was O
to O
provide O
solid O
evidence O
that O
environmental O
exposures O
during O
early O
development O
can O
affect O
faithful O
reproduction O
of O
individual O
parental O
epigenomes O
without O
changing O
DNA O
sequence O
in O
the O
offspring O

330 O
: O
Chemical O
biology O
approaches O
are O
a O
powerful O
means O
to O
functionally O
characterize O
epigenetic O
regulators O
such O
as O
histone O
modifying O
enzymes O

To O
date O
, O
there O
exists O
no O
technique O
which O
can O
successfully O
monitor O
the O
epigenomics O
of O
CSC O

The O
budding O
field O
of O
Ecological O
Epigenetics O
seeks O
to O
extend O
our O
knowledge O
of O
epigenetic O
mechanisms O
and O
processes O
to O
natural O
populations O
, O
and O
recent O
conceptual O
and O
technical O
advances O
have O
made O
progress O
toward O
this O
goal O
more O
feasible O

Additional O
evidence O
indicates O
that O
SNCA O
promoter O
polymorphisms O
increases O
alpha-synuclein O
expression O
and O
increases O
susceptibility O
to O
sporadic O
PD O

Results O
: O
Using O
numerical O
models O
simulating O
the O
evolutionary O
changes O
in O
the O
gene O
regulation O
network O
required O
to O
achieve O
a O
particular O
expression O
pattern O
, O
we O
first O
confirmed O
that O
gene O
expression O
dynamics O
robust O
to O
mutation O
evolved O
in O
the O
presence O
of O
a O
sufficient O
level O
of O
transcriptional O
noise O

In O
particular O
, O
DNA O
methylation O
assays O
are O
widely O
applied O
to O
formalin-fixed O
, O
paraffin-embedded O
archival O
tissue O
specimens O
as O
clinical O
pathology O
tests O

In O
the O
light O
of O
the O
fact O
that O
the O
epigenome O
is O
not O
only O
variable O
between O
individuals O
, O
but O
that O
it O
also O
varies O
between O
different O
tissues O
of O
the O
same O
individual O
and O
with O
the O
age O
of O
the O
individual O
, O
it O
is O
still O
a O
long O
journey O
to O
transit O
from O
the O
correlation O
to O

Epigenetics O
describes O
a O
mechanism O
for O
controlling O
gene O
expression O
and O
cellular O
processes O
without O
altering O
DNA O
sequences O

Although O
our O
minimized O
epigenetic O
clock O
yielded O
slightly O
higher O
age O
prediction O
errors O
compared O
to O
other O
epigenetic O
clocks O
, O
it O
still O
represents O
a O
viable O
alternative O
to O
the O
genome-wide O
epigenotyping O
array O

Importantly O
, O
all O
of O
the O
major O
epigenetic O
mechanisms O
in O
mammalians O
also O
occur O
in O
plants O

Using O
CRISPR O
gene O
editing O
, O
we O
use O
TRIAGE O
to O
experimentally O
validate O
RNF220 O
as O
a O
regulator O
of O
Ciona O
cardiopharyngeal O
development O
and O
SIX3 O
as O
required O
for O
differentiation O
of O
endoderm O
in O
human O
pluripotent O
stem O
cells O

499 O
: O
The O
study O
of O
epigenomics O
has O
advanced O
in O
recent O
years O
to O
span O
the O
regulation O
of O
a O
single O
genetic O
locus O
to O
the O
structure O
and O
orientation O
of O
entire O
chromosomes O
within O
the O
nucleus O

Here O
, O
we O
review O
various O
factors O
governing O
epigenetic O
dysregulation O
of O
cancer B-Disease
stem O
cells O
ranging O
from O
the O
role O
of O
epigenetic O
mediators O
such O
as O
histone O
and O
DNA O
methyltransferases O
, O
histone O
deacetylases O
, O
histone O
methyltransferases O
to O
various O
signaling O
pathways O
associated O
with O
c O

Clinical O
evidence O
of O
epigenetic O
manipulation O
from O
MDR O
bacteria O
mainly O
arises O
from O
Mycobacterium O
tuberculosis B-Disease
as O
well O
as O
Helicobacter O
pylori O
, O
Escherichia O
coli O
, O
Listeria O
monocytogenes O
, O
Pseudomonas O
aeruginosa O
, O
and O
Legionella O
pneumophila O

Here O
, O
I O
describe O
a O
novel O
live-cell O
imaging O
system O
based O
on O
" O
Momiji O
" O
mice O
for O
monitoring O
XCI O
at O
the O
single O
cell O
level O

We O
find O
that O
scientists O
' O
efforts O
to O
identify O
the O
molecular O
effects O
of O
stress O
, O
trauma B-Disease
, O
and O
adversity O
results O
in O
a O
temporal O
focus O
on O
the O
mother-child O
dyad O
during O
early O
life O

We O
discuss O
the O
opportunities O
and O
challenges O
of O
mass O
spectrometry O
(MS)-based O
proteomics O
for O
characterizing O
the O
plant O
chromatin O
interactome O

Companies O
are O
also O
required O
to O
submit O
to O
the O
EMA O
paediatric O
investigation O
plans O
aiming O
to O
ensure O
that O
the O
necessary O
data O
to O
support O
the O
authorisation O
of O
a O
medicine O
for O
children O
in O
EU O
are O
of O
high O
quality O
and O
ethically O
researched O

To O
determine O
the O
causes O
of O
infertility O
it O
is O
necessary O
to O
understand O
the O
altered O
epigenetic O
modifications O
of O
associated O
gene O
and O
mechanisms O
involved O
therein O

86 O
: O
Purpose O
of O
review O
: O
The O
interplay O
between O
lipids O
and O
epigenetic O
mechanisms O
has O
recently O
gained O
increased O
interest O
because O
of O
its O
relevance O
for O
common O
diseases O
and O
most O
notably O
atherosclerosis O

This O
paper O
attempts O
a O
general O
overview O
of O
currently O
available O
resources O
, O
together O
with O
remarks O
on O
their O
data O
mining O
and O
analysis O
capabilities O

307 O
: O
Purpose O
of O
review O
: O
Studies O
indicate O
that O
environmental O
factors O
, O
acting O
at O
various O
moments O
throughout O
the O
life O
cycle O
, O
can O
result O
in O
epigenetically O
mediated O
alterations O
in O
gene O
expression O

Here O
, O
we O
have O
developed O
unique O
sub-10 O
nm O
Self-functional O
Gold O
Nanoprobes O
( O
GNP O
) O
as O
a O
CSC O
epigenomic O
monitoring O
platform O
that O
can O
easily O
maneuver O
into O
the O
nucleus O
while O
not O
producing O
any O
conformal O
changes O
to O
the O
genomic O
DNA O

From O
a O
methodological O
point O
of O
view O
, O
we O
suggest O
that O
Darwin O
's O
plastic O
approach O
to O
habits O
, O
from O
his O
early O
writings O
up O
to O
the O
mature O
works O
, O
can O
provide O
today O
's O
evolutionary O
scientists O
with O
a O
viable O
methodological O
model O
to O
address O
the O
challenging O
task O
of O
extending O
and O

In O
this O
review O
, O
we O
will O
study O
what O
3D O
genome O
folding O
means O
in O
epigenetics O
, O
what O
types O
of O
3D O
genome O
structures O
there O
are O
, O
how O
they O
are O
formed O
, O
and O
how O
the O
technologies O
have O
developed O
to O
explore O
them O

Dr O
Kelsey's O
laboratory O
mainly O
investigates O
susceptibility O
to O
smoking-related O
lung B-Disease
cancer I-Disease
and O
studies O
multi-racial O
and O
ethnic O
populations O

Epigenetics O
in O
its O
various O
senses O
has O
implications O
for O
development O
, O
heredity O
, O
and O
evolution O
, O
and O
also O
for O
medicine O

Administration O
of O
a O
DNMT O
inhibitor O
SGI-1072 O
effectively O
hypomethylated O
the O
promoters O
, O
derepressed O
NRF2/KLOTHO O
, O
and O
mitigated O
the O
structural O
and O
functional O
alterations O
of O
renal B-Disease
aging I-Disease
in O
D-gal O
mice O

But O
is O
recovery O
of O
ovarian B-Disease
fitness O
possible O
, O
even O
if O
only O
briefly O
prior O
to O
IVF O
? O
Alterations O
in O
gap O
junctions O
, O
bio-conductive O
features O
, O
and O
modulation O
of O
gene O
regulatory O
networks O
after O
PRP O
use O
in O
other O
tissues O
are O
discussed O
here O
alongside O
early O
data O
reported O
from O
re O

74 O
: O
Neurodevelopmental O
disorders O
, O
such O
as O
autism B-Disease
, O
are O
complex O
entities O
that O
can O
be O
caused O
by O
biological O
and O
social O
factors O

When O
Waddington O
mentioned O
it O
in O
1956 O
, O
the O
notion O
of O
epigenetics O
was O
not O
yet O
popular O
, O
as O
it O
would O
become O
from O
the O
1980s O

500 O
: O
Objectives O
: O
To O
identify O
epigenetic O
and O
transcriptional O
factors O
controlling O
osteoclastogenesis O
( O
OCG O
) O
, O
that O
have O
been O
shown O
to O
play O
a O
role O
in O
the O
pathogenesis O
of O
skeletal O
diseases O

133 O
: O
In O
1956 O
, O
in O
his O
Principles O
of O
Embryology O
, O
Conrad O
Hal O
Waddington O
explained O
that O
the O
word O
" O
epigenetics O
" O
should O
be O
used O
to O
translate O
and O
update O
Wilhelm O
Roux O
' O
German O
notion O
of O
" O
Entwicklungsmechanik O
" O
( O
1890 O
) O
to O
qualify O
the O
studies O

Cellular O
reprogramming O
technology O
can O
be O
used O
to O
actively O
modify O
the O
epigenome O
without O
affecting O
the O
underlying O
genomic O
sequences O

Here O
, O
we O
show O
that O
infection B-Disease
of O
the O
male O
lineage O
with O
the O
common O
human O
parasite O
Toxoplasma O
results O
in O
transgenerational O
behavioral O
changes O
in O
offspring O
in O
a O
sex-dependent O
manner O

Additionally O
, O
we O
found O
three O
regions O
( O
associated O
with O
the O
genes O
SLC9A1 O
, O
SLC1A5 O
, O
and O
TNRC6C O
) O
whose O
methylation O
associates O
with O
CVD O
risk O

Bisulfite O
sequencing O
also O
suffers O
from O
a O
number O
of O
drawbacks O
that O
are O
difficult O
to O
surmount O
, O
among O
which O
DNA O
degradation O
, O
lack O
of O
specificity O
, O
or O
short O
reads O
with O
low O
sequence O
diversity O

Results O
using O
a O
constitutively O
active O
GAL O
network O
are O
in O
overall O
agreement O
with O
findings O
with O
the O
wild-type O
network O

Here O
, O
we O
discuss O
the O
structure O
that O
makes O
these O
proteins O
a O
family O
, O
the O
main O
functions O
and O
interactions O
of O
all O
protein O
family O
members O
and O
their O
role O
in O
human O
disease B-Disease
such O
as O
psychiatric B-Disease
disorders I-Disease
and O
cancer B-Disease

In O
addition O
, O
the O
interaction O
between O
genetic O
load O
and O
CSA O
predicted O
epigenetic O
change O
, O
indicating O
a O
potential O
genetic O
basis O
for O
a O
differential O
impact O
of O
CSA O
on O
epigenetic O
change O

Over O
the O
past O
decade O
there O
has O
been O
remarkable O
progress O
in O
our O
knowledge O
of O
the O
importance O
of O
epigenetic O
events O
in O
the O
control O
of O
both O
normal O
cellular O
processes O
and O
abnormal O
events O
associated O
with O
tumor B-Disease
development O
and O
progression O

Traditional O
approaches O
to O
characterize O
epigenetic O
modifications O
of O
chromatin O
or O
the O
transcriptome O
of O
cells O
have O
often O
focused O
on O
blended O
responses O
of O
many O
cells O
in O
a O
tissue O
; O
however O
, O
such O
bulk O
measures O
lose O
spatial O
and O
temporal O
differences O
that O
occur O
from O
cell O
to O
cell O
, O
and O
cannot O
un O

261 O
: O
Emerging O
single-cell O
epigenomic O
methods O
are O
being O
developed O
with O
the O
exciting O
potential O
to O
transform O
our O
knowledge O
of O
gene O
regulation O


Conclusions O
: O
This O
study O
indicates O
that O
CpGs O
with O
different O
stabilities O
are O
involved O
in O
different O
functions O
and O
traits O
, O
and O
thus O
, O
they O
are O
potential O
indicators O
that O
can O
be O
applied O
for O
clinical O
epigenetic O
studies O
to O
outline O
underlying O
mechanisms O


Overall O
, O
neuromuscular O
disorder B-Disease
epigenetic O
biomarkers O
have O
a O
strong O
potential O
for O
clinical O
applications O
in O
the O
near O
future O
Dysregulation O
of O
the O
epigenome O
is O
associated O
with O
the O
onset O
and O
progression O
of O
several O
diseases O
, O
including O
cancer B-Disease
, O
autoimmune O
, O
cardiovascular O
, O
and O

We O
tested O
different O
dCas9 O
orthologs O
(dCjCas9 O
, O
dNmCas9 O
, O
dSt1Cas9 O
, O
dFnCas9 O
, O
dSaCas9 O
and O
dSpCas9 O
) O
in O
C-terminal O
fusion O
with O
DNMT3A O
effector O
domain O
to O
find O
candidates O
that O
potentiate O
effector O
domain O
to O
perform O
its O
function O
at O
the O
target O
site O

92 O
) O

Additionally O
, O
we O
discovered O
that O
high O
efficiency O
iPSC O
reprograming O
is O
negatively O
correlated O
with O
donor O
age O
, O
positively O
correlated O
with O
African O
American O
descent O
, O
and O
uncorrelated O
with O
donor O
sex O

This O
procedure O
can O
be O
applied O
to O
a O
broad O
range O
of O
ChIP-seq O
datasets O
of O
different O
quality O
and O
chromatin O
accessibility O
ATAC-seq O
, O
including O
single-cell O
experiments O

This O
results O
in O
the O
unregulated O
expression O
of O
critical O
viral O
genes O
capable O
of O
redirecting O
cellular O
gene O
expression O

A O
vast O
number O
of O
epigenomic O
datasets O
are O
emerging O
as O
a O
result O
of O
the O
advent O
of O
next-generation O
sequencing O
